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Abstract
Family and health-care professionals managing medicines
for patients with serious and terminal illness at home:
a qualitative study
Kristian Pollock ,1* Eleanor Wilson ,1 Glenys Caswell ,1 Asam Latif ,1
Alan Caswell ,2 Anthony Avery ,3 Claire Anderson ,4 Vincent Crosby 5
and Christina Faull 6
1School of Health Sciences, University of Nottingham, Nottingham, UK
2Patient and Public Involvement Representative, Dementia, Frail Older and Palliative Care Patient and
Public Involvement Advisory Group, University of Nottingham, Nottingham, UK
3School of Medicine, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, UK
4School of Pharmacy, University of Nottingham, Nottingham, UK
5Nottingham University Hospitals NHS Trust, Nottingham, UK
6LOROS Hospice, Leicester, UK
*Corresponding author Kristian.Pollock@nottingham.ac.uk
Background: More effective ways of managing symptoms of chronic and terminal illness enable
patients to be cared for, and to die, at home. This requires patients and family caregivers to manage
complex medicines regimens, including powerful painkillers that can have serious side effects. Little is
known about how patients and family caregivers manage the physical and emotional work of managing
medicines in the home or the support that they receive from health-care professionals and services.
Objective: To investigate how patients with serious and terminal illness, their family caregivers
and the health-care professionals manage complex medication regimens and routines of care in the
domestic setting.
Design: A qualitative study involving (1) semistructured interviews and group discussions with
40 health-care professionals and 21 bereaved family caregivers, (2) 20 patient case studies with up
to 4 months’ follow-up and (3) two end-of-project stakeholder workshops.
Setting: This took place in Nottinghamshire and Leicestershire, UK.
Results: As patients’ health deteriorated, family caregivers assumed the role of a care co-ordinator,
undertaking the everyday work of organising and collecting prescriptions and storing and administering
medicines around other care tasks and daily routines. Participants described the difficulties of navigating
a complex and fragmented system and the need to remain vigilant about medicines prescribed, especially
when changes were made by different professionals. Access to support, resilience and coping capacity
are mediated through the resources available to patients, through the relationships that they have with
people in their personal and professional networks, and, beyond that, through the wider connections – or
disconnections – that these links have with others. Health-care professionals often lacked understanding
of the practical and emotional challenges involved. All participants experienced difficulties in communication
and organisation within a health-care system that they felt was complicated and poorly co-ordinated.
Having a key health professional to support and guide patients and family caregivers through the system
was important to a good experience of care.
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Limitations: The study achieved diversity in the recruitment of patients, with different characteristics
relating to the type of illness and socioeconomic circumstances. However, recruitment of participants
from ethnically diverse and disadvantaged or hard-to-reach populations was particularly challenging,
and we were unable to include as many participants from these groups as had been originally planned.
Conclusions: The study identified two key and inter-related areas in which patient and family caregiver
experience of managing medicines at home in end-of-life care could be improved: (1) reducing work and
responsibility for medicines management and (2) improving co-ordination and communication in health
care. It is important to be mindful of the need for transparency and open discussion about the extent to
which patients and family caregivers can and should be co-opted as proto-professionals in the technically
and emotionally demanding tasks of managing medicines at the end of life.
Future work: Priorities for future research include investigating how allocated key professionals could
integrate and co-ordinate care and optimise medicines management; the role of domiciliary home care
workers in supporting medicines management in end-of-life care; patient and family perspectives and
understanding of anticipatory prescribing and their preferences for involvement in decision-making;
the experience of medicines management in terminal illness among minority, disadvantaged and
hard-to-reach patient groups; and barriers to and facilitators of increased involvement of community
pharmacists in palliative and end-of-life care.
Funding: This project was funded by the National Institute for Health Research (NIHR) Health Services
and Delivery Research programme and will be published in full in Health Services and Delivery Research;
Vol. 9, No. 14. See the NIHR Journals Library website for further project information.
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Adherence The extent to which a patient takes medication as intended by the health-care professional
who prescribed them.
Advance care planning A process of planning for future care, particularly within the context of end of
life. This includes discussing and, if the patient wishes, documenting preferences regarding place of
death, decisions about resuscitation and the limits of future treatment.
Anticipatory medicines Medicines to control common symptoms occurring at the end of life that are
prescribed in advance and kept in the home ‘just in case’ they are needed.
Comorbidity The coexistence of two or more long-term health conditions (also known as multimorbidity).
Controlled drugs Medicines that are subject to additional legal controls.
Dosette box A box with small compartments that allow the medicines needed for a day or a week to
be organised and set out in advance to assist with taking them as prescribed.
End-of-life care A part of palliative care concerned with supporting patients identified as likely to be
within their last year of life. In addition to providing excellent symptom control and emotional support,
end-of-life care provides an opportunity for patients and family members to anticipate and express
their preferences for future care (see Advance care planning).
Family caregiver A family member, friend or neighbour providing care and/or support for the patient.
Life-limiting illness An illness that may be treated but cannot be cured and is likely to result in death.
Examples include advanced cancer and progressive neurological conditions, such as motor neuron
disease and dementia.
Palliative and supportive care Care takes a holistic approach to treatment and provides support to
people affected by life-limiting illness, including family and friends, as well as individual patients.
Palliative care aims to help support physical and emotional well-being and support excellent control of
symptoms, including those that occur at the end of life.
Percutaneous endoscopic gastrostomy A tube that is inserted into the stomach to allow delivery of
nutrition, hydration and medicines when a patient cannot take these orally.
Polypharmacy When a patient takes two or more medicines.
Social care Care that provides help, care and protection from harm for people with a range of
requirements, including people at the end of life.
UK Census A count of the populations of the UK nations, which takes place once every 10 years.
DOI: 10.3310/hsdr09140 Health Services and Delivery Research 2021 Vol. 9 No. 14
© 2021 Pollock et al. This work was produced by Pollock et al. under the terms of a commissioning contract issued by the Secretary of State for Health and Social Care. This
is an Open Access publication distributed under the terms of the Creative Commons Attribution CC BY 4.0 licence, which permits unrestricted use, distribution, reproduction
and adaption in any medium and for any purpose provided that it is properly attributed. See: https://creativecommons.org/licenses/by/4.0/. For attribution the title, original




24/7 24 hours per day, 7 days per week
ACP advance care planning
AM anticipatory medicine
BFCG bereaved family caregiver
CN community nurse
CNS clinical nurse specialist





DNACPR do not attempt cardiopulmonary
resuscitation
FCG family and friend caregiver
GP general practitioner
GSF Gold Standards Framework
HCP health-care professional
HCW home health-care worker
MDT multidisciplinary team
MND motor neurone disease
OOH out-of-office hours
PCN palliative care nurse
PEG percutaneous endoscopic
gastrostomy
PPI patient and public involvement
PRISM Pathway and Referral
Implementation SysteM
p.r.n. pro re nata
PSP progressive supranuclear palsy
SPA single point of access
SPC specialist palliative care
SPCN specialist palliative care nurse
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More effective treatments enable patients to be cared for, and to die, at home, even when theyhave a serious illness that previously would have required care in hospital. Managing a person’s
medicines at home in these circumstances is very difficult. Patients and family caregivers need to
organise getting prescriptions; collect, store and administer medicines at different times of day; and
fit these tasks into other care work and daily routines. Patients may be prescribed many medicines,
including powerful painkillers that can have serious side effects. This study explored the experience of
patients and family caregivers in managing medicines for symptoms resulting from life-limiting illness,
what they felt about doing this and how they were supported by health-care professionals and services
involved in providing care.
This qualitative study included:
l 21 interviews with bereaved family caregivers
l 40 interviews with health-care professionals
l 20 patient case studies with up to 4 months’ follow-up
l two stakeholder workshops to discuss the study findings and suggest ways to improve support for
patients and family caregivers.
Patients and family caregivers described the work of managing medicines to be very difficult, especially
as the patient’s condition worsened in the last weeks and days of life. Health-care professionals often
did not really understand the practical and emotional difficulties involved. All participants experienced
difficulties in communication and organisation within a health-care system that they felt was
complicated and poorly co-ordinated. Having a key health professional to support and guide patients
and family caregivers through the system was important to a good experience of care.
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The Managing Medicines study investigated how seriously ill patients, their family caregivers and
the health-care professionals who support them work together to manage medicines prescribed for the
relief of symptoms, including those experienced at the end of life. More effective treatments enable
patients to be cared for, and to die, at home, even when they suffer from serious illness that previously
would have required care in hospital. Patients may be prescribed many medicines, including powerful
painkillers, which can have serious side effects. The everyday work of medicines management includes
ordering and collecting prescriptions, and storing, organising and administering medicines in different
ways and at different times of day. These tasks must be organised around other commitments and
daily routines. Little is known about how patients and family caregivers undertake the physical and
emotional work of managing medicines or the support that they receive from health-care professionals
and services. The experience of patients affected by conditions other than cancer or who come from
minority, diverse or disadvantaged groups of the population have been under-researched.
Aim
To explore how patients, their family caregivers and the health-care professionals who support them
engage in the tasks of managing complex medication regimens and routines of care in the domestic
setting for patients with severe and terminal illness who are approaching the end of life.
Objectives
l To understand the experience of medicines management in end-of-life care for patients and family
caregivers, especially from minority, under-researched and hard-to-reach groups. These include
patients affected by illness other than cancer, living alone, affected by sensory or physical
impairment, from ethnic minority communities, who are homeless or who are affected by serious
mental illness.
l To compare and contrast the experience of symptom control and family caregiver involvement in
medicines management for patients who have been referred to specialist palliative care services
with those who have not.
l To establish what further support, information and training family caregivers and health-care
professionals need to feel confident in managing medicines for seriously ill patients being cared for
and dying at home.
l To explore lay and professional stakeholder perspectives about how community pharmacists could
be better integrated into the network of care and support for families and health-care professionals
in medicines management and end-of-life care.
Design and methods
A qualitative study of 30 months’ duration based on three workstreams:
1. single semistructured qualitative interviews with bereaved family caregivers, and interviews and
focus group discussions with health-care professionals
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2. longitudinal patient case studies, including patients, family caregivers and health-care professionals
with approximately 3 months’ follow-up, including one to three interviews for each participant
3. end-of-project stakeholder workshops to disseminate and discuss study findings, implications for
practice and priorities for future research.
Setting and recruitment
Participants who took part in workstreams 1 and 2 were recruited purposively through general
practices, hospices, community nursing services and specialist palliative care services throughout
Nottinghamshire and Leicestershire, UK. The recruitment of bereaved family caregivers and friends
was also promoted through local community organisations. Stakeholder workshop participants included
national and regional representation from education, practice and public and third-sector organisations.
Inclusion criteria
Workstream 1: interviews with bereaved family caregivers and friends and health-care
professionals
l Bereaved family caregivers and friends of patients who were cared for at home during a substantial
part of the last 6 months of life and who died at least 8 weeks prior to the invitation to take part in
the study.
l Health-care professionals from specialist and community health-care services with relevant
experience of supporting medicines management with seriously ill patients being cared for at home.
Workstream 2: patient case studies
l Patients identified as likely to be within the last 6 months of life by a health-care professional who
is providing care.
l Family caregivers of eligible patients who are significantly involved in providing patient care at home.
l Health-care professionals directly involved in care and medicines management.
Workstream 3: stakeholder workshops
l Health-care professionals (including study participants).
l Representatives from national, regional and local voluntary groups, third-sector groups and patient
and public involvement groups.
l Academics and educators.
All participants had relevant direct, personal, professional and/or research experience of medicines
management. They were aged ≥ 18 years and able to give informed consent with the exception that
patients lacking such capacity could be included subject to consultee agreement.
Analysis
Interviews and discussion groups were recorded with permission. The software package NVivo 12
(QSR International, Warrington, UK) was used to facilitate a thematic analysis of anonymised transcribed
interview and focus group data based on the principle of constant comparison. The case study analysis
triangulated different data sources, including baseline and follow-up interviews with patients, family
caregivers and health-care professionals; observation of consultations between patients/family caregivers
and health-care professionals; field notes; photographs of medicines in the home; and review of case notes;
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and patient-centred ecograms depicting individual networks of care and informal support. A detailed
narrative summary and composite ecogram was undertaken of each case using a structured template to
facilitate cross-case analysis. Each data set was subjected to both separate and integrated analysis to
enable identification and comparison of themes occurring within and between professional interviews and
patient cases. Coding and analysis were ongoing throughout the study.
Ethics approval
NHS Research Ethics Committee approval was obtained in March 2017 (reference 17/EM/0091) and
for two subsequent amendments to allow an increase in the sample size for workstreams 1 and 2
and to include the option to seek consultee advice in relation to research involvement of patients
lacking capacity.
Patient and public involvement
The study has been supported by the University of Nottingham Dementia, Frail Older and Palliative
Care Patient and Public Involvement Advisory Group. Members have discussed and commented on the
study design, ethics issues and findings and have submitted written reviews of the final report.
Results
Participants
Twenty-one interviews were completed with bereaved family caregivers (15 women and six men).
Thirteen of the patients described in the bereaved family caregiver interviews had a primary diagnosis
of cancer, although multimorbidities were common and a wide range of conditions were represented.
Reflecting on the high incidence of cancer in this group, the majority (n = 16) of patients in the
bereaved family caregiver accounts had been in receipt of specialist palliative care. Forty health-care
professionals, who came from a variety of professional roles from community and specialist palliative
care services, took part in individual or group interviews. Twenty patient case studies were completed,
each of which included between one and five participants (total n = 48). Fifty-four interviews were
completed with patients, family caregivers and health-care professionals. Eleven observations were
carried out and ecograms were completed for each case. Photographs were taken in 13 cases and
a medical records review was completed in eight cases. Patients had a wide range of conditions and
comorbidities, including heart failure, chronic obstructive pulmonary disorder, diabetes, motor neuron
disease, renal failure and Parkinson’s disease. Five patients had a primary diagnosis of cancer. Two
end-of-project stakeholder workshops took place in Leicester and Nottingham in June 2019.
The work of managing medicines
The study findings have documented the considerable effort required by patients and family caregivers
in carrying out the complex work of medicines management for serious illness. This tended to intensify
as the patient’s illness progressed, especially in the last months and weeks of life. Families varied in
terms of their circumstances and composition, and in relation to the resources that they could mobilise
through their informal and professional networks. Patients gradually relinquished responsibility for
managing medicines to family caregivers, usually to one key individual, with some tasks delegated to
others (e.g. collecting prescriptions from the pharmacy). The key family caregiver was usually a spouse,
in the case of couples, or an adult son or daughter, in the case of patients who lived alone. Primary
family caregivers who were spouses tended to be old and affected by frailty and poor health themselves.
Problems with prescribing and accessing medicines were frequently reported by lay and professional
participants, especially in critical situations and those arising out of hours.
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Patients and family caregivers described the effort and anxiety involved in taking on the responsibility
for managing complex medication regimens, and making judgements about administration dosage when
the limits to their coping strategies had been reached, and when they needed to call for additional help
and support. Control of pain was a frequent concern and not always achieved. Families commented
that, although there were lots of resources and information available, they were not often pointed
at these resources and often had to find information themselves. The family caregivers often found
themselves in an ambiguous position. On the one hand, they desperately sought clarity and confidence
in managing medicines, and ready access to help when critical situations arose. On the other hand, they
felt frustrated when professionals failed to acknowledge their expertise, particularly their knowledge of
the patient, the nature and severity of their symptoms, and how they responded to specific drugs.
The professional interviews revealed the considerable efforts and resourcefulness that health-care
professionals could bring to bear in addressing issues of medicines management for terminally ill
patients, especially those affected by disadvantage. They also reveal the extent to which professionals
often had a limited awareness of the burden of treatment confronting families and the difficulties that
they encountered, particularly in accessing help during a crisis.
System and complexity
Families developed more or less elaborate and personally effective systems for managing medicines
and recording use. Patients and family caregivers varied in the extent to which they felt supported by
professionals and services with which they interacted. The development of a strong relationship with a
key professional was an important (but not sufficient) determinant of a positive experience of care.
Although broadly appreciative of the care that they received from an NHS that they perceived to be
under-resourced and under strain, lay participants described an experience of services that was often
bureaucratic, task focused and poorly co-ordinated. Patients and family caregivers described taking on
the role of a care co-ordinator, maintaining vigilance in their dealings with professional services and
the medicines that could be prescribed, and changed, by different health-care professionals. They
maintained and communicated up-to-date information about the patient’s medicines and tried to fill in
the gaps in interprofessional co-ordination and communication.
The quality of relations and communication between professionals could have a critical impact on
families’ experience. It was important to feel known within the system, but this was not achievable
when patients saw a range of different professionals without continuity. This increased the difficulties
of communication with and between health-care professionals. Problems and delays in accessing
services, and problems of communication between and with professionals and services, were
frequently encountered and criticised. Families who had worked out stable systems of medicines
management were vulnerable to changes in prescribing or service provision, over which they had no
control. Particular points of hazard were transitions to and from hospital and during the cascade of
care, which often occurred during the last weeks or days of life when families’ coping mechanisms
were stretched beyond their capacity. Variations in family resources and responses to extending
responsibility for administration of medicines in the home raise questions about the limits of what
family caregivers could and should be asked to do, and how professional support can be tailored to
individual preferences and circumstances. In this context, the largely unacknowledged role of home
health-care workers in supporting medicines management at home, especially for patients living alone,
will become increasingly critical in future.
The nature and function of small-world networks seemed to be a key determinant of the quality of
experience of communication and care by patients and their families, rather than organisational
properties of the system. The efficiency of transfer of information between staff and services was also
crucial. Several bottlenecks were described, including delays in specialist clinicians communicating with
general practitioners, lack of integration between systems of electronic records used by different parts
of the system, and lack of information available to out-of-hours clinicians and community pharmacists.
Hospices sometimes provided a nexus of care in which patients might attend outpatient consultations,
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day care services and receive home visits from specialist nursing staff. The availability of a 24-hour
hospice-based advice line was also highly valued by the few participants who knew about or had access
to it. The existence of an efficient relationship between the general practitioner and the pharmacist was an
important determinant of family experience of accessing medicines. The pharmacist’s role was usually
confined to supplying prescribed medicines and participants found their home delivery service valuable.
However, both professional and lay participants identified problems of supply and access to medicines,
especially controlled drugs and when out of hours.
Conclusion
The Managing Medicines study has documented the work involved in managing medicines at home
for patients approaching the end of life as a core part of a considerable burden of care. In this
respect, it adds considerably to the available literature on this topic, particularly through the case
study triangulation of professional, patient and family caregivers’ perspectives, and the narratives of
bereaved family caregiver’s experiences of the period leading up to the patient’s death. The findings
reveal the resourcefulness of many participants in developing routines and schedules of medicines
management and the process of gradually working things out as they grappled with the confusion and
impenetrability of a complex, fragmented and bureaucratic system of care. They also highlight the
extent to which families struggled with different tasks and stages of illness, particularly in the weeks
and days prior to the patient’s death. The difficulties caused by complexity, the need for specialist
palliative care for dying patients and their families 24 hours per day, 7 days per week, and the value of
a key professional to help families navigate the system have been widely reported over a considerable
time. NHS policy has been directed towards developing effective solutions and a clear vision of
streamlined, supportive and co-ordinated care. Integrated care remains a long-term goal, and the
commitment to providing access to support for terminally ill patients 24 hours per day, 7 days per
week, is well established. Translating this vision into reality remains elusive, but must surely be based
on an understanding of patient and family caregivers’ experiences and perspectives of illness, and what
is most valued in the provision of excellent health care.
Funding
This project was funded by the National Institute for Health Research (NIHR) Health Services and
Delivery Research programme and will be published in full in Health Services and Delivery Research;
Vol. 9, No. 14. See the NIHR Journals Library website for further project information.
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Chapter 1 Context and introduction
This report presents findings of a 30-month study that was funded by the National Institute forHealth Research Health Services and Delivery Research programme [URL: www.nets.nihr.ac.uk/
programmes/hsdr (accessed 16 March 2021)]. The study investigates how patients, their social
networks and the health-care professionals (HCPs) who support them engage in the tasks of managing
complex medication regimens and routines of care in the domestic setting for patients with severe
and terminal illness who are approaching the end of life. In recent decades, there has been a shift of
care from hospital or institutional settings to the home for increasingly complex and serious illness.1–5
This transition has been made possible by advances in treatment and technologies of care that enable
patients to remain at home despite experiencing serious and debilitating conditions, which would
previously have required institutional care.6–8 Home as a place of care and death is widely regarded
as the best and preferred option for most patients.9 However, a consequence has been that patients
and their family and friend caregivers (FCGs) are required to take on the responsibility for increasingly
demanding programmes of care, including managing complex medicines regimens.6,10–14 Managing the
demands of serious illness and the health-care system that provides treatment is hard work.15,16 Family
caregivers are critical in enabling seriously ill patients to be cared for and die at home.17,18 To date,
however, there has been little professional acknowledgement or understanding of the nature of the
tasks undertaken or the burden of care assumed by families.13,19 There has also been little research into
how patients and family caregivers manage the challenges of home health care or what they feel about
the responsibilities involved in the tasks of medicines management for terminally ill and dying patients.
The Managing Medicines study used qualitative methods to investigate these issues from the multiple
perspectives of patients, FCGs and HCPs from a wide range of roles in community and specialist care.
Increasing need for palliative and end-of-life care
Worldwide, it is predicted that the number of people dying in need of palliative care will double in the
next four decades, with the most rapid increases being among those aged > 70 years and those with
dementia.20,21 Indeed, it has been proposed that expertise in palliative care should be promoted among
all HCPs as ‘everybody’s business’.22,23
In the UK, most people die in late old age and after prolonged and increasing comorbidity and/or
frailty.24 The UK population of those aged > 85 years has increased by almost one-third in the last
decade.25 Demand for health care continues to rise, not just from the ageing population but because of
the increasing number of people living with complex, multiple and chronic conditions.26 Alongside this
increased demand, there has also been a reduction in social care provision and a promotion of policy
drivers to encourage death at home, which is presumed to be the preference of the majority of
people.27–29 Regardless of the place of death, patients usually spend much of their last year of life being
cared for at home, where they and their FCGs are often required to manage complex medication
regimens, often involving powerful medicines that have a high risk of adverse side effects.6,7
Informal care
The UK health-care system is heavily indebted to the contribution of informal carers.30,31 The UK Census
of 2011 estimated that 6.5 million people provide informal care for a friend or relative. More recently,
Age UK (London, UK)32 puts the figure at 9 million people, with 18% of the population helping friends
and family members with increasingly complex care needs. In 2015, unpaid care work was estimated to
have an economic value of £132B per year.30,31,33 The number of carers continues to increase, as does
the intensity and duration of the support that they provide.30,34,35 Many carers (especially spouses) are
themselves old and in poor health.36 Recent polls suggest that over > 2,000,000 carers are aged > 65 years.34
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Carers UK (London, UK) reports evidence of the detrimental effects that caring can have on carers’ physical,
mental, social and financial health and well-being.37,38 The critical role of FCGs in supporting patients to
remain at home and be cared for at the end of life has not been widely recognised.39 Questions have been
raised about whether or not we are reaching the practical limits of informal carer capacity.35,40 Support for
medicines management to control distressing symptoms is a core area of home health care in which FCGs
are heavily involved.41 However, little is known about the complex realities of managing medicines from the
point of view of patients or carers or how they respond to the challenges involved.42,43
Managing medicines
Medicines management is a socially situated activity that is carried out mainly within the domestic
setting.6,44 Its work is embedded into daily routines and organised in terms of space, as medicines are
located in different places within the house, and time, as medicine-taking is scheduled alongside the
goals and activities involved in carrying on with life.17 Therefore, different medicines may be laid out
daily in different parts of the house to correspond with the movement of people through their daily
routines (e.g. some by the bedside table, some on the kitchen sideboard and others in the sitting room
beside the television). Some people may prefer to keep medicines concealed in cupboards rather than
on display, given their signification of compromised health.45 However, this may prove difficult, if not
impossible, where space is restricted and the number of medicines and the amount of associated
equipment and medical paraphernalia becomes extensive. Some medicines must be taken with and
some without food and some must be taken at specified times before or after meals. Others may be
taken on an as-needed basis. Medicine-taking must be managed around ongoing activities, such as
work, leisure and social arrangements, and, when necessary, medicines may need to be taken outside
the private space of the home. The complexity of the relationships between patients, prescribers and
family caregivers, and the practical and lifestyle issues that medications may impose on patients, are
substantial and infrequently acknowledged or understood by HCPs.7,18,41,46–49
Many people are reported to express ambivalence towards medicine-taking. Medicines may be
valued as a means to sustain an active life or be resisted as toxic substances, signifying loss of health
and personal agency.50–52 Low adherence has been a long-standing professional concern. It is often
stated that up to 50% of patients do not take their medicine as prescribed.19,53 However, accounts of
how patients and FCGs undertake the work of medicines management suggest that non-adherence is
often unintentional rather than deliberate and a common by-product of attempts to integrate complex
regimens of medicine-taking into the demands of everyday lives.17–19,52,53
The tasks of managing medicines are complex and various, and include organising timely access and
supply of medicines; ordering prescriptions; acquiring information and understanding the purpose, use,
dose and side effects; monitoring the benefits and harms; taking as prescribed; and liaising effectively
with a range of different HCPs and services.18,42,43 In addition to the practical work of medicines
management, many patients contend with a subjective and emotional burden resulting from concerns
about loss of health, personal autonomy and the adverse effects and potential toxicity of taking
powerful medicines over the long term.50,54
Managing medicines at the end of life
The burden of care, including medicines management, increases with illness severity and complexity,
and as patients approach the end of life.55 The palliative care population is identified as being at high risk
for experiencing inappropriate prescribing and medicine side effects.56,57 Twenty per cent of patients take
eight or more medicines at the point of referral to palliative care, and the number of prescribed medicines
increases as death approaches. Some reduction in long-term medicines tends to be offset by prescribing of
new medicines to control symptoms (such as pain, nausea and agitation) as the end of life approaches.22,58,59
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As patients become more ill and severely debilitated, the tasks of medicines management are increasingly
delegated, most often to family caregivers. Increasingly complex tasks can be involved, including giving
injections, changing syringe driver cartridges and managing peritoneal dialysis, chest drains and
percutaneous endoscopic gastrostomy (PEG).8,33,60
Our literature review of carers’ experience of managing medicines for patients dying at home
identified that FCGs face increasing demands for care, but there was limited professional knowledge
or understanding of the challenges that they face, how they cope with these challenges or how they
can best be supported.61 The literature reports widespread concerns among carers about managing
end-of-life medication for the dying person in the home.12,42,43,56,62–64 Patients and their FCGs report
being inadequately informed and supported in medicines management.42,43,62 They experience anxiety
about administering powerful medicines, especially for pain relief.65 Morphine carries a high symbolic
load as being addictive, causing loss of consciousness and a signifier of impending death.65,66 There are
concerns about giving correct and timely doses and balancing the control of symptoms with the risk of
overdosing or hastening death. Although FCGs can struggle to manage medications for someone who
is seriously ill and dying at home, there is an expectation that they will take on these roles, and the
performance of this is often judged by professional standards.8,61 Conflict and disagreement between
FCGs and professional staff have been widely reported.12,42,43,62,63
Previous studies report a high incidence of pain and other distressing symptoms among dying
patients.62,66,67 The last days of life often involve aggravation of existing symptoms, including pain, or
the sudden onset of nausea, vomiting, shortness of breath, agitation, confusion, retained respiratory
secretions and weakness.68 Patients may also become unable to swallow, requiring medicines to be
administered in other forms, including patches, liquids, sublingually or subcutaneously. Pain is reported
to be the greatest fear, and pain control is accorded a higher priority than place of death in public
surveys.69–72 However, evidence suggests that a high incidence of pain and distress is reported for
patients dying at home62,66,67,72 and that pain is less well controlled in the home than in institutional
settings.29,73 In addition to the distress caused to patients and FCGs, failure to control symptoms at
home leads to costly and unwanted use of health-care resources, including out-of-office hours (OOH)
visits and unscheduled hospital admissions.19,57,68
Burden of treatment theory
The work of managing medicines carried out by patients and FCGs, especially at the end of life,
involves considerable burden and sometimes unwanted responsibility.7,74 de Swaan’s75 characterisation
of patients and carers as ‘proto-professionals’ is applicable in this context, where the home is annexed
as an extension of the hospital and patients and FCGs are increasingly required to undertake the
administration of complex regimens of care. These regimens also involve considerable effort, time and
cost, which are required to attend appointments for routine tests and consultation with a wide range
of different health professionals and services outside the home. The extent of work being carried out
in the informal sector is not widely acknowledged by professionals, nor are the very considerable
demands and associated burden placed on patients and FCGs confronting the considerable challenges
and vulnerabilities of old age, serious illness, frailty and incapacity within a bewilderingly complex and
bureaucratic system.48,56
May et al.7,74,76 have theorised burden of treatment relating to four main areas of work:
1. Coherence involves the unfolding process of making sense of illness and developing an
understanding of treatment within a complex system of care.
2. Appraisal involves the work of assessing efficacy and quality of health care, and monitoring and
adjusting treatments.
3. Relationship work refers to the effort required by patients and FCGs in negotiating support from
others within informal and professional networks.
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4. Enacting work is the effort put into operationalising treatment, including taking/administering
medicines, monitoring supplies, ordering prescriptions, attending appointments and communicating
with HCPs.
May et al.7,74,76 propose that treatment burden should be a barometer of the quality of health care and
that the goal should be to achieve ‘minimally disruptive medicine’. The question then becomes not
how an overstretched health-care system can cope with the pressure of unrelenting demand from
patients, but rather how do overburdened patients and FCGs cope with the pressure of the unrelenting
demand imposed on them by a complex and bureaucratic system? The patient deficit model is rooted
in a discourse of non-adherence, non-participation and a presumed lack of competence. By contrast,
a professional deficit model can be proposed, which is rooted in poor communication and lack of
organisational co-ordination.
Some patients have a more positive experience of health care than others. May et al.7,74,76 highlight
the extent to which individual responses are shaped by the opportunities afforded by their location
within interconnected structures of socioeconomic advantage, environment, local infrastructures and
health-care resources, and the resilience enabled by personal and professional networks of care through
which information and material resources flow.7 The acquisition and deployment of social capital is
particularly difficult for people who are old, frail or lacking capacity or who have other challenges to
contend with, such as belonging to a disadvantaged or underserved group. The burden of treatment
theory proposes that care, and the capacity of patients to benefit from care, must take account of the
wider context of social and structural constraints in which they are embedded. It highlights the extent
to which personal agency is underpinned and enabled by the relationships that the individual has with
others and how personal and professional networks may enable or disable access to key resources,
including effective health care.
Diversity and disadvantage
Inequalities in access and provision persist in palliative care, particularly for patients affected by
conditions other than cancer, from social and economic disadvantage and who come from ethnic
minority groups.77–81 Little research has been carried out into how terminally ill patients from socially
and ethnically diverse backgrounds or patients who confront forms of social and personal disadvantage
(e.g. homelessness, serious mental ill health, substance misuse or cognitive or sensory impairment or
disability) manage medicines at home.82,83 Ethnic and cultural differences can influence health-seeking
behaviour, illness experiences and access and use of services and treatment.84 The UK continues to be
more ethnically diverse, with ethnic minority groups accounting for one-fifth of the population in
England and Wales in 2018.85 Ethnic minority populations are also ageing and increasingly experiencing
life-limiting illnesses, which has considerable implications for the provision of palliative and end-of-life
care.86 Reduced access results, in part, from lack of information about the services that are available.
Markham et al.’s84 study to explore the reasons for low levels of hospice use among ethnic minority
groups found that many had very limited or erroneous knowledge of palliative care services. A further
barrier was that many key terms, such as ‘cancer’, ‘palliative care’ and ‘terminal care’, did not have direct
translations into languages such as Hindi and Gujarati. Differing cultural approaches to death and dying
meant that frameworks [e.g. advance care planning (ACP)] and decision-making could be problematic.84
Little is known about how attitudes to medicines and medicines use, especially pain relief, are shaped by
religious and cultural beliefs, or how HCPs respond to the consequences of these.87–89
There has been very limited exploration of how people with disabilities manage medications,
particularly at the end of life. In a study of the pharmacy needs of people with visual impairments
in Scotland, Alhusein et al.90,91 found that pharmacists had limited training and no policy to support
them when dealing with patients with visual and hearing impairments. Patients reported that they
did not always tell pharmacists about their impairment, but struggled to identify medications when the
name, shape or colour of them changed. Patients also reported finding the layout of pharmacies to be
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challenging, not knowing if they had been seen or not hearing their name called when collecting
medications. This led many to prefer to use the telephone or online ordering services, although these
have communication challenges of their own.90
Research is lacking into the needs of other underserved and marginalised groups, such as the homeless,
asylum seekers, travellers and people affected by substance misuse and serious mental ill health. Symptom
control and pain management can be a critical issue in end-of-life care for people with substance misuse.92
Fractured relationships and family conflict can also make end-of-life care challenging.81 Services for
substance misuse often use a ‘recovery’-focused approach, which may not be useful as a patient shifts
into palliative care because it restricts the dialogue that can be had around end-of-life care and ACP.93
Optimising medicines management at the end of life
Good communication between patients and FCGs, between families and HCPs, and between HCPs, is
fundamental to identifying and managing issues with medication in end-of-life care.94,95 Timely access
to medicines and support in understanding their purpose, dose and use are critical for patients and
their FCGs in managing care at home. However, interprofessional communication and co-ordination of
services is frequently reported to be poor, particularly in relation to securing patient and FCG access
to medicines OOH.12,42,62,96–98 Links between community and secondary care providers and between
usual care and OOH providers are particularly unstable.99,100
Community pharmacists
Although community pharmacists (CPs) evidently have relevant and specialist expertise in medicines
management, historically they have predominantly occupied a medicine supply function in relation to
community health-care teams.57,101 Nevertheless, there is considerable scope for CPs to be involved
in more direct and proactive advice giving to HCPs, patients and carers about the safe management,
storage and disposal of medicines. Several initiatives have explored the extension of CP roles and
clinical contact in community care, including Medicines Use Reviews, the New Medicine Service and
non-medical prescribing.57,101 However, it is not clear if, as a profession, pharmacists are keen to engage
in greater involvement in supporting medicines management in palliative and end-of-life care or the
logistical barriers that this would entail.97 It is still rare for pharmacists (as well as other non-medical
prescribers) to prescribe in palliative care.102 A few schemes have indicated promise in developing
greater involvement of CPs and greater integration of pharmacists within care pathways and integrated
multidisciplinary teams (MDTs).55,57,103–106 Lack of public and professional awareness of the existence or
scope for such role development is one obstacle to greater CP involvement in medicines management.107
However, CPs reportedly remain uncertain about their role in direct patient care and communication.108
Indeed, Ziegler et al.109 report that half of all qualified non-medical prescribers, including pharmacists,
who work in palliative care do not prescribe. The current impact of non-medical prescribing in palliative
care remains minimal.
Deprescribing
Polypharmacy is a major contributor to the burden of managing medicines for patients approaching
the end of life, as well as increasing the risks of non-compliance and medicine incompatibility and side
effects.56,110 Evidence suggests that, far from reducing, the number of prescribed medications can increase,
particularly for older patients.110–113 Arevalo et al.114 state the average number of medications taken
in the last 7 days of life to be nine medications. Additional prescribing may often be required for the relief
of symptoms, such as pain and nausea, occurring in the last days of life. However, in a Swedish cohort
study of 58,415 decedents, Morin et al.111,112 report that 32% of patients continued and 14% initiated
at least one medicine of questionable clinical benefit in the last 3 months of life. Such ‘potentially
inappropriate medications’ or ‘problematic polypharmacy’56 is common in palliative care.59,115 Reasons
for deprescribing not taking place include the reluctance of prescribers to broach difficult conversations
about the significance of patients no longer needing to take medicines that were formerly prescribed to
help keep them alive.116,117 In addition, clinicians may want to avoid the additional workload of monitoring
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withdrawal or making changes to dosette boxes, as well as having concerns about creating conflict with
the professional who originally prescribed the medication.118,119 This example illustrates the continuing
impact of professional hierarchy and deference, and the pitfalls that can occur when the professional
network becomes overly complex. Different prescribers may become involved in individual patient cases
without having a clear picture of the active care network or a sense that any one individual role should
assume responsibility for undertaking an overview and rationalisation of what has been prescribed and
is still needed. This is another area in which CPs could potentially play a greater role: in rationalising
and simplifying the prescribed medicines with which patients and FCGs contend. Patient responses to
deprescribing are unknown; however, given what is established about a widespread tendency to minimise
medicines consumption, it is likely that many would be receptive.50,54 Indeed, the tendency of many
patients to undertake their own experiments to establish the efficacy and acceptability of particular
medicines,120 often considered to be ‘non-compliance’ from a professional perspective, could alternatively
be considered a form of patient-initiated ‘deprescribing’.
Anticipatory prescribing
The prescribing of anticipatory medicines (AMs) in end-of-life care has become widespread.121,122
AMs presented in ‘just in case’ boxes comprise a small supply of injectable medicines and necessary
equipment to treat the symptoms most likely to occur in the period shortly before death (e.g. pain,
nausea, agitation, respiratory distress and excessive salivary secretions).123 Most AMs continue to
be prescribed by general practitioners (GPs), although other clinicians, including OOH doctors and
non-medical nurses and CP prescribers, may also do so. The medicines are kept in the patient’s house
in anticipation of future need. In most cases, the AMs are administered by community nurses (CNs),
who undertake on-the-ground decisions about the appropriate time and dose of medicines to be
used.124 If regular or increased doses are required, a syringe driver is likely to be set up. In most cases,
this would be prescribed by a GP but administered by CNs. Given the frequently reported problems of
access to end-of-life care medicines,125 AMs have been widely welcomed as a means of ensuring that
HCPs have a rapid and effective means of responding to an exacerbation of symptoms and distress in
dying patients. However, the availability of AMs, especially in care homes, is also expected to reduce
the demands and costs of OOH care and unscheduled patient hospital admissions.68,121
Although AMs have become widely used and are recommended as good practice, they have been
subject to little formal evaluation or research and their safety and efficacy have yet to be established.121
Concerns have been raised about the increasingly early timing of prescribing AMs, the tendency for
their use once prescribed and available in the home, and the potential risks keeping controlled drugs in
patients’ homes for prolonged periods of time.99 In addition, as most prescribed AMs are not actually
used, there is a great deal of waste, with little supervision of their use or disposal.121,126
Prescribers remain responsible for the use of AMs, but have little control over how and when they are
administered. Lack of trust and communication between professionals and services can be a major
obstacle to their timely and effective delivery.12,62,99 There is evidence that CNs can struggle with
administration, decision-making and ethics issues.96 Appropriate use of AMs requires a reasonably
accurate assessment of the likelihood of imminent death, which is notoriously hard to achieve. Wilson
et al.127 also found that district nurses (DNs) tend to err on the side of caution, adopting a conservative
and parsimonious approach to the initiation and subsequent use of AMs, especially for pain relief.
In a situation of rising patient need and increased pressure on health-care resources, including a
declining number of available professionals (e.g. CNs),128 questions have been raised about the scope
for extending patient and FCG roles to directly administering medicines, including AMs, particularly to
enable prompt relief of pain and other acute symptoms. The provision of such ‘emergency medication
kits’ and the giving of subcutaneous injections for use by patients and relatives at home is well
established in countries such as Australia129–131 and the USA.132 Such practices remain uncommon in the
UK, with only a small body of exploratory work and local policy having been developed to date.133–136
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The prescribing and subsequent use of AMs is a very significant moment in the patient’s dying trajectory.
Little is known about what patients are told or understand about these or how they respond to such
information, or about what FCGs would feel about taking a more active role in making decisions and
using AMs directly. A few studies have reported that AMs are welcomed by families, who find their
availability reassuring, especially when experiencing increasingly difficult circumstances of care at
home,131 although these findings tend to be based on professional perceptions rather than patient
and FCG testimony.122,124 However, much more research needs to be undertaken to establish the
understanding and acceptability of AMs for patients and FCGs, and the extent to which FCGs are
willing to take a more proactive approach to managing medicines in end-of-life care.
Networks of care in a complex system
As health care has shifted from the institution to the home, domestic households are at the centre
of complex networks of practice and health-care management that involve diverse health and social
services and professionals, as well as wider informal networks of friends and family and technologies,
including the internet and social media.5,6,137 The consequences of colonising the private space of the
home as a site of care for co-resident family members as well as patients have yet to be established.
FCGs (co-resident or otherwise) are critical to enabling terminally ill patients to remain at home,
increasingly often to the point of death. However, little is known about the experience of care, the
nature of the tasks undertaken or how the labour of care, including medicines management, is
distributed across the informal network. Cheraghi-Sohi et al.17 found that chronically ill patients
preferred to retain administrative and functional responsibility for medicines management and
delegated relatively few tasks to family members. Medicine-taking was a moral practice and the
capacity to self-manage care was bound up with patients’ sense of self and agency. However,
patients confronting terminal illness often face extended periods of increasing dependency on
others to support them with the tasks of care, including medicines management. We know little
about the distribution of labour within the home, how FCGs feel about the practical and emotional
responsibilities of managing complex regimens of care, or how their changing roles affect relationships
within the home. Professional services and the relationships established between professionals and
between professionals, patients and FCGs can be critical to the experience of end-of-life care and
to enabling patients to remain at home. For patients approaching the end of life, the experience of
great debility and vulnerability occurs in conjunction with increasing care needs from informal and
professional networks and often an increase in the complexity of care. At a time of great physical
effort and emotional distress, the family must adjust to increasing complexity of care and rapidly
changing inputs from professional services. Effective medicines management is critical to the control
of symptoms and to the experience of death and dying for patients and their FCGs.
In the Managing Medicines study, we wanted to explore the range of services and people involved
in supporting patient care, particularly in relation to how the tasks of medicines management were
distributed throughout the patient’s informal and professional networks.17,138 Reflective accounts of
bereaved family caregivers (BFCGs) provided insights into the entire trajectory of end-of-life care and
the nature and impact of the experience of informal care provision. We also wanted to understand
the experience of care of patients from disadvantaged and underserved groups, and how professional
services identify and respond to the difficulties and concerns arising in medicines management for
patients in these groups.82,83
Aims and objectives
Aim
To explore how seriously ill patients, their FCGs and the HCPs who support them engage collaboratively
in managing medicines prescribed for relief of symptoms towards the end of life, and to provide evidence
from a detailed study of barriers to, facilitators of, and information about and training needs for the
improved support at home of terminally ill people and their families.
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Objectives
1. To explore how patients and FCGs, particularly from minority, underserved and hard-to-reach
groups (e.g. ethnic minority groups, the economically disadvantaged, those affected by severe
mental health problems or those affected by non-cancer disease) manage medicines prescribed for
patients with serious and terminal illness being cared for and dying at home.
2. To compare and contrast the experience of symptom control and FCG involvement in medicines
management for patients who have been referred to specialist palliative care (SPC) services and
patients who have not been referred.
3. To establish what further support, information and training FCGs and HCPs need to feel confident
in managing medicines, including those for end-of-life care, for patients being cared for and dying
at home.
4. To explore lay and professional stakeholder perspectives (including those of GPs, CPs and nurses)
about how CPs could be better integrated into the network of care and support for families and
professionals in medicines management and end-of-life care.
5. To use the knowledge gained, from the perspective of all stakeholders, to make empirically founded
recommendations for service development and effective commissioning in relation to medicines
management to improve the care and experience of patients being cared for and dying at home and
that of their FCGs.
Structure of the report
This chapter has provided a background to the study and considers the policy context in which it is set,
alongside evidence available from previous studies. The next chapter outlines the design and methods
of the study before five further chapters present a summary of patient and public involvement (PPI),
participant demographics and the empirical findings from workstreams 1 and 2. Chapter 8 presents
a summary of the stakeholder workshops that constitutes workstream 3 and the conclusions and
recommendations resulting from these. Chapter 9 includes a discussion and critical appraisal of the
findings in relation to the current literature and health-care policy. Finally, Chapter 10 provides a
summary of the findings and their significance, and considers their implications for the development of
policy and practice to optimise service development and professional support for patients and FCGs
confronted by the challenges of managing medicines for serious and terminal illness within the home.
CONTEXT AND INTRODUCTION




The Managing Medicines study explored how terminally ill people, their families and the HCPs who care
for them engage in the tasks of managing complex medication regimens and routines of care at home.
A qualitative study design was employed to generate data in three workstreams:
1. HCP and BFCG interviews
2. family-centred case studies
3. stakeholder workshops.
Qualitative methods of data collection and analysis facilitate the in-depth exploration of participants’
experiences and their views. They are particularly suitable for use where little is known about the
issue and in the study of sensitive and complex topics. Semistructured interviews allow participants
and researchers to explore core topics, while simultaneously offering the flexibility to follow-up on
new issues of interest and importance.139–141 Case studies are eminently suited to the examination of
complex real-world situations in which a variety of perspectives are at play.142,143 The engagement of
several participants within each case enables the comparison of different perspectives, and longitudinal
follow-up allows for an exploration of processes and experiences developing over time, rather than
the cross-sectional snapshot provided by one-off interviews. Interview data were supplemented by
additional data sources, including observations, photographs and medical records. Each case was
followed up, where possible, for a period of approximately 3 months.
Setting/context
The study was based in the East Midlands, UK, with participants recruited across the counties of
Nottinghamshire and Leicestershire.
Ethics and governance approvals
NHS Research Ethics Committee approval was obtained in March 2017 (reference 17/EM/0091) and
for two subsequent amendments to allow an increase the sample size for workstreams 1 and 2 and to
include the option to seek consultee advice in relation to research involvement of patients lacking
capacity. Permission was also sought, via the Health Research Authority, from the appropriate NHS
trusts for their sites to act as patient identification centres in recruiting participants to the study.
Engaging severely ill patients and, recently, BFCGs in research projects presents challenges and requires
flexibility and sensitivity throughout the process. Previous research has reported that participants find
taking part in qualitative research to be a positive experience, even when they anticipate that this might
involve discussion of distressing issues. Indeed, some people find the opportunity to reflect on their
experience in the ‘neutral’ context of a research interview to be helpful and may value the opportunity
to contribute to a research effort that may benefit others.144,145 As a research team, we believe that not
offering vulnerable people the opportunity to take part in research because of assumptions made about
their experiences and preferences is discriminatory and exclusionary.146,147 Prior to the decision take
part, participants were asked to consider how they would feel about discussing their experience of
illness and dying. They were assured that participation was voluntary and that they could withdraw
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from the study at any time. Some participants did become emotional during the interviews, but all
clearly indicated their preference to continue the discussion.
Eligibility
Workstream 1: health-care practitioner and bereaved family caregiver interviews
Health-care professional interviews
The purpose of the HCP interviews was to explore participants’ experience of supporting medicines
management for seriously ill patients being cared for and dying at home. HCPs with experience of
providing care or prescribing, dispensing or administering medicines for such patients were eligible
to participate.
Bereaved family and friend caregiver interviews
Interviews with BFCGs explored participants’ experiences of professional and informal support for
medicines management in relation to the last months of care of their deceased relative or friend. These
included the extent to which participants had undertaken different types of tasks and responsibility
for medicines management, the support that they had received from their professional and informal
networks, and how well they felt that the health-care system had co-ordinated this aspect of care.
BFCGs of patients who had been cared for at home during a substantial part of the last 6 months of
life were eligible to take part.
Workstream 2: case studies
Patients who were identified by a member of their clinical team as likely to be in the last 6 months of life
and to be experiencing issues with medicines management were eligible to participate in workstream 2.
Where a patient did not wish or was not able to take part directly in the study (e.g. because of poor
health), the key participant was a FCG who might be a family member or a friend. HCPs were also
invited to take part after being nominated by the patient as someone closely involved in their care.
Each case was developed on its own terms. There was no standard configuration. Some cases lacked
a FCG or nominated HCP (e.g. where the patient lived alone). More than one FCG or HCP could be
recruited for each case. Participants had to be ≥ 18 years of age and with capacity to consent.
Workstream 3: stakeholder workshops
The purpose of the stakeholder workshops was to disseminate the study findings, identify priorities for
implementation in education and practice, and promote collaboration in the development of education
and training resources and research. Members of lay and professional stakeholder groups who had
experience and/or expertise of medicines’ management for patients being cared for at home at the end
of life were eligible to take part in the workshops.
Recruitment
The data collection period for all three workstreams ran from June 2017 to June 2019.
Workstream 1: health-care practitioner and bereaved family caregiver interviews
Eligible HCPs were identified through service managers and professional networks, or following
presentations about the study given by members of the research team to local services and practices.
Each HCP was given or e-mailed the information about the study and was invited to contact the
research team if they wished to take part.
Bereaved family and friend caregivers were identified through general practices and palliative care
registers, hospices, the caseloads of community and SPC professionals and through local community
organisations. BFCGs were approached between 8 weeks and 6 months after the death of their
METHODOLOGY
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relative by a HCP known to them. They were posted or given an information pack, which included a
covering letter, the information sheet and a reply slip with return envelope, along with contact details
for the research team. Individuals then made contact directly with the researchers if they were
interested in taking part in the study.
Workstream 2: case studies
Family-centred case studies were established around the care of a patient who was likely to be in
the last 6 months of life and who was in receipt of a complex medication regimen or experiencing
issues with medicines management. Such complexity was associated, for example, with the number of
medicines required, but could also be related to the need for different routes of administration or the
use of technologies to support medicines’ use. Key HCPs were also invited to take part after being
nominated by the key participant. In case studies where the patient was not recruited as a participant,
a FCG was identified as the core participant.
A purposive sampling strategy was employed to promote recruitment of a culturally and socially
diverse sample of patients and FCGs. This included individuals from communities underserved by
palliative care services, such as those from ethnic minority groups, those with learning disabilities and
those with experience of conditions other than cancer [e.g. chronic obstructive pulmonary disorder
(COPD) and renal failure]. In addition, we aimed to recruit approximately equal numbers of participants
from SPC services and generalist community services; Figure 1 shows the recruitment flow chart.
HCP identifies eligible family and  gives
information pack
Patient and/or FCG returns
slip and agrees to contact
by a researcher 
Participant (patient and/or FCG)
returns the reply slip but indicates
that they do not want to take part:
they are not contacted again
about the study
The study team make
contact to arrange







wish to participate 
Additional FCG
interviewed, either with





wish to participate 
HCP is
interviewed 
Participant (patient and/or FCG)
does not return reply slip and
is not contacted again about
the study 
FIGURE 1 Flow chart of participant recruitment to the study.
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Workstream 3: stakeholder workshops
Members of stakeholder groups who had experience and/or expertise of medicines management for
patients being cared for at home at the end of life were invited to take part in one of two workshops,
which were held in Nottingham and Leicester in June 2019. Invitations were sent to all of the HCPs
who had participated in the study, all key professional links to the study and our professional networks,
the University of Nottingham Dementia, Frail Older and Palliative Care Patient and Public Involvement
Advisory Group (Nottingham, UK) and the Marie Curie Research Voices PPI Group (London, UK). We
also asked all invitees to disseminate to their own networks and promoted these events on Twitter
(Twitter, Inc., San Francisco, CA, USA; URL: www.twitter.com) and ResearchGate (ResearchGate, Berlin,
Germany; URL: www.researchgate.net). The workshops took place in Nottingham and Leicester to make
them as accessible as possible to the local teams who had engaged with the study throughout.
Data collection
Workstream 1: health-care practitioner and bereaved family caregiver interviews
A single semistructured interview was carried out with BFCGs to explore their experiences and
perspectives of looking after their deceased relative and the management of their medicines. HCPs
were also interviewed once about their experience of supporting patients towards the end of life with
medicines management.
Workstream 2: case studies
The key participant in each case study was interviewed at least once and, in most cases, also on at
least one further occasion over a period of 3–4 months. This could be the patient or the FCG and, in
some cases, both, where interviews were undertaken jointly. Where appropriate, participants (i.e. the
patients and/or FCGs) were invited to nominate a HCP who they considered to play a significant part
in patient care to take part in an interview. Each case was singular and established in its own terms
and could be composed of patients, FCGs and key HCPs. In addition to semistructured interviews,
participants were invited to construct simple ecograms to represent their support networks. Where
participants had given written consent to consider photographs being taken of medicine storage and
equipment used in the home, verbal consent was confirmed prior to these being recorded. Care was
taken not to include identifying information or images of people. With the permission of all of those
involved, observations were carried out of some consultations with professionals and medicine-taking.
The patient consent form also included an option to allow permission to review medical notes. In cases
where the patient was not a participant, their medical notes were not reviewed. These data were
collected via general practices and one of the participating hospices. Figure 2 shows the potential types
of data generated as part of a ‘case’. A narrative summary and composite ecogram for each case is















FIGURE 2 Types of data generated from each type of participant within the cases.
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All interviews were recorded with permission. We experienced one failed recording in the BFCG data
set and one participant requested not to be recorded. Comprehensive field notes were made after
each interview.
Workstream 3: stakeholder workshops
The purpose of the workshops was twofold. First, they were dissemination events for representatives
from a wide range of stakeholder groups, including HCPs, managers, commissioners, educators and
PPI representatives. Workshop participants were, in turn, encouraged to disseminate awareness of
the study findings and its implications for practice through their wider networks. Second, they were
a forum to identify priorities for implementation and to initiate collaboration with members of the
research team to develop further research proposals, training and information resources, and strategies
to implement the findings in education and practice at regional and national levels and for lay and
professional audiences.
During the first part of the session, data were presented on three key topic areas. For the second
element, participants were allocated to a table for a small group discussion based on one of the three
topics. Each table was provided with a topic sheet, which included three questions central to that issue
to be used as guidance for the discussions. With permission, each discussion was audio-recorded and
used as a form of group interview data. Each group was led and guided by a researcher, who also
asked participants to make a note of what they considered to be three key points or issues raised as
part of their discussion group. The workshops were half-day events held in Nottingham and Leicester.
The findings and recommendations arising from the workshops are presented in Chapter 8.
Patient and public involvement
Patient and public involvement was a key element of this study from the outset. The Dementia, Frail Older
and Palliative Care Patient and Public Involvement Advisory Group gave feedback on the developing
proposal, were involved in two engagement sessions to discuss the issues raised by one of the cases, and
co-designed a patient poster to encourage greater consultation with CPs about medication issues. Several
members of the group, including Alan Caswell, have reviewed and commented on sections of this report.
Alan Caswell was a co-applicant on the grant application and has been very actively involved from the
outset as a key member of the project team. He has been involved in a wide range of activities, including
study design, ethics review, data analysis and dissemination. PPI involvement is discussed further in
Chapter 3, including Alan Caswell’s reflections on his role throughout the study.
Analysis
Workstream 1: health-care practitioner and bereaved family caregiver interviews
The qualitative software program NVivo 12 (QSR International, Warrington, UK) was used to facilitate
a thematic analysis of the data set based on the principle of constant comparison.139 The analysis was
carried out through an initial process of open coding, when segments of interview transcripts were
allocated to one or more broad ‘nodes’ within NVivo to capture all text relating to an idea or topic.
The coding frame was then developed through an iterative process of reading coding and discussion of
the data to identify, compare and link ‘themes’ occurring within and across the two data sets involved
in workstream 1. After open coding was complete, a more refined and selective process of coding
of individual nodes was undertaken to explore, differentiate, reorganise and relate the themes
identified as of greatest relevance to the study objectives. These were grouped hierarchically within
broad categories that represented key themes identified in each data set. Further exploration was
undertaken by comparing themes between each series of interviews to enable an understanding of
the key issues relating to medicines management for BFCGs and HCPs, and the degree of difference,
overlap and mutual understanding that exists between them.
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Workstream 2: case studies
Case study analysis combined different data sources, including baseline and follow-up interviews
with patients, FCGs and HCPs, observations, medicines lists, photographs, reviews of clinical records
and analysis of ecograms (Figure 3).142 Individual case narratives (see Appendix 1) synthesised the
entire body of data for each case to provide a clearer view of the key elements in participants’ living
situation, care input, support, medications and changes over time. These were the basis for within- and
between-case comparison, using matrix charting. Follow-up interview data went beyond cross-sectional
and static accounts of specific participants and groups of stakeholders to enable an understanding of
how medicines at the end of life are managed over time within a complex network of care.142 In addition,
each parallel data set within the case studies (i.e. patients, FCGs and HCPs) was subject to a separate
and comparative thematic analysis.139
The ecograms were used to generate context and perspective on how the work of medicines
management is undertaken within the patient’s home and through professional communication and
inter-relations within the wider network of services and family involved in each case.17,44,148–150 When
obtained from the patient or FCG, medicines lists were compared with data generated from record
reviews. These provided greater detail around prescribing choices, information about the prescriber
and the most up-to-date list of current medications. Photographic data could also be compared across
the cases to identify similarities and be specific examples to use as visual illustrations. Such cross- and
within-case analytical formats allow for complexity of themes to be explored without losing the context
of each case.
Analysis of social networks
The ecograms constructed during interviews with case study participants were intended to provide a
diagrammatic representation to support the researchers’ understanding of the network of people and
organisations involved in supporting the patient’s care, particularly in relation to medicines management.
The process of completing the ecograms provided a prompt for participants to think through and reflect
on the nature and significance of the different kinds and sources of support that they received, including
those that were negative or absent. We wanted to identify key contacts within the network and get










FIGURE 3 Sources of data within each case.
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differently to the task of drawing an ecogram, with variable levels of detail and criteria for inclusion.
In most cases, it became clear that these omitted many sources of support and information mentioned
throughout the interviews and other sources of data. In addition, ecograms drawn by different participants
showed some variation in the links identified and how these were assessed. As we wished to gain an idea
of the range of individual networks and the resources to which participants had access, we opted to draw
on all relevant information available throughout the case, rather than confine analysis to the more limited
content of ecograms drawn by individual participants. Moreover, participant ecograms were generated
at different points in the illness trajectory. For example, some included information relating to a late stage
in the patient’s illness, including after death, and may, therefore, be considered more comprehensive than
others. The diagrams included in each case summary (see Appendix 1) indicate which links were included
in the initial ecograms drawn by participants and which were subsequently added by the researchers.
The ecograms include, in addition to informal and professional caregivers, a range of services and
institutions (e.g. hospice, hospital and pharmacy) where these were referred to generically, as well as
other links identified by participants as important resources. We have been careful not to overinterpret
the comprehensiveness or significance of an interpretive exercise in reconstruction. However, taken
together with the wider data we have about each case, we have found the ecograms valuable as a means
of visualising the network of care, including informal and professional links, and the range and nature of
contacts as a way of aiding analysis of each case. They also provide a simple way of exploring the range
and distribution of informal and formal contacts and their significance within each case (see Appendix 1).
Workstream 3: stakeholder workshops
The researcher facilitating each group made detailed notes of the discussion. Further notes were
made from listening to the audio-recordings from each of the workshop table discussions and key
passages were transcribed verbatim. The recorded discussions echoed and reinforced many of the
themes identified in the study data. These notes were amalgamated with the written notes provided
by the participants. Already grouped into the three broad topics presented on the day, these notes
were then further examined using a thematic approach to identify additional themes within and across
the three topics, with a particular focus on potential areas of implementation and learning for practice
(see Chapter 8).
Reflexivity
The researcher carrying out social research inevitably has an impact on, and is impacted by,
the research. During this project, three researchers carried out recruitment, data collection and
analysis and here we reflect briefly on our positionality and its impact. We are white female social
scientists from non-clinical backgrounds. Our experience in terms of research into medicines and
their use varies: the principal investigator has a substantial track record in the field, but we are
all experienced qualitative end-of-life researchers. We utilised several techniques to enhance the
quality of the data we generated and the analysis that we carried out. First, for each instance of data
collection we wrote field notes, enabling reflection on the content, process and outcome of each
interview and observation. Second, we consulted regularly with our PPI team member, the project
team and the project oversight group to share findings and our developing analysis of them. In this
way, we were able to access input from a range of relevant professions, including pharmacists, nurses
and doctors. Third, we worked together on the analysis, with regular discussions of the ongoing process,
ensuring that each transcript was coded by at least two researchers. We believe that, as non-clinicians,
we are well placed to explore processes of medicines management for people approaching the end of
life, but that our analysis is enhanced by input from our clinical colleagues.
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Chapter 3 Patient and public involvement
Introduction
The Managing Medicines project team has been fortunate to work with the established University of
Nottingham Dementia, Frail Older and Palliative Care, Patient and Public Involvement Advisory Group
(Nottingham, UK). The group supports a wide range of research projects undertaken in the Schools
of Health Sciences and Medicine. Members advise on every stage of the research process, including
early discussion of topic, design, ethics issues, content of information sheets and interview schedules.
They also contribute to data collection, data analysis and publications, including review of the final
project reports. The Managing Medicines study has benefited from the inclusion of group member
Alan Caswell as co-applicant on the grant. This has enabled greater integration and continuity of PPI
involvement from the outset and has enabled Alan Caswell to develop a deep understanding of the
study and its challenges. As researchers, we have benefited from Alan Caswell’s involvement in many
ways. His perspective as a public advocate has allowed us to see the study from a different perspective,
and this has improved the way in which the study was planned and delivered. He has embraced working
with clinicians, researchers and academics and has been considered by the team to bring considerable
expertise, as well as collegial support. From the outset, we agreed with Alan Caswell that he should take
on elements of study engagement only to the extent that he felt comfortable in doing so. However, his
involvement has been considerable and has extended throughout all stages of the research. Alan Caswell
has taken on active roles in data analysis, dissemination and public engagement. We have welcomed
Alan Caswell’s support as a very level-headed ‘critical friend’, as well as his encouragement and ongoing
support through all stages of the study. Alan Caswell’s account of his involvement in the study is given
below (see Box 1).
At the outset, members of the PPI group endorsed the value of the research and its resonance with
their personal experience, as well as the research priorities identified by the James Lind Alliance
(Southampton, UK). The group has commented on participant materials, including information sheets
and consent forms. Group members have discussed and commented on the study design, ethics
issues and findings. They have contributed to the co-produced patient poster workshop and to the
two end-of-project stakeholder workshops. Members expressed concern about the sensitive nature of
the topic, the need for skilled interviewing and the risk of the interviews causing distress to participants
at a very challenging and vulnerable period of their lives. It was also suggested that FCG participants
might, in reflecting on their experience, become aware of shortcomings in the care received by their
relatives. The researchers have been mindful of these concerns throughout the process of data collection
for the project. Illustrative extracts from the PPI member reviews of the final report are given below.
Case study: Mr Conner
The case study in its depth and quality of narration was brought to life for us. It brought back our
memories of our different experiences of managing medicines but also our lived pain of coping as
carers in end-of-life situations.
The detail was its strength, its authenticity. It read as though the researcher was walking alongside
Mr and Mrs Connor and knew their path. The journey showed the professional strengths and unspoken
underlying compassion of health-care staff. It also realistically showed the gaps in end-of-life care
provision which pointed to how hard joined-up care can be when so many are involved.
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Demographics
I found this section difficult to read. Could more of the figures be presented in diagrammatic or tabulated
form, as is done later in this section? I appreciate from a research point of view for future reference it is
valuable to know the uptake achieved from each source but is it necessary for this project?
Findings
Initially I had reservations about the photographs, however I now consider they graphically show the
intrusion and medicalisation of the family home and are integral to understanding how the participant
and carer had to make space and adjust to the burden of storing and administering medicines and aids
placed on them. It shows a home changed to a medical storeroom. It highlights the narrative, showing the
distress of illness, the responsibility of managing so many medicines and acknowledges the inevitability of
the outcome of the following months.
Conclusions: consequences of managing medicines at home
Experience of a loved one dying at home can be a nightmare and one which lives with the FCG for ever.
Sitting with a dying loved one unsure/unable to administer medication, without support of a HCP and not
knowing what to expect; death is not always peaceful. Accessibility of HCP 24/7 [24 hours per day, 7 days
per week] needs to be alongside managing medicines at home. FCGs are not only managing medicines at
home but managing daily life – cooking, cleaning, changing beds, sometimes dealing with highly charged
stressful situations. It cannot be assumed that FCGs have a good relationship with the terminally ill patient.
Overarching comment
This research has exposed the complexity of how we live and how we die. How do the many disciplines of
health care, pharmacists, consultants, GPs, physiotherapists, occupational therapists, community nurses of
all types, social care workers, social workers interact with each other and with their patients and their
families and friends when people become ill?
Patient and public involvement group members have identified with the problems reported by study
participants in relation to decisions about when to use medicines, getting the dose right, problems
of access and supply, and, especially, effectively managing pain. Their own experience of problems
resulting from poor communication between members of the MDT, particularly GPs and nurses, were
shared and also the value of carers having 24-hour access to advice and information. They anticipated
that provision of such a service would result in saving NHS costs by reducing unscheduled hospital
admissions and achieving more rational and effective prescribing. PPI group members highlighted
the importance of considering diversity and the problems of minority and disadvantaged groups in
medicines management at the end of life, and of maintaining focus on the lived experience of families
caring for a dying relative at home. All of these issues feature in the report of the study findings, which
are detailed in the following chapters.
In addition to Alan Caswell, we thank four members of the PPI group, Kate Sartain, Maureen Godfrey,
Margaret Kerr and Marianne Dunlop, for their reviews and detailed feedback on the draft final
report. They provided reassurance about the depth of detail included in reporting the study findings,
particularly in the extended case study presented in Chapter 5, and identified priority areas for further
research. Reviewers also pointed out parts of the draft chapters that were unclear or difficult to read,
overly detailed and unnecessarily complex. These comments have been extremely helpful in revising
and improving the text of the final report.
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The PPI reviewers highlighted the importance of further research into the following areas:
l the prescribing and use of AMs, in particular the emotional and psychological as well as practical
issues that these entailed for patients and FCGs
l the great variation in patient and FCGs’ experience of treatment and input from different HCPs and
services, particularly the lack of co-ordination, structural barriers and bureaucracy that they encounter
l the lack of communication between HCPs involved in patient care and the apparent unwillingness of
individual HCPs to take on a ‘liaison’ role in helping patients and HCPs navigate the health-care system
l the role of domiciliary home health-care workers (HCWs) in supporting families and the much
greater recognition that should be awarded to training and development of staff in this role
in future
l the variability in FCG capacity and willingness to engage with managing medicines at home
l the role of GPs and their expectations of their role in supporting patients at the end of life
l the consequences of COVID-19 for changing norms in patient and public attitudes and discussion of
death and dying, and how recently configured primary care networks will impact on social care and
its integration with health-care services.
Box 1 gives an account by Alan Caswell, our PPI co-applicant, of his involvement in the Managing
Medicines study and collaborative working with the research team. This is followed by a summary of
the extension work undertaken for the project, which resulted in a learning article and positional paper
about extending pharmacist involvement in supporting medicines management for seriously ill patients
and a co-produced patient-facing poster for display in pharmacies, general practices and other
community settings. The extension work was led by Asam Latif.
BOX 1 Personal reflections of being a co-applicant on the Managing Medicines grant: Alan Caswell
In 2015, at the University of Nottingham, at a meeting of the Dementia, Frail Older and Palliative Care,
Patient and Public Involvement Advisory Group, Professor Kristian Pollock spoke to the group about a
proposed research project titled ‘Managing medicines at the end-of-life: supporting patients, carers, and
professionals in community care settings’. During this discussion she suggested that if a member of the
Patient and Public Involvement Group (PPI) felt that they wanted to be involved with this research as a
PPI representative, they should contact her.
A couple of days later after giving this proposed research project some thought I contacted Professor Pollock
and said that I would like the opportunity to discuss this further with her. The following week we met and
during a couple of hours’ discussion, we explored both personal and work experience in this area. I agreed to
be involved and most importantly, from my point of view, Professor Pollock felt that I would have something
to offer to the research working group.
Before making the application for funding to the National Institute for Health Research (NIHR) there was a lot
of work to do to prepare the proposal and all the necessary documentation. During this time the research title
changed to ‘Managing medicines for patients with serious illness being cared for at home’ (MM@H). I became
a study co-applicant, contributed to, and approved, the ‘Plain English summary’ section of the application and
undertook to review and comment on the protocol and associated documents.
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During this period, it was agreed that my PPI involvement would be in the following areas:
l involvement in the design of the research
l contributing to the development of research protocols
l being a co-applicant for funding applications
l being an active member of the Study Management Group
l being involved with the development of participant information sheets and study processes
l involvement with the conduct analysis and interpretation of the research findings
l contributing to study reports and supporting the development of dissemination strategies
l as a stakeholder involved in the different workstreams as appropriate.
Once NHIR approved funding, I was next involved with the preparation of documents so that we could apply
for ethical approval through National Health Service National Research Committee (NRES). I contributed to,
and reviewed, all patient-facing materials, such as patient information sheets, consent forms and letters. I also
went with Professor Pollock to the NRES committee meeting at which our application was reviewed, and even
answered a question. We received a favourable opinion, so enabling MM@H to start.
My ongoing involvement in the project has been in the following areas:
l Attending all project team meetings held, nine meetings in total.
l Attending all Project Oversight Group meetings held, five meetings in total.
l Analysing data for four interviews, a total of 47 hours input over several weeks.
l Giving two presentations on data from one interview to a project team meeting and a Project Oversight
Group meeting.
l Giving the PPI Group updates on how MM@H was progressing on a regular basis.
l Arranging for Professor Pollock to speak to the PPI Group towards the end of the project.
l Involvement with a session for the PPI Group with Professor Pollock and Dr Glenys Caswell concerning a
patient case study; this session lasted 3 hours.
l Attending the two workshops at the end of the project, my involvement was to welcome people, complete
sign in forms and give them the day’s format and relevant information, ensure any PPI attender received
an expense claim form and knew how to complete and return. I also participated in the table discussions.
At all the project team meetings I was an active participant and was, on occasion, directly asked what my
thoughts were on any given subject. I always felt that my views were listened to and given due consideration
by all the other members of the team. The discussions covered many aspects of the study and we often had
to consider ethics dilemmas. On one occasion we even went back to the NRES committee on a particularly
vexing issue, and we were given ethics approval to go ahead with it.
At the end of the study, MM@H was given a no-cost extension of 6 months, during this time work was
ongoing around the area of pharmacy data, and a 1-day workshop was arranged to look at the possibility
of producing a poster for use at pharmacies to explain their role in advising about medication. As a PPI
member I was involved with that workshop, again greeting people, giving out information packs, ensuring the
participants received vouchers for attending. I also participated in the workshop and we produced a poster at
the end of the day.
BOX 1 Personal reflections of being a co-applicant on the Managing Medicines grant: Alan Caswell (continued)
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Co-produced pharmacist learning article, positional paper and co-produced patient-facing
poster: Asam Latif
The findings of this study151 revealed considerable scope for better co-ordination and streamlining
of the processes of medicines prescribing, supply and access, and greater involvement of CPs in
providing support for patients and FCGs, as well as to other HCPs. The findings particularly exposed
opportunities for HCPs to better engage patients and carers. An educational learning article aimed
at front-line CPs was written to illustrate the practical ways that pharmacists could help patients
manage their medicines at the end of life. The learning article covers the following areas:
l What is palliative and end-of-life care?
l A holistic approach to palliative care.
l The case for greater involvement of CPs in palliative care.
l Opportunities for pharmaceutical care.
l Medicine optimisation.
l Understanding the work that patients do to manage their medications.
l Diversity and disadvantage.
l Appreciating the system and the complexity from the lay perspective.
l New palliative care models.
l Pharmaceutical care after the death.
I was approached by Katie Porter, Assistant Research Manager NIHR, and asked if I would be willing to speak
at a workshop about my experiences as a PPI co-applicant in MM@H. On 6 February 2020 I attended a PPI
workshop at NIHR Southampton and along with Doreen Tembo, Patient and Public Involvement and External
Review, Senor Research Manager NIHR, gave a joint presentation which lasted 2 hours. My involvement was:
l The perspective of a public co-applicant, which included my background, how I got involved, what duties
I carried out as a PPI co-applicant.
l Benefits and challenges, which included my own experiences, where I thought I had made a difference,
what did I find most difficult. During this session Professor Pollock had joined the workshop by Skype™
and also gave her input to this item on the workshop agenda.
It is hoped that a paper I am writing with Dr Eleanor Wilson on PPI involvement with MM@H will eventually
be published.
From being involved with this project I have become more informed on how patients, relatives and friends
view the support they are given at a very difficult point in their lives; the experiences varied from good to
pretty poor. Likewise, I gained a better understanding about how differing staff views on risk could lead to
disagreements. For example, in one case professionals differed in their views as to the acceptability of just in
case pain relief medication being given by relatives or friends, which could lead to an accidental overdose.
This is a serious area and one where both relatives and professionals need support.
I also developed a better understanding of how the researchers approached the subject and at times had to
develop strategies to achieve the goals of the research.
Overall, I am pleased I took the opportunity to be involved with this research project, and I would encourage
other PPI members to become involved with research projects that they would have an interest in.
BOX 1 Personal reflections of being a co-applicant on the Managing Medicines grant: Alan Caswell (continued)
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A positional paper aimed at pharmacy professional bodies, commissioners and policy-makers is currently
under review. This aims to provide clarity and vision for future medicines management for palliative and
end-of-life patients. Through this, we intend to spark a debate and illustrate the need for pharmacists to
take on new roles, as well as provide guidance for educators on how best to support them.
Poster workshop
One significant finding was that patients/FCGs were often unaware of the support available from
the CP. It was decided that a co-produced patient-facing poster displayed in CPs and general practices
could be a simple way to raise patient and carer awareness of ways to access much needed help with
medicines from their CP.
Twelve participants were recruited to a 3-hour mixed patient and professional workshop to discuss the
findings and co-produce a poster. There was a range of participants, all of whom had personal experience
as a FCG or an interest in palliative care. They included three patients/PPI representatives, two FCGs,
three pharmacy support staff (two pharmacy dispensers and one accredited checking technician), three
pharmacists and one GP. A £25 goodwill voucher was given to each participant as a token of appreciation.
Prior to the workshop, a draft patient poster was developed by the study team based on the findings
of the study (Figure 4). It was intended that this would not be revealed to workshop participants until
after they had co-produced their poster. The workshop began with an overview presentation of the
study findings. Participants were then divided into two groups, each comprising a mix of patients and
professionals. Each group formed ideas for the poster, which were then produced onto an A4 flip chart.
Finally, the study team draft poster (see Figure 4) was then compared with the workshop participant
poster and a composite version was produced. The new poster was subsequently circulated after the
workshop to participants via e-mail for further editing, minor revision and refinement for producing a
final version (Figure 5).
Conclusion
Patient and public involvement has played a very significant part in the Managing Medicines study,
and we are grateful to group members for their continuing support throughout the project. We have
been encouraged by members’ endorsement of the topic and its importance, and their response to the
study findings, which resonated with their own experience. At the outset, members expressed concern
that the study should be conducted in such a way as to minimise the risk of distress or burden to
participants. Throughout, they have stressed the importance of incorporating diversity in recruitment
and representation of diversity within the findings, as well as staying close to the lived experience of
participants in managing medicines at home. Although we have not managed to incorporate every
point raised by the PPI reviewers, the comments and concerns they have expressed throughout the
study have made a significant contribution to its focus and reporting of the findings.
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Do you need help with medicines?  
It’s OK to ask… Speak to our pharmacist today! 
 
 
Caring for someone with serious illness at home can be difficult. Our 
pharmacy team are here to help and support you. Our pharmacist is 
able to offer free and friendly specialist advice and information 
about medicines. For example:  
 
 Do you have concerns about taking your medicines, or their side effects?  
 
 Are you finding it difficult to cope, manage 
your medicines, or think you may be taking too 
many?  
 
 Do you have trouble opening packets or 
containers, or remembering when to take your 
medicines?  
 
 Have you recently had changes to your medicines, or have you been discharged 
from hospital? 
 
We are available without an appointment and have a consultation 
area if you wish to speak privately 
 
You are also welcome to call us on …………………………… 
 
We are open from ………………   Until …………………….. 
 
If we are closed you can access help: 
Online (111.nhs.uk) or by phone (NHS 111) 
 
 
If you need help with medication, ask your pharmacist today 
۔ ںيضرورت ہے تو براه کرم آج اپنے فارماسسٹ سے پوچه یمدد ک ںيم وںيدوائ یاگر آپ کو اپن  
Jeśli potrzebujesz pomocy z lekami, zapytaj dziś farmaceuty. 




FIGURE 4 Poster 1: pre-workshop poster designed by the study team.
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ASK YOUR PHARMACIST 
 
Managing medicines at home can be difficult.  
If you are not sure about why, when or how medicines should be 






… your Pharmacist is able to offer free and friendly 
specialist advice, support and informaon about 
medicines.  
We have a consultaon area if you wish to speak privately  
If we are closed you can access help: 
Online (111.nhs.uk) or by phone (NHS 111) 
If you need help with medicines, ask your pharmacist today 
۔ںيضرورت ہے تو براه کرم آج اپنے فارماسسٹ سے پوچه یمدد ک ںيم وںيدوائ یاگر آپ کو اپن  
Jeśli potrzebujesz pomocy z lekami, zapytaj dziś farmaceuty. 
Your Pharmacist is here to help
 
Why have I been given 
this medicine? 
Why have my medicines 
been changed? 
What if I miss a dose? 
I’m finding my medicines 
difficult to take 
Do I have to take them 
all? 
Where should I keep my 
medicines? 
FIGURE 5 Poster 2: post-workshop co-produced poster.
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Chapter 4 Findings: participant demographics
This chapter presents demographic information about participants in workstreams 1 and 2. Detailsof participants in workstream 3 are given in Chapter 8.
Recruitment
Workstream 1
Twenty-one BFCGs were recruited over a 15-month period between August 2017 and November
2018. Although we do not know how many information packs were subsequently given or sent to
BFCGs, we have recorded that at least 94 information packs were given to 16 different HCP teams to
distribute. Over half (12/21) of the participating BFCGs were referred via two hospices engaged with
the study. Five were recruited through hospital teams across three hospitals. Two more were recruited
via community nursing teams and the final two via community organisations.
Forty HCPs were recruited through a variety of routes over a 16-month period between June 2017 and
October 2018. Information about the study was sent directly to key professional contacts, primarily via
e-mail, and they were asked to distribute this to their networks. We also employed a snowball sampling
technique by asking those interviewed to suggest other suitable HCPs or pass on information packs to
colleagues. The Clinical Research Network representative supported engagement with general practices
and several were visited to explain the study and leave information packs for both workstreams. We
particularly targeted SPC teams, GPs, pharmacists and community nursing teams to obtain a range of
perspectives from different professional roles.
Workstream 2
Over 136 patient information packs and 103 FCG information packs were provided to 16 different HCP
sources. We do not know how many of these were given out. Twenty-two patient cases were recruited
over a 15-month period between August 2017 and November 2018. Two patients were subsequently
withdrawn: one died before sufficient data could be collected and it emerged, during interview, that the
other did not meet the eligibility criteria for the study. Twenty patient case studies were completed.
Nine further patients or FCGs expressed an interest in the study, but subsequently died or became too
ill to take part. In addition, we are aware of 26 potential patients identified by HCPs and discussed with
the research team for eligibility who did not go on to engage with the study. In some instances, the HCP
subsequently decided that it was not appropriate to discuss the study, often because of a deterioration
in the patient’s condition or family circumstances. In other instances, the patients or FCGs who received
information packs decided against taking part and did not contact the researchers.
The 20 completed case study participants were recruited through one of three hospices (9/20), a
hospital team such as respiratory (5/20), their GP (3/20), a CN (2/20) or a community organisation
(1/20). The central participant in the case could be a patient or FCG, who could then go on to nominate
other key people. Nominated individuals were then given information about the study and were asked
to take part. We utilised a range of key contacts to recruit patients with conditions other than cancer
and, where possible, from diverse or disadvantaged groups.
Study participation
Workstream 1: bereaved family caregiver interviews
Twenty-one BFCGs were interviewed (15 women and six men). All were single interviews conducted face
to face. Nineteen took place in the participant’s own home and two took place at the university. In relation
to the patient, 11 identified as a wife, three as husbands, six as sons or daughters (including two in-laws)
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speaking about a mother, one was a father and one was a friend. The patients referred to in the BFCG
interviews were 12 males and nine females and had a range of diagnoses (Table 1), with many having
multiple comorbidities. Of the 13 patients with cancer, there was considerable variety in the types of the
disease, and for one patient cancer was not the primary diagnosis. Reflecting the high prevalence of cancer
in this group, the majority (n = 16) of patients in the BFCG accounts had been in receipt of SPC.
Workstream 1: health-care practitioner interviews
We completed 27 interviews with HCPs, including one joint interview and three group interviews, with a
total of 40 different participants from different professional roles (Table 2). These were single interviews,
usually taking place face to face at participants’ place of work, with four conducted by telephone.














a Many patients were reported to have multiple comorbidities and,
therefore, the number of conditions listed exceeds 20.
b Types of cancer (n= 12 as a primary diagnosis): ampullary, bowel (n = 2),
kidney, lung, oesophageal, ovarian, pancreatic, prostate (not primary
diagnosis), salivary gland, soft tissue sarcoma, vulva and one unspecified.










CNS, clinical nurse specialist; SPCN, specialist palliative care nurse.
a CNs includes all bands and those with the additional district
nursing qualification.
b These were disease-specific nurses for heart failure, neurology and
complex needs.
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Workstream 2: case studies
The workstream 2 case studies included several different data sources (Table 3).
Fifteen of the 20 cases had patient participants who took part to a variable extent, depending
on their health and abilities. Each of the 20 cases had between one and five participants, involving
48 separate participants (Table 4). In four cases, the patient was the only participant, and in two other
cases the FCG was the only participant. Fourteen HCPs were involved in 11 cases, with 11 of those
participating in interviews and three in observations. Patients and FCGs reported that patients often
had a number of conditions and it was not always possible to identify their primary diagnosis (Table 5).
TABLE 3 Case study data collection
Data source Number of data
Interview 53




TABLE 4 Case study participants
Participant (n= 20 cases) Number of participants
Patients 15 participated to some extent (male, n= 9; female, n = 6)
FCGs 19 as participants (male, n = 3; female, n = 16)
HCPs 14 (11 in interviews and a further three in observations)a
a One HCP participated in interviews in relation to two cases and another participated in an
interview and an observation.









MND, motor neuron disease.
a Some patients had more than one primary diagnosis and,
therefore, total numbers exceed 20.
Note
Many patients also reported being affected by additional
conditions, such as kidney failure, dementia, stroke, frailty,
vascular disease, tuberculosis and blood clots.
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Across all 20 case studies, a total of 54 interviews were conducted with patients, family members,
friends and HCPs. FCGs were predominantly wives, but also husbands, siblings, sons, daughters and,
in one case, a friend. HCP participation in the case studies included six HCWs/support workers, four
consultants, two GPs, two clinical nurse specialists (CNSs) and one specialist palliative care nurse
(SPCN). All interviews with case patients and FCGs took place at their home. Fifteen interviews
were conducted as joint interviews with the patient and FCG (four with two FCGs present). In one
interview, a HCW was also present. One patient chose to participate solely by telephone throughout
their engagement with the study. Two follow-up FCG interviews were conducted by telephone. Three
of the 11 interviews with HCPs were carried out by telephone. All others took place at the participants’
place of work.The average duration of data collection for each case, excluding review of medical records,
was just under 4 months.
Observations
Over the period of case study data collection, 11 observations were carried out with 10 case participants.
The specific length of time spent on each observation was not recorded, but ranged from a few minutes
to almost 2 hours. Observations were predominantly undertaken during visits to interview participants.
Two were undertaken at outpatient appointments. These included observations of:
l general care and feeding via a PEG
l storage and management of medications in the home
l pain management consultation
l renal clinic outpatient appointment observation
l support worker administering medications
l a specialist nurse visit to discuss injections and ACP documents
l the delivery of medications from the pharmacy
l equipment (including hospital bed, hoist, lift, wheelchairs, walking aids, non-invasive ventilation,
oxygen machine and wheelchair adaptation for digital tablet use).
Photographs
With consent, photographs were taken as part of data collection in 13 of the cases. Participants gave
an overarching written consent to allow photographs to be taken, and verbal consent was then used
to check for each individual photograph once an item of interest was identified. Where a participant
expressed an interest, they were also shown the photograph to check that they were happy with the
content. These were visual ways to document medication storage, medication devices and equipment
and to illustrate their impact on the space and environment of the home. They include pictures of
dosette boxes, blister packs, personal storage boxes, locations of medication storage (e.g. kitchen
cupboard), mobile telephone applications, alarms, non-invasive ventilation and oxygen machines,
and equipment such as hospital beds, hoists and a lift installed in a living room. All photographs
(see Figures 7–17 and Box 2) used in this report have been anonymised to remove both patient- and
pharmacy-identifying data and each has been reproduced with permission from copyright holders
Eleanor Wilson and Glenys Caswell (University of Nottingham, 21 January 2021).
Ecograms
Case study participant ecograms were completed during interviews, where appropriate, and
subsequently included in diagrammatic summaries of each case compiled by the researchers on
the basis of all data available within each case (see Appendix 1).
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The largest network included 32 links and the smallest network included nine links (mean, n = 22 links;
median, n = 20 links). Key caregivers or links were identified as individuals or services of particular
emotional and/or practical importance to the case participants (indicated by dark colours in the ecograms
in each case summary in Code Key – for case summaries). The number of key informal caregivers within
each network was between zero and two, with two cases recording no informal caregivers as ‘key’. Key
formal caregivers ranged from zero to four, with seven cases considered to have no key formal caregivers.
Thirteen out of 20 cases had accessed SPC by the end of the study. In five cases, SPC links featured as key
caregivers eight times. The most frequent formal caregiver link was with GPs (n = 7) and the most cited
informal caregiver link was a wife (n = 10). Spouses in total were the most common key informal caregivers
(13/20). Where HCWs were in place, they were always seen as key to care (four cases). Disease-specific
CNSs were identified as key in three cases and DNs in two.
Records review
Given the considerable time that sometimes elapsed between the completion of case interviews and the
records review, we felt that it was appropriate to check consent given by patient participants at the start
of the study. In five of the cases, there was no patient participant and in one other case the patient had
refused consent. We deemed three further patient cases unsuitable to contact, either because we were
aware that the patient had died or because the research team felt that it was inappropriate to make
further contact. This left 11 cases for which consent had originally been given that needed to be checked.
We endeavoured to follow up on each of these cases and to establish GP contact details to undertake
reviews. Where the patient had died (in three cases), we discussed this with their FCG and each wanted to
support the patient’s initial decision. One patient decided to revoke his initial consent. In two further cases,
we were not able to contact the participant to confirm consent. This left eight participants with records





(n = 11 cases) 
Consent checked
and confirmed
(n = 8 cases)
GP records reviews completed
(n = 8)
(with additional hospice
records, n = 2) 
• Consent revoked, n = 1
• Unable to check,
    therefore unable to get
    GP contact details, n = 2
No consent
(n = 9 cases) 
• Refusal, n = 1
• No patient to consent, n = 5
• Not applicable/appropriate to ask, n = 3
FIGURE 6 Process of reviewing patient records.
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Specialist palliative care
Initially, we had intended to search for differences in the experience of care between patients who
had and patients who had not been referred to SPC. For the purposes of the study, the term SPC
covers access to SPCNs, consultants and hospices. In practice, however, we found that this distinction
was not particularly useful. In part, this was because of the very diverse conditions affecting patients,
as well as the different stages of their illness and natural variation between these. All but three of the
patient cases survived past the end of the study and would likely be referred for palliative care at
a later stage of their illness. Consequently, we have not considered quality or experience of care in
terms of a contrast between ‘specialist’ and ‘generalist’. All patients in workstreams 1 and 2 who were
affected by cancer and half of those with other conditions had been referred for SPC. Some patients
without cancer reported having prolonged input from specialist teams, including those dealing with
long-term conditions, respiratory specialists and disease-specific nurses who had considerable
experience and expertise in palliative and end-of-life care [e.g. nurses specialising in Parkinson’s disease,
COPD, renal disease and motor neuron disease (MND)]. The most significant resource available to patients
was the establishment of a key caregiver relationship with a particular HCP, and this resource was drawn
from a wide range of general and specialist roles.
However, the established association between cancer and palliative care was apparent in the study
data. Based on primary diagnosis, all four cancer patients in the case studies had prolonged hospice
stays, outpatient appointments and SPC nursing at home. In comparison, for respiratory disease
(e.g. COPD and emphysema), only one of four patients reported access to SPC. Several of these patients
described a pattern of bypassing community professionals and contacting emergency and ambulance
services directly when they recognised onset of an acute exacerbation of their condition that they
anticipated from past experience would require hospitalisation. Three patients with MND had some
access to SPC. The experiences of those with conditions such as heart failure, progressive supranuclear
palsy (PSP), renal failure or multiple comorbidities all varied. In total, 13 out of our 20 cases reported
accessing SPC at some level during their involvement in the study. The majority of BFCGs reported
SPC input for their relatives prior to death in a group in which most patients were affected by
cancer. The care of some patients in both workstreams had been predominantly managed by GP
and DN teams.
Do not attempt cardiopulmonary resuscitation
Do not attempt cardiopulmonary resuscitation (DNACPR) status was not routinely discussed during
the interviews and it was not often mentioned in the BFCG interviews (6/21). However, from the
cases for which we have been able to draw on multiple sources of data, we know that 12 patients
had a DNACPR in place and two had some form of advanced directive (one with and one without
a DNACPR).
Anticipatory medications
Thirteen of the BFCGs reported that the patient had been prescribed AMs. In six instances, these were
reported to have been used. Six of the case study participants also reported that AMs were in place.
This number is likely to have increased as more of the participating case patients reached the end of life.
A further four case study patients held a prescription for ‘just in case’ or ‘rescue’ antibiotics for chest
infections. Across both groups, there did not appear to be any association between having anticipatory
medications in place and having access to SPC.
FINDINGS: PARTICIPANT DEMOGRAPHICS
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Syringe drivers
Ten of the patients described in the BFCG interviews had a syringe driver put in place for symptom
management at the end of life. All but two of these patients had a diagnosis of cancer. Three of the
case study patients also had syringe drivers in place. Two of these patients had cancer and one had
renal failure. Across both groups, all of the patients recorded to have syringe drivers also had SPC input.
Medications
Patient case studies
Within the 20 patient cases a total of 222 prescribed items were identified. Appendix 2 provides a
list of all of the medication prescribed, as reported by participants or found in medical notes. We were
able to review the medical notes of eight patients and in the other 12 we relied on participants’
accounts. Supporting information was also obtained in some interviews with HCPs who had immediate
access to medical notes. On average, case patients had just under 12 prescribed medications and this
ranged from 6 to 20. These include equipment and machines, such as oxygen concentrators, non-invasive
ventilation and nebulisers, creams, eye drops, supplements (e.g. vitamins and fortifying drinks), laxatives
and anticoagulants. There were a range of formulations prescribed, including tablets, liquids, injections,
inhalers and patches. Complementary medicines were mentioned by participants, but not often and we
did not enquire specifically about their use.
The aim of Appendix 2 is to illustrate the number, complexity and range of prescribed items across a
relatively small cohort of 20 patients. The data show that participants frequently had more than one
medication prescribed from a certain group of medications. Opioid analgesics were the most frequently
prescribed medications, followed by proton pump inhibitors, which reduce acid in the stomach and are
often prescribed to manage the side effects of other medications in palliative care.
Bereaved family caregiver interviews
We do not have extensive knowledge of the medications used by the relatives of BFCG participants
and we have not attempted to collate this. Information was accessed during a single interview and
based on participants’ recall of past events. However, some BFCGs gave very detailed accounts based
on meticulous records maintained during the patient’s illness. The researchers were sometimes shown
prescription and medicine lists. We cannot, of course, know how medications were taken by patients
and whether or not they were taken as prescribed.
Conclusion
This chapter has presented background information on the participants who took part in the study and
the different sources and extent of data collected. It includes a summary of the process of recruitment,
characteristics of participants in workstreams 1 and 2, their involvement with SPC and the medications
prescribed for case study patients. The next chapter gives a detailed account of a single case as a way
of understanding the experience of treatment and decision-making at the end of life and to provide
context for the key themes and issues presented in the chapters that follow.
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Chapter 5 Findings: case study
Mr Connor
We begin the presentation of the study findings with a detailed account of a single case study. This is
intended to convey something of the lived experience of patients and family caregivers confronting
the challenges of terminal illness, the work involved in managing medicines and how this work is an
integral component of a wider regimen of care involving visits to clinics and hospitals, communication
with HCPs and maintaining records, alongside managing the demands and aspirations of ongoing daily
life. None of the case studies included in the study can be considered ‘typical’. However, we have
selected Mr Connor’s case to illustrate an experience that was neither particularly good nor particularly
bad, and about which we have information extending from the start of his participation in the study to
his subsequent death several months later.
Mr Connor and his wife participated in the study over a period of 3 months. They took part in two
interviews and guided the researcher to draw an ecogram illustrating the support that they had in place
in terms of managing medicines. The data for this case study also included photographs of Mr Connor’s
dosette box, his medicines’ storage and the syringes used to give him his weekly injections, plus a list of
his medicines. Seven months after the second research interview, Mr Connor died at home and his GP
records were reviewed 3 weeks later.
Mr Connor was in his late 70s and had been retired for about 15 years. He had end-stage kidney
disease, having suffered with renal problems for about 20 years. Several years previously, Mr Connor had
experienced a stroke, which had left him with no feeling in his dominant hand and a tremor in the other,
and this had an impact on many of his daily activities and meant that he was unable to write. He also had
type 2 diabetes and diverticulitis. He lived with his wife, who was his carer, particularly in relation to his
medicines. Mrs Connor also had health issues. She had a heart condition and blocked arteries, which caused
a problem with one of her legs. This meant that she could not walk very far and found driving difficult.
Health
Mr Connor’s main health problem was end-stage kidney disease. He had known for about 20 years that
he had kidney problems and thought that his kidney function was ‘49%’. Although this was a serious
matter, he was not too troubled about it because as he said ‘people live with one kidney, 49% is OK’.
As far as Mr Connor was aware, his level of kidney function had not altered in about 10 years. During
a period when Mr Connor’s diverticulitis was causing him a great deal of pain, his GP referred him to a
consultant, who would have liked Mr Connor to undergo a computerised tomography (CT) scan. However:
. . . and well he said, ‘Can’t do a CT scan because it will kill you’. And we sort of sat there and went, he
[Mr Connor] said . . . ‘Well how do you mean it will kill me?’. And he [consultant] said, ‘Well, you’re stage
four kidney failure!’ . . . So I said to him, ‘I’m sorry but I don’t understand stage four kidney failure, what’s
that?’. So, he said, ‘Well, stage five you’re on dialysis’.
Mrs Connor
About 1 year before taking part in the study, Mr and Mrs Connor learned that his kidney function was
down to 18%, which came as a great shock to them both as did the fact that ‘nobody bothered to tell
me’ (Mr Connor).
Mr Connor was referred to the renal team, which meant outpatient appointments with the consultant
and occasional meetings with a CNS. His kidney function continued to decrease and he kept an eye on
its progression. Dialysis was suggested as a treatment option, but Mr Connor decided against this with
the agreement of his wife.
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Mr Connor understood that his condition was terminal:
I said, ‘How long am I going to last now?’. And because my results have fallen and he says, ‘Well, I don’t expect
to see you this time next year’. And that’s the only thing that come out of it, wasn’t it? . . . Well, I’ve come to
terms with it. The only thing is it’s like living with a time bomb, you don’t know when it’s going to go off.
Mr Connor
At the time that Mr Connor took part in the research he was experiencing a number of symptoms,
including fatigue and itching. He was advised by his renal consultant that the fatigue would increase
and he would gradually sleep more until eventually he would not wake up.
Medicines
Mr Connor was taking a range of medicines, although the medication for his type 2 diabetes had been
stopped. He had lost weight because of his kidney problems, Mrs Connor thought, and his blood sugar
levels were well maintained and so it seemed he no longer needed the medication, although he did
continue to monitor his levels. He had an inhaler for asthma, medicines to help manage the tremor
resulting from his stroke plus medication to reduce the risk of a future stroke.
Managing medicines day to day
When Mr Connor came out of hospital after his stroke, he brought his discharge medicines home with
him in a dosette box. This seemed like a good idea:
[When] he came out of hospital, they gave him his medication in a dosette box. Prior to him going in,
I’d noticed that he was suddenly ordering a lot of one thing or not enough of something else, so it was a
bit erratic. So, I thought if I asked them at the local chemist if they could do the same thing, the dosette
boxes, it would solve the problem of me having to give him medication because he wasn’t well, and it
would also solve the problem of having to order things at a particular time because it all just came
together. So, we approached the chemist and they agreed to do that . . . So, we’ve been having dosette
boxes ever since. So, the only things that he needs to order are things like for his asthma, you know,
inhalers and things that they can’t actually put in the dosette box.
Mrs Connor
This worked well. The pharmacy ensured that they had the necessary prescription from the general
practice, dispensed the medicines and placed them in the dosette box (Figure 7). The pharmacy then
delivered 4 weeks’ worth of medicines to the couple’s home.
FIGURE 7 Mr Conner’s dosette box. Reproduced with permission from Eleanor Wilson (University of Nottingham, 2021,
personal communication).
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It is easy to see from looking at the box which medicines have or have not been taken:
They send you a month’s supply and you know you’ve got a month’s supply of all the drugs that you need really.
Mrs Connor
However, there were drawbacks. Although the boxes came with a list of medicines that were included,
the couple did not always know which one was which. When his blood pressure medication was
changed, Mr Connor said ‘I had to take it [dosette box] into the pharmacy one day to find out . . .
what they were’. It could also be problematic if a change was made to the medication part way through
the 4-week period. For example, on one occasion, Mr Connor’s prescription for alfacalcidol was
doubled. Sorting this out and accessing the extra medicine necessitated Mrs Connor to make four or
five trips to the pharmacy. Mr Connor requested other medicines, such as his asthma medication and
creams, from the general practice online.
Mr Connor’s medicines were mainly stored in the kitchen cupboard, with his erythropoietin and
asthma medication kept in the fridge. The dosette box in use was kept in the kitchen, with the stock of
boxes stored upstairs in the bathroom cabinet. When it was time for Mr Connor to take his medicines,
his wife would put them in a small cup to make it easier for him. She had taken on this task when
Mr Connor started to drop some of his pills on the floor but did not notice.
Injections
Given that he was anaemic, Mr Connor was given ‘. . . an infusion of red blood cells – which did a fair job’
(Mr Connor), and this was followed up with weekly injections of erythropoietin, which was intended to
increase the production of haemoglobin in his body. They were shown a DVD (digital versatile disc) about
the process and Mrs Connor was given the job of doing the injections (Figure 8). A DN came to the house
to demonstrate how to do it. Mrs Connor said ‘No I’m not really squeamish. I’m not thrilled about having
to inject him, but it’s fine’. She described the process:
The syringes are such that you stick the needle into the flesh, and it releases the contents of the syringe
and then it just disappears up itself, so there’s no messing about with syringes. It comes fully loaded . . .
Mrs Connor
Support
Although there were a number of HCPs involved in the care and support of Mr Connor as well as his
adult children and grandchildren, Mr and Mrs Connor were committed to remaining independent and,
as far as possible, self-sufficient, and said that they supported themselves:
We support ourselves. We don’t have any support do we?
Mr Connor
No, we don’t really need any, do we? If we really need something we’ll ask, but we don’t ask very often, do we?
Mrs Connor
FIGURE 8 Injectable medication. Reproduced with permission from Eleanor Wilson (personal communication).
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Mr and Mrs Connor took part in joint research interviews. Although Mr Connor was the person with
the terminal illness and the one whose medicines were the focus of the interviews, they both spoke in
an inclusive way. This is demonstrated by their use of the first-person plural, talking about how ‘we’ are
supported or visited by ‘our’ kidney nurse, highlighting the relational nature of managing medicines and
the practice of care in a domestic setting.
Professional support
A number of different HCPs worked with Mr Connor at different times. His GP was regularly involved
and occasionally made home visits, particularly towards the end of Mr Connor’s life. DNs tended to
visit when there was a specific task for them to carry out, such as demonstrating how to give the
weekly injections. The local pharmacy dispensed and delivered the prescriptions.
Mr Connor was also under the care of the renal team, with outpatient appointments every couple of
months. The couple was unsure how useful these appointments were:
All we’ve heard from the hospital appointments are things like, you’ve got to decide whether you’re going
to have dialysis or whether you’re just going to manage your condition as best you can . . . and really
every appointment has been, you’ve got to make a decision as to how you’re going to die really, and it’s
not been very pleasant to go to the hospital, to say the least, and sometimes you’ve come away a bit
shell-shocked from it and sometimes a bit resigned to it.
Mrs Connor
Mr Connor had a renal CNS allocated to him and his wife said that if they encountered any kidney-
related problems they would get in touch with her:
Yes she would be the first port of call, because she is our designated kidney nurse.
Mrs Connor
During a home visit, the renal CNS began to write a care plan, laying out Mr Connor’s wishes for his
future care. She asked if he had completed a DNACPR order and said that she would check with his
GP. She did so and later:
He [GP] came back really to make sure that that’s what [Mr Connor] wanted and the nicest thing that
anybody’s said to us in a year, he sat where you’re sat now and he said, ‘Of course, it’s not going to
happen any time soon’.
Mrs Connor
The DNACPR identified Mr Connor’s preferred place of death as a hospice. There were reasons for this:
But the issue of not wanting to die here was more it’s a very small house, we’ve got no room in the
bedrooms really . . . So, if he needs equipment, like if he’s very weak and he can’t get in and out of bed
and has to be hoisted and things, we haven’t got room for those sorts of things.
Mrs Connor
The couple anticipated further difficulties that might arise if people they knew wished to visit Mr Connor
when there was not room in the house for people to sit round the bed. In addition, Mrs Connor felt that
she would be unable to cope with an influx of visitors in the house at this time. In addition:
You see, what worries me is if one morning she [my wife] gets up and goes down, makes a cup of tea and
comes back with the cup of tea and I’ve been dead for about 4 hours.
Mr Connor
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Mr Connor had been referred to a counsellor. He stopped attending after three sessions because,
as Mrs Connor explained, he felt that they were not helping him. She, herself, felt that they could
have been beneficial, but that the sessions were misdirected:
I felt that she could have helped him more. I don’t really know. She’d got him saying, ‘Oh, I want to do
this and I want to do that, and I’d like to go here and I’d like to go there, and I just sit at home and I
don’t do anything’. Well, none of these things are practicalities and yet she was trying to tell him that,
‘Yes, you can do this!’, and actually he can, provided he can get somebody to take him or go with him,
because I can’t walk round these places and do these things.
Mrs Connor
This raised another concern for Mrs Connor: that there were certain aspects of caring for her husband
that she was not physically able to undertake.
Work of being a carer
Mr Connor handed responsibility over to his wife for his medication, except for his inhaler, which he kept
in his pocket ready for use. Mrs Connor felt the responsibility involved in looking after her husband and
ensuring that he took his medicines. She had her own health issues, including heart disease. She had been
offered surgery to clear blocked arteries, which should improve her quality of life. However, she said:
. . . well I can’t take the risk, because who knows what’s going to happen and I can’t go and have another
cardiac arrest, can I, at the moment?
Mrs Connor
Mrs Connor was concerned about who would look after her husband should she become unable to do so:
[My wife] does a fantastic job looking after me. I wouldn’t want anyone else to do it, but it’s not that fair
on her really.
Mr Connor
Although the couple had stated that they supported each other and needed little support from others,
Mrs Connor did acknowledge that they sometimes felt isolated and unsure who they might turn to
in case of a query or an emergency, saying ‘we feel a bit left alone here, who do we go to? The GP?’.
Mrs Connor was told by a friend about the single point of access (SPA) service that was designed
to co-ordinate referrals and to provide one telephone number that patients and their families could
ring when in need of assistance. She took the initiative and contacted their GP to ask about this and a
referral was made to the SPA service. Thereafter, Mr and Mrs Connor had a single telephone number
to call if they needed help. From this (late) point onwards, Mrs Connor felt that she had access to a
‘very valuable’ service.
Last week of life: from the review of Mr Connor’s medical records
Six months before Mr Connor took part in the first research interview, and 15 months before he died,
Mr Connor’s GP placed him on the practice’s Gold Standards Framework (GSF) register. He was then
classified as green, that is with unstable/advanced disease and a likely prognosis of months. Twelve
months later, Mr Connor was reclassified as yellow, with his condition deteriorating and a prognosis
assessed at weeks.
During the month before Mr Connor died, he became increasingly unwell, with several GP home visits and
a hospital admission with a suspected gastrointestinal bleed. The GP noted that Mr Connor was probably
entering the terminal phase. The original DNACPR had been lost and so a new one was completed, with
this one noting Mr Connor’s preferred place of death to be home. The next day the GP stopped most of
Mr Connor’s medicines and prescribed morphine (Oramorph®, Boehringer Ingelheim Ltd). The palliative
care nurse (PCN) visited and carried out an assessment. A DN arranged for the delivery of a hospital bed
and a referral to Marie Curie (London, UK) for sitters for three nights per week over the following 4 weeks.
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This was to allow Mrs Connor to have some nights of good sleep. Mr Connor also had carers twice per
week to help with his personal care. He was not keen on this, but agreed to it to help his wife. The DN
noted that end-of-life medicines (i.e. AMs) were in place and signed for. A few days before he died, the DN
delivered a syringe driver and set it up with morphine, midazolam, levomepromazine and glycopyrronium.
A PCN visited later in the morning, showing Mrs Connor how to carry out mouth care and noting that the
couple both realised that Mr Connor was dying.
Two days later, Mr Connor was visited by a DN, an OOH doctor and a PCN. Marie Curie Care rang
to say that they would be sending a sitter for that night. When two DNs visited the next morning,
Mrs Connor told them that her husband had died. They recorded that this had happened shortly before
their arrival. They stopped the syringe driver and took it away with them. Mrs Connor said that she
wished to be left alone to wait for her son to arrive. The GP called and confirmed death 1 hour later.
Conclusion
Managing medicines was one aspect of dealing with life in the face of terminal illness for Mr and Mrs
Connor. Their approach was relational, in that the decisions that they made took into account the
perceived impact on each other. One of Mr Connor’s reasons for wishing to die in a hospice, for
example, was that he was concerned about the effect on his wife of finding him dead in bed. Mrs
Connor felt the responsibility involved in helping her husband to manage his medicines, alongside the
other tasks she carried out in her role as carer, such as accessing help when needed and supporting
her husband in his interactions with HCPs. In addition to monitoring and arranging access and supply,
this case illustrates the extent to which managing medicines was a joint endeavour and also how the
responsibilities of providing care could have a negative impact on the FCG’s well-being and health.
Although clearly committed to supporting her husband, Mrs Connor acknowledged the responsibility
and effort involved, as well as the need to prioritise his health-care needs over her own. She was also
concerned about his dependence on her in relation to the restrictions imposed by her own poor health
and limited mobility. The couple saw themselves as self-contained and neither needing nor wanting
support from others. This was portrayed in their ecogram, which was unusual in excluding family
members or friends and included HCPs in terms of their roles rather than as individuals. It appears that,
despite quite extensive involvement with different HCPs and services, neither partner had established
a relationship with an individual HCP who could be identified as a key worker to be a first point of
contact if they needed help and assist in co-ordinating care. Despite their stance of independence and
self-sufficiency, both partners were aware of Mr Connor’s limited prognosis and inevitable decline. They
expressed uncertainty about how they would manage this. Mrs Connor was pleased to have found out
about the SPA service during a meeting with a friend (who is not included in their ecogram). Although
there is no record of them having used this service, knowledge that they could access a dedicated
helpline 24 hours per day was very reassuring.
The medical records review indicates that Mr Connor’s care during the last days of his life was well
organised and that the system responded well in co-ordinating care, although, at this point, we have
no knowledge of the couple’s experience and assessment. The GP recognised Mr Connor’s approaching
death and ensured support from DNs and PCNs. A few days before he died, a new DNACPR was
put in place, as it appeared the original one had been misplaced. It was not possible to tell from the
medical notes if Mr and Mrs Connor had changed their minds about preferred place of death, which
had previously been hospice, or if home was assumed to be his inevitable place of death given that
there had been no hospice referral. However, Mr Connor achieved his wish of not dying in the night
while his wife slept beside him.
The Connors’ experiences prefigure issues explored in the following findings chapters, which cover the
themes of the work of medicines management, diversity and disadvantage, and systems and complexity.
FINDINGS: CASE STUDY
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Chapter 6 Findings: the work of medicines
management
When someone is seriously ill and dying at home, the burdens of care can be considerable forpatients and their FCGs. In this study, issues such as washing, dressing, moving the patient,
toileting, cooking, laundry, cleaning, prompting eating and medicine-taking, being ‘on call’, providing
emotional support, liaising with HCPs, attending appointments and encouraging social interaction
were just some of the activities that were undertaken alongside the diverse tasks involved in medicines
management. These tasks intensify this workload and further deplete the already limited physical
and emotional resources of many patients and their FCGs, who may themselves be old and in poor
health, or juggling complex obligations of care, family and work. A few HCPs acknowledged the
difficulties that the debilitating effects of illness combined with the complexity of medicines management
routines could pose, and the adverse consequences, intentional or otherwise, for patient compliance:
It was a bit of an ongoing issue of trying to convince him to take the medicines that were appropriate and
necessary, at the same time as him wanting to not be on them at all . . . So, he was weak, weary, tired,
had no appetite and then on top of that, I was trying to get him to take a concoction of medication.
SPCN, HCP15
As patients’ health deteriorates, FCGs increasingly bear the brunt of this wider workload, taking on the
substantial practical, physical, emotional and knowledge-based aspects of managing medications. All but
three of the patient cases in our study lived with a FCG who supported their care and medicine needs
(see Box 2 for a focus on some of the issues for patients). BFCGs had experienced the entire trajectory
of care preceding their relative’s death and were able to reflect on their experiences throughout. For
FCGs, the work of managing medicines occurred in the context of increasing exhaustion, poor health,
emotional distress and sometimes the experience of inadequate support and social isolation:
Everything I have to do, and I have to be here, and have to make sure that he’s safe if I go out and make
sure he eats, because he doesn’t want to eat half the time these days and, so it’s all onerous, being a
carer is onerous. But it’s no good thinking like that or you’ll just go under. So, I just try and just deal
with what needs doing on a day to day basis and . . . you know, I just get on with it, really, no choice.
Mrs Crump, FCG, Int1
BOX 2 Patient focus: Mrs Crane
Mrs Crane was a 69-year-old woman living alone. She had a diagnosis of heart failure, but also suffered
with advanced arthritis in her knees, asthma, considerable sleep apnoea and depression (for further details
see Appendix 1, Case summary: Mrs Crane).
Mrs Crane managed her own medications (Figure 9), with prompting from her friend in the evening when
she was tired. Her medications were delivered in blister packs from the pharmacist (each cell containing
12 tablets), with a further five additional medications and an inhaler. Mrs Crane appeared to be very well
organised and reported knowing what each of the medications were for, if not their names:
The dosette box are made up with the regular tablets. If there’s a new tablet they bring it in either a small box
or similar. There’s some of the medication that don’t go in the dosette boxes because it can vary the amount
I take . . . I’ve got a routine, between eight and nine I take my first lot. Dinnertime I take one or two. I’ve got
my inhalers as well. You just get yourself in a routine.
Int1
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FIGURE 9 Patient focus: Mrs Crane. Reproduced with permission from Glenys Caswell (University of Nottingham,
2021, personal communication).
Mrs Crane reported finding the blister packs from the pharmacy to be helpful and was reassured to know
that these were organised and consistently delivered to her as she needed them. This had taken a lot of the
work out of managing her medications and supported her by keeping her organised when her depression
clouded her thinking:
They deliver them. It’s done automatically every month . . . last time I was at [the hospice] they changed one
of the medications. They get in touch with the doctor, the doctor gets in touch with the chemist and they’re
delivered . . . main thing, there is times when I get depressed that I can’t remember whether I took my tablets
or not. So, then I know looking in my boxes whether I’ve took them or not.
Int1
However, Mrs Crane reported frustration at finding changes in the size, shape or colour of her medications
that she had not been informed about and suggested that this was because of pressure to cut costs. These
changes created additional work to investigate and clarify these issues:
It’s confusing because you could have the same tablet but under a different name. A cheaper version. I mean
that’s another problem they don’t inform you. You’re ringing back, I’ve not got so and so. Oh, you have, it’s
under another name. Well please let me know!
Int1
. . . last time I sent my carer all the way back to say you sent the wrong tablets . . . So she took the tablets
back up there and they said, ‘Oh no, it’s just another name for them . . . They’re different colours’. That’s how
I knew it. . . . That’s what worries me, things like that.
Int2
Mrs Crane recognised that she was starting to struggle and was putting plans in place for additional help
and support at home (by the time of her records review the HCW was attending daily):
I don’t feel so confident as I used to . . . That’s why I’m asking for extra care . . . if I have a really bad day you
don’t always focus.
Int1
Mrs Crane’s hospice notes indicated that she had, on at least two occasions, asked her family to remove
medications from her house for her own safety. In relation to her medications, Mrs Crane’s ecogram depicts
a small network of support, including her friend, occasionally her daughters, her HCW and the hospice.
Latterly, the long-term conditions team had been added. GP records documented two instances when
Mrs Crane had telephoned the SPA line with medication queries. Her call had been referred to, returned
and advice given by the long-term conditions team.
BOX 2 Patient focus: Mrs Crane (continued)
FINDINGS: THE WORK OF MEDICINES MANAGEMENT
NIHR Journals Library www.journalslibrary.nihr.ac.uk
40
Regimens can be complex, with patients prescribed multiple medications to be administered through
different routes and at different times throughout the day and night. Some medicines need to be taken
at a specified period before or after meals. Others should be taken with food. Many also had
medications to be taken ‘as needed’ or pro re nata (p.r.n.):
Eventually, we ended up on a buprenorphine sublingual. Which he had as a p.r.n. He had paracetamol as
a regular, trying to think of the one he had at night, gabapentin, he used to have gabapentin at night
which used to help him through the night. And then, there were his renal medications, I can’t remember
them all now, but one of them was a calcium, which he hated. And then he was on supplement drinks,
went from Fortijuce to Fortisip, back to Fortijuce, but coming up to the last 4 to 5 weeks, before his
death, we were struggling to get medications down him, he wouldn’t swallow them, so we did end up
changing to syrup form, and the syrup form we was having to syringe. He wouldn’t take it off the spoon.
But he’d suck on the syringe. Some of his medications weren’t available in syrups. So, them medications
were then omitted from his treatment plan. But he did have the subcut hyoscine bromide, because he had
chest infection after chest infection after chest infection. He’d got a lot of secretions, unable to cough
because he hadn’t got the strength, so I was delivering the subcut hyoscine until 5 days before he passed




Patients and FCGs engaged in many aspects of practical medicines work, such as reordering, collecting
and checking medications (Box 3), keeping track of their use and organising their storage (Figures 10–12).
Given that there is little guidance or information on how best to manage medications in the home,
patients and family caregivers often worked out their own ways to organise and store medications.
Many described keeping these in different locations in the house to access them as needed. For
example, most might be stored in a kitchen cupboard, with night-time medications kept by the bed and
those needed throughout the day on a table by a lounge chair.
BOX 3 Medication focus: Mrs Crawford
Mrs Crawford (FCG) explained not only the practical issues with monitoring, reordering and collection of
medications, but also the sheer effort it takes to keep track of them all, in this case 10 (Table 6):
I find this quite onerous, to be honest, because I put them into daily . . . boxes, that you buy yourself. But, of
course, because we’ve had such varying amounts and different drugs, nothing finishes at the same time. So,
you’ve got to keep a constant tally of what you’ve got, so I tried to make up two boxes, so I’ve got a week in
advance, and I know how short I’m going to be of medication. Then I have to make sure, see how many I have
left over, because, by the time I’ve got a prescription down to the surgery, it takes them 2 days to actually get
a doctor to write the prescription. Now we have this wretched system that’s been introduced, whereby it’s
sent online, but some things aren’t sent online. If they’re controlled [drugs], you have to then go and get your
prescription, so you don’t know what’s going to be sent to this pharmacy online and what’s you have to go
and collect. So that can be a week, so you’ve got to think to yourself, it might be a week before I can get more
medication, so you have to always be thinking, ‘What do I, what am I going to need?’. And I’ve got to get,
obviously, I have to make sure that I have sufficient tablets, so, it’s not particularly a system. It’s just, I make
them up weeks in advance so I know where I am with it.
Mrs Crawford, FCG, Int1
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TABLE 6 Mrs Crawford’s medications
Drug Prescription
Hyoscine patch Change every 72 hours
Liquid morphine As needed
Lorazepam Up to every 2 hours (maximum four tablets over 24 hours)
Mirtazapine Orodispersible at night
Beclomethasone Nasal spray
Rivaroxaban Once per day
Ipratropium bromide Inhaler
Propranolol Once per day
Amantadine Once per day
Clonazepam At night
FIGURE 10 Storage: kitchen cupboard. Reproduced with permission from Eleanor Wilson (personal communication).
FIGURE 11 Storage: portable box. Reproduced with permission from Glenys Caswell (personal communication).
BOX 3 Medication focus: Mrs Crawford (continued)
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Some patients reported a dislike of having their medication visible and cited a lack of storage options
as problematic. This was particularly an issue for larger items, such as boxes of continence pads,
convenes, fortifying drinks, oxygen cylinders and PEG feeds. Medications could also add to already
overcrowded living quarters when a hospital bed, hoist, specific chair or lift might be in situ in the
home. Examples can been seen in Figures 13–17.
FIGURE 12 Storage: easy daytime access. Reproduced with permission from Eleanor Wilson (personal communication).
FIGURE 14 Specialist bed in the living room. Reproduced with permission from Eleanor Wilson (personal communication).
FIGURE 13 Space limitations. Reproduced with permission from Glenys Caswell (personal communication).
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We had boxes of stuff and we had all the boxes and bags that the carers were using, all upstairs in the
bedroom. Couldn’t get in the bedroom and then I had a wheelie commode up there in the bedroom.
We had this all singing all dancing bed.
Mrs Bruce
When you’re in a drugs regime, it ties you down almost as much as this [oxygen] machine. I always
have to eat first thing in the morning if I want to or not, simply because I’m taking the rivaroxaban . . .
So it gets complicated. You have to think about it all the time.
Mr Campbell, Int1
Some participants kept detailed records of the dose and time that each medicine was taken every day.
A few had been encouraged to undertake this by HCPs, but the majority who had undertaken some
form of written log did so of their own accord (Box 4).
FIGURE 15 Multiple sizes and types of medications. Reproduced with permission from Eleanor Wilson (personal
communication).
FIGURE 16 Storage alongside other household items. Reproduced with permission from Eleanor Wilson (personal
communication).
FIGURE 17 Bulky items, such as oxygen machines. Reproduced with permission from Eleanor Wilson (personal
communication).
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BOX 4 Management focus: Mrs Blakemore
The sheet below was devised by Mrs Blakemore (Figure 18). It shows eight different medications, along
with supportive supplements, such as folic acid and calcium carbonate (Adcal, Kyowa Kirin Ltd), and
monitoring of bowel movements. The chart shows that these elements could be tracked up to six times
per day and included a log of the dosage given for pain medications.
Interviewer: So, when he was sort of taking this quite extensive list of medications, how was that, did he
manage that himself or were you?
Mrs Blakemore: No. No. I did it.
Interviewer: OK. So how did you sort of work out what he needed when and all of those kind of things?
Mrs Blakemore: Oh, I drew up a drugs chart.
Interviewer: OK, so you would tick these off when they were given?
Mrs Blakemore: Yes, yeah, yeah. Filled them in at the time, whatever time it was. Like paracetamol, it had to
be 4-hourly so, I would write in the time and . . . I did that sort of thing for whatever I was doing, because you
can’t remember, you can’t remember, and I didn’t want to be writing out a list every day. So I thought, Well,
that’s the easiest way to manage it . . . I’m very pragmatic.
FIGURE 18 Mrs Blakemore’s chart. BO, bowel movement. Reproduced with permission from Eleanor Wilson
(personal communication).
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Interviewer: Did somebody at the hospice sit down with you and go through what it all was and what it
was for?
Mr Cramer: No . . . No. Because it’s, because I started to ask about it, and she said, ‘Everything is down
on paper. Everything you need to know, what time of day, what dosage, and what it’s for’. So, I was quite
happy with that. Because, if she was to tell me, verbally, I’d more than likely forget half of it, but it’s all
written down, so I just have to look, it’s not a problem.
Mr Cramer, FCG, Int1
Monitoring medicine-taking and keeping track of stocks became more challenging for FCGs when they
did not live with the patient, as in the case of adult children who were supporting a parent. In some
cases, participants reported that it was a medication incident that compelled them to become more
involved in supporting medicines management for their relative. Most of these caregivers used dosette
boxes to manage medications and undertook the task of filling these each week and subsequently
monitoring their use (Figure 19 shows an example of a dosette box).
Mum would usually look after her own medication. Initially she would deal with it by herself. But there
came a point in time when there was so much medication she was taking clearly she was getting
confused . . . And from that point on, I bought mum a pillbox and then we’d sort out her medication . . .
And then I took over and started doing it so I knew what was what.
Mr Bhuta
Physical work
Medicines management sits within the wider physical work of care, including cleaning, food preparation,
laundry, attending clinical consultations, supporting someone to wash and dress, and supporting
someone with moving and handling tasks, such as getting upstairs or in and out of the car. Dropping
tablets, shaking and being unable to pick up small pills were reported to be problematic. Mrs Bruce, an
80-year-old BFCG, described some of the challenges that she faced when supporting her husband’s
mobility as his Parkinson’s disease progressed:
He’d dropped a tablet . . . he tried to get it himself, and he fell off the chair. Fortunately, he fell that way,
so I was able to get my arms underneath his. Although he was thin, he was heavy, and I managed to lift
him on to this chair . . . And that was difficult to move him, especially when he wanted to go to the loo . . .
because eventually we did have commodes, but at first we didn’t, [I] managed to get him upstairs . . .
I used to lift his feet, like that, on one stair, then the other. And then push him up with my head.
Mrs Bruce
FIGURE 19 Self-fill dosette box. Reproduced with permission from Eleanor Wilson (personal communication).
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Medicines can add to this workload when there are additional visits to collect prescriptions. This may
involve travelling considerable distances or visiting different pharmacies on multiple occasions when
specific items are not available or kept in stock:
So, I had to go to the doctor’s first, get the charts changed by them. And then, go into the chemist
with the new prescription. And as soon as you went into the chemist for a new prescription, they’d go,
‘Well, we haven’t got that much morphine in, you’ll have to come back tomorrow’, or, ‘We’ll get it in for
you later this afternoon’.
Mr Berger
Emotional work
The emotional work of medicines management can involve prompting, providing reassurance in terms
of supporting reasons for medicines-taking and being vigilant about when medication is required and
the potential side effects. Box 5 provides a FCG focus. This is embedded in the emotional work of
managing loss, personality changes and the patient’s reduced abilities and capacity. In addition, there is
a strong sense of responsibility and anxiety about administering medications correctly and not causing
harm. Family caregivers reported finding medicines work stressful and, at times, frightening:
It was hard and stressful. It was like the enoxaparin, he was on 7 mls but the things are 8 mls, that
you get, so I think, ‘Hang on a minute, he’s on 0.7. This says 0.8’. So, it’s Monday morning, I’m thinking,
‘What do I do here?’ . . . I’ve got squirt a bit out, obviously. I don’t know how much to squirt out, and that
was quite traumatic for me, that day. I’m thinking, ‘Is it dangerous?’ ‘Could I be giving him too much or
too little?’ ‘Is he going to collapse now because I’ve given him 0.7 and a bit, rather than nought point?’.
Mrs Baker
Managing someone else’s medications was felt as a considerable responsibility, and FCGs were keen to
do it to the best of their abilities. They were often also advocates for the patient and needed to draw
on emotional resources to be assertive, insistent and sometimes prepared to argue with HCPs to make
sure that the patient received the medications needed:
So, then we went to the hospital pharmacy to pick it up, and they didn’t stock it. So, we had a prescription
but no supply. So, at that point I then rang the GP pharmacy . . . I remember having to be extraordinarily
assertive to say ‘No you can do this, you must do this, she is in pain, you can’t leave a cancer patient who’s
on regular painkillers in pain’ . . . And it sounds simple, a very low dose of co-codamol . . . she could have
spent the whole weekend in pain without painkillers.
Mrs Best
In taking on such considerable responsibilities, FCGs are also open to the emotional consequences of
making a mistake that could have an impact on their loved one’s health as well as the emotional work
involved in having to persuade the patient to take their medication when they were reluctant to do so.
In some instances, patients felt that the medication was not helping them in any way, whereas others
did not like the taste or struggled to swallow the drug. In other cases, their illness caused confusion
and resistant behaviour. This role as a persuader could be an added emotional burden, jarring with
the FCGs’ perceptions of caring, and could cause conflict in relationships in the family:
It is her father who gets the meds out of the pack and adds any additional items . . . and encourages his
wife to take them. [Mrs Creasy] has told him that is all he can do – if her mother will not take the tablets
he can’t make her . . . [she] describes the relationship between her parents as increasingly strained –
sometimes they don’t speak for weeks. She feels very bad about the firm stand she tries to take with
her mother – but says that she has to support her father [as he is] the main carer for her mother.
Mrs Creasy, FCG, interview notes
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BOX 5 Carer focus: Mrs Baker
Mrs Baker’s partner was diagnosed with a very rare form of soft tissue sarcoma. He was told that his
condition was palliative from diagnosis. The couple were given very little information, and the rarity of
Mr Baker’s cancer made it difficult to find any information for themselves. Mr Baker had started with
paracetamol to relieve the pain in his leg, but was reluctant to take it or anything stronger, leaving
Mrs Baker to take on the emotional work of prompting him to take his medication:
It was hard to get [him] to take them because from a man who never took anything . . . so I, it was my [job] –
I prompted him throughout the day . . . I kind of turned into a bit of a carer quite quickly.
About 9 months after his diagnosis, Mr Baker’s pain had increased and the introduction of a SPCN resulted
in a significant change in his medication regimen; he was prescribed a number of different pain medications.
Mrs Baker expressed concern and fear in managing these new medications and conveyed the strain that this
placed on her to acquire knowledge about administering these medications:
I was terrified because I’d never done anything like this before, I was terrified of overdosing [him], because
I knew nothing about nothing . . . I read all the bottles and I was very sort of, as good as I could be so there
was not much explaining, at that point . . . you’re not instructed how to give it and everything. It’s just, you get
it and you look at the leaflet and the instructions on the box and hope that’s how it goes.
Mr Baker continued to struggle with pain and underwent a course of palliative radiotherapy. He was also
prescribed steroids for the swelling in his leg, which caused severe side effects. Mrs Baker reported his
behaviour becoming extremely out of character. He barely slept, became disagreeable and argumentative,
and expressed strange ideas. After a number of telephone calls and requests for help, the consultant from
the hospital instructed Mrs Baker to take him off the steroids. From this time onwards, Mrs Baker felt that
she had to constantly battle with HCPs to make sure he was not prescribed steroids again. This meant that
she had to undertake administration and information work, alongside the emotionally taxing work of having
to liaise, inform and, potentially, dispute with multiple HCPs:
And every time he was admitted to the hospital . . . at 12 at night, 2 in the morning, or whatever . . . I had to
be with him, ‘What, what medication are you on?’. Because I always had a sheet in my bag or, because I knew
what they had on the computer wasn’t what [he] was on at that point. It was always different. And every
time, ‘We’re going to put him on steroids’. ‘No. No, please don’t put him on steroids’ . . . [the adverse reaction
was noted in his notes] . . . but they always prescribed them, and they just seemed to ignore it . . . I had
to hammer that point home. To every doctor . . . So, every time I’d go through this with everybody – every
doctor, nurse . . .
As his illness progressed, her husband’s medication needs became more complex and Mrs Baker expressed
feeling quite isolated, not only managing his care by herself but not knowing who to contact for support
when needed. This lack of knowledge is expressed as stressful and emotionally draining:
I did feel very, I did feel a bit lonely and concerned . . . and I did all of [his] care myself, and it was just me,
I did everything . . . I’d got all his medications, and his needs are very complex at this time . . . He got a sore on
his anklebone, and that’s when they [DNs] started coming every couple of days . . . which I found reassuring.
Just somebody coming round. Because I was a bit paranoid: ‘Am I looking after him properly, am I giving his
meds?’. You really are, the responsibility is enormous.
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Knowledge and emotional work were closely linked because it was often lack of knowledge and/or
limited access to information that caused concern, distress and fear.
Knowledge work
Knowledge work must be undertaken to establish information and understanding about what each
medication is for, when and how much to take, and what kind of adverse effects to be aware of.
Patients and FCGs also needed to have knowledge about identifying who to call for assistance
and in what circumstances:
But it was also the knowing what your maximums were . . . knowing I wasn’t going to poison him, because
it’s at what level am I going to kill him basically? That was the scary part. You know, when am I physically
overdosing him?
Mrs Bailey
Control and knowledge of medicines management varied across the case and BFCG data. Sometimes
the patient retained full or partial control of their medications while delegating some tasks. Other
cases involved a collaborative effort, and in others FCGs assumed all responsibility. The complexity of
some regimens required FCGs to learn new skills, such as giving injections (e.g. Mrs Connor) or dialysis
(e.g. Mrs Brown). FCGs needed to have a good working knowledge of what each medication was for
and when to give it. Even when efforts had been made to simplify this through pharmacy-prepared
blister packs or dosette boxes, as patients deteriorated these systems were often no longer suitable.
Mrs Crump describes how she deals with two sets of blister packs and three additional medications,
one of which was to be given three times per week and another given at different times:
We have blister packs from [pharmacy] for the medication provided by the GP. And then I have another
blister pack which is delivered for medications provided by the renal clinic. And there is also a particular
medication . . . I have to incorporate that into the rest . . . And then, they’ve just added another separate
one . . . he has that three times a week, and I have to pop that into the mix. And he also has warfarin
which again, because it’s variable, I just have them in the packets, and I have to put them into the packs.
Mrs Crump, FCG, Int1
Although pharmacy-prepared blister packs were reportedly beneficial for some patients and FCGs,
others found that the pace of change could quickly make them redundant.
Most patients and families reported being given at least some information about their medications.
However, even when this was reinforced and checked, verbal information alone was considered to be
insufficient. Mr Butcher had recently cared for both his mother with Alzheimer’s disease and his wife
who had died of cancer. He explained that he was given information and why he was unable to process it:
Yes, it was processing it. And, the problem is that, when you’re dealing with your stress, you are really
running on adrenalin constantly. So, you’re not thinking completely clearly. You’re adrenalin based, and your
stress levels are high, and your sleep hours are low. Because you’re constantly, when you’re sleeping, you’re
waiting for her to shout or be sick or something like that, so you are at the absolute top point of your stress
levels. So yes, you’re given the information, but, sometimes, I had to think, ‘Now, what did she say?’.
Mr Butcher
Despite often feeling that they did not understand the complexities of many medications, some FCGs
displayed detailed knowledge of the medications and kept excellent track of what had been given and
when, so that HCPs could work from this information. Some patients were not able or willing to take
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an active role in managing medicines. Others remained involved in decision-making, at least for as long
as they could, requesting certain drugs and deciding what to taken, as in Mr Butcher’s account of close
collaborative working between himself, his wife and different HCPs providing care (Box 6). Another
key element of Mr Butcher’s narrative is an insightful recognition of the difference between pain and
agitation. He also describes the types of support that he and his wife received and the ways in which
they accessed and utilised input from SPC nurses, DNs and their GP.
Managing pain
The challenges involved in effectively managing pain were raised by patients, their FCGs and the HCPs
across all data sets. Sometimes unwanted side effects, such as nausea or drowsiness, could be an
important issue:
So, we didn’t really have problems until, real problems, until the end, really. The last couple of weeks at
home, were probably the worst at persuading him to take things and him refusing to take things . . .
Oramorph was, just persuading him to take it really, because he knew that it could make him drowsy,
and he wanted to be in complete control, all the time.
Mrs Becker
Some patients were considered sensitive to certain medications, resulting in particularly disturbing side
effects, such as altered personality and behaviour and generally feeling out of control or disorientated:
You know, when they get on to morphine, quite a bit, they completely change . . . Mentally, they change . . .
Everything. Everything. Everything. It seems to change them, they’re not the person you know. And, he
lost patience, with everything you were doing, you were just a damned nuisance to him. You know what
I mean? I knew it was the morphine because we could see [it] in, gradually increased the dose.
Mrs Brooks
BOX 6 The collaborative work of managing medicines
Collaboration focus: Mr Butcher
And the nurses were working very carefully with me on what I’d given, as against, what they were about to
give, and we kept very close records. If I’d given her a sort of full lorazepam, they would not give a full dose
of midazolam . . . If I called them and sort of said, ‘We need something here’, they would say, ‘OK, what’s
happened now?’. I said, ‘Well, I gave her at 2 o’clock a lorazepam or, about two or three strange named ones,
[laughs]’ and they would say, ‘Well, we can’t give the midazolam now, but what we can do, we can give her
morphine’. And, and they, we balanced it very carefully between us . . . [with the patient’s input] . . . She was,
even though, in late stages, she would say, ‘I would like a lorazepam’ and would say, ‘Well, are we going to go
for a half or a full?’. And she was quite conscious of, look, ‘I’ll just go for a half’. And then if it isn’t working, we
can either put another half in, or we can go and call a district nurse and get something a little bit stronger. We
just worked through on a, on a level of, sort of, orange, red, and crimson. [laughs] Whether it was pain or just
pure distress and anxiety. The anxiety was probably, more so than the pain was sometimes. You know, so long
as you know what’s going on . . . And we, again, we used to make decisions ourselves, and then sometimes,
I would actually say ‘Well, OK, well, let’s just give the nurses a call’, or ‘let’s just give the GP surgery a call’.
And get a call back and say, ‘Look, this is the situation, we’re thinking about doing this, what would you say?
Would you think we should get someone for midazolam or something else?’, or, and, you know, they would
then sort of say, ‘Yeah, let’s go with, let’s try this one, but if [wife]’s no different, do please call back’. So, there
was a lot of support and guidance a helluva a lot.
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Experimentation with different drugs, different doses and different routes of administration could be
tried to balance pain management and side effects:
She’s on pregabalin, which she takes different doses different times of the day . . . And we jiggled around
with those, because they tried her with, because she was in pain, 100 in the morning, but then, she was
just asleep so they’ve jiggled it and worked it through, and they’ve got that on her.
Mr Carter, FCG, Int1
Health-care practitioners acknowledged the prescribing challenges that they faced when adverse reactions
to standard drugs significantly limited their options for supporting pain control for their patients. Cases in
which it proved impossible to achieve adequate pain control were described by HCPs and FCGs:
. . . It’s been a bit complex really . . . because he’s not tolerated a lot of opioids. As they’ve increased in
dose he’s become quite symptomatic of side effects, confusion mainly . . . He has got complex needs,
because whatever we’ve increased it to has helped a bit, but it’s never got rid of the pain. And I don’t
know whether we’ll ever get on top of [his] pain. And we’re running out of pharmacology to do that.
Mr Cole’s HCP2, Int1
Interviewer: So, when they put up the syringe driver, was that simply because of the amount of drugs she
was needing to have?
Mr Berger: Yes. They were hoping to control the pain. It never happened. They never, because . . . every
time they upped it, it needed going up again, they were always two steps behind the actual pain threshold
so the illness just, that’s the rapid rate it was going at, so.
The consequences of pain control had great significance for the emotional and practical burden of care;
for example, when the prescribing decision was made to introduce patches as an alternative delivery
mechanism for pain medication or when swallowing tablets became problematic:
She had quite a lot of nausea from morphine, a certain type of morphine, and they changed it to a patch,
and that, the nausea went away with the patch, so it was a big help. And, the constipation-type side
effects of the morphine as well were massively reduced with a patch. So, there was definitely a lot of,
you know, shunting things around to try and get to the best possible set of drugs that would help.
Mrs Booth
The management of medications for pain relief caused considerable anxiety for FCGs. Many reported
taking meticulous care in their monitoring, recording and use of pain medications. They felt great
responsibility for getting the management of pain right. This led to concerns about wanting to relieve
the symptoms, but not to ‘overdose’ the patient. FCGs could feel intimidated by their responsibility
for administering powerful medications and the limitations of their knowledge about their use and
side effects:
I wasn’t quite sure about these Oxy [Oxycodone hydrochloride] [. . .] this short, Shortec®, Longtec®, because
the hospitals are always that busy that they don’t give you a lot of information . . . I just was constantly
worried that I’d overdose him with the [laughs] with the Oxy, you know, with the Longtec and the . . . but I
never did. Well, I don’t know, I may have done.
Mrs Bristow
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Prescribed pain relief, particularly opioids, could have complex meanings and significance. For some
participants, however, being prescribed these drugs was a powerful indicator of the severity of their illness:
. . . we had paracetamols and they were effective . . . [but then the pain got worse] . . . Oh, you can try this,
and he brought the bottle [of Oramorph] home . . . And he didn’t really touch it. Just sat there for a long
time . . . he was putting it off going down that route. I know, latterly, he always did avoid it, because I,
it was like acknowledging, you know, what was happening to him, maybe, a bit.
Mrs Baker
The management of pain at home forced families to engage with all of the elements of medicines work.
FCGs, in particular, took on considerable responsibility in supporting someone to manage their pain.
They were often tasked with keeping track of the type, frequency and dosage of pain medication
administered and in providing emotional support. All participants wanted to help in this way, but some
were anxious about the limitations of their knowledge about how to manage controlled drugs safely
and effectively, make judgements about when and how much to give, and who and when to contact
for advice and support. Opiates and morphine, in particular, held negative connotations for patients,
often signalling disease progression and ‘things getting worse’.
Specialist palliative care
Specialist palliative care was often introduced when generalists required additional support to manage
pain. Contact with SPC through outpatient appointments and hospice inpatient stays meant that
patients, such as Mrs Clarke and Mrs Cramer, had tailored packages of care in place at home, including
medications and syringe drivers to manage their pain:
It [syringe driver] definitely helped the pain. She slept a lot better when they put that in, because she
wasn’t having to, there wasn’t that cycle of take a tablet, or take some morphine, feel a bit better, and
then the pain’s set in again, so you have to wake up and start it all again, overnight, because the syringe
driver was in, she just was much more settled.
Mrs Booth
Mr Bryman reports how the introduction of the hospital SPC team resulted in positive adjustments to
his mother’s care:
They pretty quickly switched her from oral medication to a syringe driver . . . So, I think it was, watching
them in action, watching them discuss things with her and sort things out, I think they were quite
impressive. And so, she was having a laugh and a joke with them about things. But we could see in
that last period, that last 24 hours when her pain was better controlled and her breathlessness was
better managed. I think they were the best 24 hours in the 6 weeks.
Mr Bryman
As these extracts illustrate, referral to SPC, which occurred close to the patient’s death, could bring
about a reprieve for the family and enable the experience of a (relatively) ‘good death’ at home. However,
it was clear from participants’ accounts throughout the study that families often experienced a period of
weeks, or even months, of very difficult and distressing emotional and practical ‘work’ in managing the
patient’s care, especially where deteriorating symptoms were not adequately controlled. The nature and
intensity of the burden of care during this period are rarely acknowledged in conventional discourses
about dying at home as a prerequisite for a ‘good death’.
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Conclusion
This chapter has explored aspects of the extensive ‘work’ with which patients and FCGs engage in
managing medicines at home. ‘Focus boxes’ have been included to provide detailed context and
illuminate key areas. Participants varied in the extent to which they felt supported by professional
services. Instances of collaborative working between patients, their FCGs and the HCPs were described.
More often, however, patients and FCGs described the effort and anxiety involved in taking on responsibility
for managing complex medication regimens and making judgements about administration dosage, when the
limits to their coping strategies had been reached and when they needed to call for additional help and
support. Professional awareness of the nature and extent of the practical, physical, emotional and
knowledge-based work being undertaken by patients and FCGs was not common. Control of pain was a
frequent concern and not always achieved.
DOI: 10.3310/hsdr09140 Health Services and Delivery Research 2021 Vol. 9 No. 14
© 2021 Pollock et al. This work was produced by Pollock et al. under the terms of a commissioning contract issued by the Secretary of State for Health and Social Care. This
is an Open Access publication distributed under the terms of the Creative Commons Attribution CC BY 4.0 licence, which permits unrestricted use, distribution, reproduction
and adaption in any medium and for any purpose provided that it is properly attributed. See: https://creativecommons.org/licenses/by/4.0/. For attribution the title, original
author(s), the publication source – NIHR Journals Library, and the DOI of the publication must be cited.
53

Chapter 7 Findings: system and complexity
Introduction
The previous chapter has considered the different kinds of work of managing medicines and
the considerable effort involved for both patients and their FCGs (Box 7). Despite the very great
demands imposed by the patient’s illness, most lay participants were positive about professional
services and care. Complex judgements were based on mixed and diverse experiences of care. Some
BFCG participants expressed praise and appreciation for professionals, even when the patient’s illness
and death had been very difficult and distressing. They were also prepared to make allowances for
a system that they recognised to be overstretched, with staff trying to do their best. Nevertheless,
most participants described occasions when they felt inadequately supported and, in some cases, when
their difficulties were prolonged. A strong theme throughout the data was frustration with a complex
system that was experienced as fragmented and poorly integrated. Even those who felt that they had
established good and supportive relationships with key services and personnel reported that their
knowledge of the system and how to work it had been built up over time, and that they had,
effectively, been ‘left to figure things out’.
As described in Chapter 6, many participants reported developing considerable expertise in evolving
their own systems and detailed procedures for organising, accessing, administering and recording
medicines into relatively stable routines. However, these networks of care were dynamic systems
and vulnerable to change. This applied especially during the later stages of the patient’s illness when
deterioration could be rapid and frequent changes were made to the nature and dose of medicines
prescribed. A particularly distressing consequence of this stage of the illness was the difficulty in
accessing help, particularly in a crisis. In this chapter, we present issues relating to participants’
experience within a complex system of care and how this constrains or enables their capacity to
manage medicines and effectively access professional support.
Networks of care
In the Managing Medicines study, we were interested to explore how the work of medicines
management was distributed across patients’ informal and professional networks and if it was
possible to determine structural features that had a bearing on the support available to patients.
BOX 7 Tipping the balance of care
So it’s made me more conscious of, as the regime of tablets starts to get more and more complicated, so the
network of people around that patient needs to be broadened so that the responsibility for that can’t rest with –
I don’t think we can leave it to a patient to manage a complicated medication regime without there being
support in place. And some people will be absolutely fine, but I think what it taught me is if people just tip over
the edge a little bit, how quickly things can go wrong. How easy it is for a simple regime, well, within the space
of a couple of weeks how easy it is for a simple regime that you’re managing with to somehow become a very
complex regime that at your best you could probably just about manage, but add in a little bit of confusion and
it just goes out of the window.
Mr Bryman
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Cases differed in terms of the specific disease and comorbidities and the stage or severity experienced
by the patient at the point that they engaged with the study. These factors had a major bearing on the
input of services and the family’s experience of care, and make it difficult to establish patterns within
the small number of patient cases included in the study. Nevertheless, we have found the construction
of the ecograms in Appendix 1 to be a useful way of informing and visualising our analysis of the
dynamics of each case, viewed from the perspective of the researchers and constructed from all data
generated with the study.
Networks were made up of informal and professional links (i.e. individuals and services) and included
electronic systems of prescribing, sharing records and accessing information in the media and internet.
Networks ranged in size from 9 to 32 links (mean 22 links; median 20 links) (see Chapter 4). Most
ecograms included a small number of informal links and usually contained one or two key individuals
(lay and/or professional) who were involved in supporting medicines management. Most patients had
retained control over the process of ordering, organising and taking medicines for as long as they
could, perhaps with practical tasks, such as collecting medicines from the pharmacy or storing these
in different parts of the house, delegated to FCGs. As their health deteriorated, however, patients
gradually relinquished responsibility for all aspects of medicines management, even to the point of
requiring physical assistance with administration (e.g. swallowing liquid medicines from a syringe). With
little formal training or support, key FCGs tended to assume and maintain responsibility for most of the
work. This work was not widely distributed across the patient’s network. However, informal links, within
and outside the family, were valued for other kinds of practical and emotional support:
Family were at the top of the tree though, because we had four children . . . grown up, and they were
there constantly, on the phone, visiting every weekend, taking it in turns, setting a rota up, and they were
there all the way, and they were grieving, they still are.
Mr Butcher
Mrs Best describes a striking case of the extent to which a local community rallied to the support of a
dying neighbour who lived alone and without nearby kin. For several months, a network of neighbours
had taken on the care of this woman who was dying of cancer. This involved providing practical care,
including extensive engagement with the tasks of medicines management, liaising with services and HCPs,
accompanying the woman to many hospital appointments, organising a rota to provide company and
division of tasks, and, eventually, keeping an extended vigil at her bedside in the days prior to her death.
In the course of managing the patient’s medicines, FCGs undertook a great deal of work liaising with
different parts of the system, including a wide range of HCPs and services. There is great contrast
in the range and complexity of professional links within the ecograms. The degree of complexity
could fluctuate over time and there was not a unilateral tendency for this to increase. For example,
participants described complex interactions with different services and personnel during the sometimes
protracted period of obtaining a diagnosis and then a reduction during the more stable process of
treatment. Discharge from active specialist treatment was a significant transition for some patients,
mainly those affected by cancer, and could be followed by a reduction in active professional links.
However, as they approached the end of life, patients were often subject to a cascade of care, which
FCGs described as burdensome if not overwhelming.
Networks were dynamic and potentially vulnerable. Families took time to build stability in the
connecting links, but these could be jeopardised quickly by changes in the system of professional
or informal care. Some patients were dependent on the support of relatives, often elderly spouses,
who were themselves in poor health. Several FCGs reported putting off treatment that required
hospitalisation for themselves because they felt that they could not leave their relative alone at home.
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Feeling supported by the system
Participants varied widely in the extent to which they felt supported by the system. This was often
experienced as fragmented and bureaucratic. The quality of relationships established with individual
professionals was often key to confidence in managing the patient’s care, a large part of which was
bound up with medication. What we term key professionals could be drawn from any service (e.g. GP,
consultant, DN, CN or SPCN) and appeared to result from the serendipitous development of good
relationships rather than from a designated role. Indeed, several respondents referred to having been
allocated a ‘key worker’ with whom they had failed to establish any engagement or rapport, and in one
case had never seen. Key professionals were identified as the ‘go to’ people whenever difficulties arose
and took a proactive role in fixing a wide range of issues, often related to symptom management and
medicines use:
It would have been either [SPCN] or the doctor’s surgery . . . But, definitely in the first instance, [SPCN].
You know, because she was always available on the phone so yeah.
Mrs Bristow
Ease of access and rapid response were critical to the sense of security that participants derived from
these relationships. This could become of great significance during the period before the patient’s
death, during an experience of great emotional distress and vulnerability throughout which FCGs
had to deal with rapid changes in prescribing, treatment and professional service input. It is worth
noting that the availability of a key professional was not necessarily sufficient for participants to
report feeling supported by the system overall, but it was certainly a powerful buffer against the
difficulties and frustrations with which they had to contend. Some participants described having
good relationships with two or three particular individuals or services, which, again, were a source
of confidence in navigating a complex system. However, patients and FCGs who had not been able
to establish any close or supportive relationships within this described a much more difficult and
frustrating experience of care (e.g. Mrs Creasy).
It was also clear that the quality of relations and communication between professionals could have a
critical impact on families’ experience. Hospices sometimes provided a nexus of care in which patients
might attend outpatient consultations, attend day care services and receive home visits from specialist
nursing staff. The availability of a 24-hour hospice-based advice line was also highly valued by the few
participants who knew about it or had access to it. The existence of an efficient relationship between the
GP and the pharmacist was an important determinant of family experience of accessing medicines. Pharmacies
co-located with a general practice were considered very convenient and tended (although not always) to be
associated with a positive experience of co-ordinated care. Mrs Blakemore described having a good
relationship with her CP and considered them her first port of call for medication-related issues. She
found that the pharmacist was more easily accessible than her GP, especially as she could walk to the
pharmacy and speak to someone who was able to spend time explaining medications and their side effects.
This reassurance boostedMrs Blakemore’s confidence in dealing with her husband’s medication at home:
Couple of times, there was major problems with prescriptions, you know, where they’d been changed
and the, they’re weren’t updating the records, and everything, I would just go and have a word with
[the pharmacist] and she’d say ‘Oh, leave it, I’ll sort it out for you’. She was really, really good.
Mrs Blakemore
More generally, however, pharmacists were considered by lay and professional participants to be
primarily suppliers of medicines, with little wider involvement in providing advice about medicines
use or prescribing.When processes of prescribing and dispensing worked well, care was experienced
as seamless and largely invisible, especially when medicines were delivered directly to the patient’s door.
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One or two participants described personal contact with a pharmacist and a sense of being known when
they visited the pharmacy:
So, you got, big bag. So, he, the pharmacist knew what was needed. And if there was a change, the GP
would let the pharmacist know. And the pharmacist would alter what he was sending . . . himself, so we’d
just get it, we didn’t have to do anything about that.
Mrs Bishop
One area in which the lack of a joined-up system was experienced concerned delays in interprofessional
communication about prescribing changes, particularly the transfer of information from hospital and
outpatient services to GPs. The transition from home to hospital was particularly associated with delays
in updating records, which were reported sometimes to be ≥ 2 weeks. Mrs Bristow described how she
had taken the initiative in circumventing this blockage by taking her husband’s copy of the hospital
discharge letter directly to the general practice to make the information immediately available and
enable the GP to amend the prescription. Even when participants described having a good relationship
with an individual GP, the difficulty in getting direct access, by telephone or by appointment, and the
unresponsiveness of practice staff caused great frustration.
Establishing a personal relationship with a GP was difficult for some patients because of the lack of
continuity of care. In some cases, the patient’s referral to specialist treatment seemed to marginalise
the GP’s input, as the family then looked to hospital consultants and their teams as the key figures in
managing treatment. Especially when the relationship between the GP and the patient had not been
close, there was a risk that it would be difficult for this to be re-established subsequently, following the
patient’s discharge back to community care. Several participants commented that they experienced
long delays in seeing the GP of their choice and usually saw different doctors with whom they had
no relationship. Most importantly, unfamiliar professionals, in any role, were recognised to have no
knowledge of the patient or the details of the case. The feeling of ‘being known’ was important. Study
participants expressed a range of views about their GPs. Taking a personal interest and, particularly,
being willing to undertake home visits to dying patients were much appreciated. The following account
is unusual, but also illustrates what is possible:
Our doctor’s surgery, everybody at the surgery, and the office staff knew me. And I could just phone up
and they would put it straight through to our GP, one of my doctors, and he’d come straight out, he was
brilliant, absolutely brilliant.
Mrs Brooks
Good relationships with individual HCPs, especially key professionals, were intrinsically vulnerable
to change, for example if individual staff moved to different roles and services, if individual staff went
on leave or if changes were made to the services to which the patient was referred. Mrs Brown
described having a key professional relationship with a community matron that ended when this role
was abolished, and she did not establish such good relations with the SPCN who succeeded her and
whose working hours and accessibility were more restricted. Subsequently, Mrs Brown did not feel
confident or well supported by the system beyond good relationships with the three HCWs who
provided a daily package of intensive personal care for her husband but did not provide a point of
access or liaison with other HCPs or services. She reported difficulty accessing help OOH, specifically
about medication issues. When her husband was dying, Mrs Brett wanted him to remain in the hospice
to which he had been admitted so that medication to control his pain could be sorted out. However,
she felt that the hospice put pressure on her to move her husband to a nursing home. Eventually,
Mrs Brett decided to take him home, where she had a difficult experience of his death. She felt that
there had been no consultation with her or her husband or consideration of the best place of death
for him. Rather, she felt that this had been determined by the system on grounds of cost. Therefore,
patients and FCGs have little leverage on the system. Even during the experience of dying, there was a
FINDINGS: SYSTEM AND COMPLEXITY
NIHR Journals Library www.journalslibrary.nihr.ac.uk
58
sense of the system making disposals and arrangements without consultation or consideration of
family circumstances and preferences.
Some key professionals were valued, even if they were not always accessible (e.g. during office hours
only or because they worked part time). In this case, the ability to contact a wider team or a 24-hour
service, such as the hospice or SPA helplines, could be invaluable. However, these were mentioned by a
minority of participants. Several of those who were aware of extended services reported that they had
found out by chance and at a relatively late stage in the patient’s illness. Mrs Connor, for example, was
alerted to the existence of the SPA through a chance encounter with a friend.
Although participants valued good and long-term relationships with individual professionals and wider
service teams, it was not always the case that frequent contact resulted in positive or productive
experiences. As in Mrs Creasy’s case, negative relationships could simply be perpetuated with mutual
frustration all round:
But the problem is I actually have to go. If I ring, I get nowhere. So, when I deal with something over
the phone with them it takes 2 weeks to sort. So, I have to go down [to GP surgery], I have to ask for J.
Usually, I have to make a special trip and go down and try and sort it [prescription] out. I have got to the
stage where I’d just stand outside [the GP’s] door and wait until he’s done, because it was getting that
bad. But we haven’t seen [that GP] in a while. We just can’t get in to see him.
Mrs Creasy
Communication
Complexity, especially when care involved many professionals from different services, was confusing to
professionals, as well as patients and FCGs. It increased the risk of poor communication between all
members of the care network, as well as inconsistency between the professional opinions and the
advice received by families:
So sometimes, it’s around communication. So sometimes, the patients and relatives, they find it, you know,
one person will advise them something, another health-care professional might tell them something else,
and then they see a third one, so there’s that lack of continuity sometimes they find difficult. Particularly
if they’re being told different things by different people. I suppose, that can happen if they’re under
multiple different specialities. That can be quite challenging. So sometimes, it’s better to be under one key
kind of key point of contact, particularly in the late stages.
CNS, HCP19
And I got more information from the pain specialist nurse at the hospital, who explained to me about the
excretion of the opiates. And which were best for [patient]. She did actually have a discussion with my GP
and they did have a debate at one point. But I felt like I was better informed from her than the palliative
care nurse and the GP and the district nursing team. And then, the renal nurse, I used to phone her and
say ‘They’ve prescribed such and such’, and then she [said], ‘Oh no, oh no, no, we can’t have that, they
need to liaise with [the consultant]’. So, then I used to have to ring them back.’ You need to liaise with the
hospital, we need to get this sorted out’. And I always felt like I was the driver of it.
Mrs Brown
Professionals (especially nurses) described discussing medicines with patients and FCGs following
prescribing, and sometimes expressed awareness of the demands involved for families in managing
medicines. Some also described taking on the task of reviewing medicines currently prescribed, often
following referral or first contact with the patient. However, there was little apparent monitoring or
supervision of what patients actually did with the medicines prescribed. It was noted that patients
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often did not raise queries because they did not know what questions to ask, who to ask or that
they even have something to ask about. HCPs, often nurses, who visited patients at home had the
advantage of being able to observe the settings in which patients were receiving care. Some noted
incidents when their explanations had been insufficient for the patient or FCG to fully understand and,
therefore, a different approach might be required:
So, there’s a lady that I wanted to increase her Parkinson’s tablets . . . And so I wrote it all out for her, and
I said ‘Right so on Thursday you’re going to do this’ . . . And I had a phone call, she phoned my secretary
about 2 hours later and just went ‘I don’t get it’. And I’m like, ‘Oh no, I thought I’d written it down really
clear’. She’s like, ‘So, what am I doing on Friday and Saturday?’. I’m like, ‘Well, you stick with whatever’s
happened before’ . . . So I think that was a learning point for me that actually . . . I assumed that she’d
followed my logic, and she very clearly didn’t.
Consultant, HCP27
Although the communication in this case had not been effective, it was unusual as an example of
a professional offering personally written, tailored information for the patient. Most professional
accounts of providing information focused on direct discussion and the time that was invested in this,
as if duration was the significant factor rather than effectiveness. Despite being effective, even the
time required to provide individually written guidance was clearly a disincentive:
Group interviewer, GP, HCP25: . . . And you said you’d typed it all out for her [patient] so that she knew
what to take when? And does she use that, does she use it?
Group GP1, GP, HCP25: Yeah, it seems to have enabled her not to worry about stuff. I don’t know if
I’d type it out again if we changed the doses of things or timings of things . . .
Group GP2, GP, HCP25: I was thinking it’s quite time consuming to type it out, isn’t it, really? . . .
I can’t really see myself doing this, because of such a time . . .
Group GP1, GP, HCP25: Well, it took a long time, it took, because she’s . . .
Group GP2, GP, HCP25: Because she’s on multiple medications, it’s not just one medication and you just
type it quickly out.
The nature and function of small-world networks seemed to be a key determinant of the quality of
experience of communication and care by patients and their families, rather than organisational
properties of the system. However, the efficiency of transfer of information between staff and services
was also crucial. Several bottlenecks were described, including delays in specialist clinicians communicating
with GPs, a lack of integration between systems of electronic records [e.g. EMISWeb (EMIS Health, Leeds, UK)
and SystmOne (The Phoenix Partnership, Leeds, UK)] used by different parts of the system and a lack of
information available to OOH clinicians and CPs:
It would be really helpful on a discharge summary if they said, you know, someone is managing the
medications. Because you get this discharge summary of quite ill patients, maybe never met, your
colleague’s on holiday. There’s 10 new drugs which are quite dangerous. You don’t know is someone
managing those, do I need to arrange a dosette? All of a sudden, you know, in the afternoon, there’s no
information about who’s managing this.
GP, HCP26
Alongside the systems that families worked out for themselves, some HCPs described taking the
initiative to implement simple strategies and aids that would help patients and FCGs to manage
medicines more easily. The emphasis here is on simple, and virtually cost-free, measures, such as
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providing laminated sheets or simple charts with information about drug, dose and frequency, or
writing directly instructions directly on the boxes:
I feel like maybe people need, I don’t know whether they’d read it, but need information or flash cards or
something, about each medication. So, obviously, if you’re getting the medication in a box, and you’ve got
that leaflet, it is huge, isn’t it? Whereas I’ll often, on boxes, write for people, ‘This is for’, and will write, big,
‘Muscle cramping’. You know.
CNS, HCP06
Provision of such simple, tailored information would take less time than lengthy discussion, which, as
indicated above, may not result in mutual understanding. Although by no means a substitute for direct
communication about medicines, this is a task that could be undertaken by the pharmacist when
dispensing medicines. Within the study, however, there is only a single reference to a pharmacist
engaging in this kind of initiative. Mrs Baker described a hospital nurse printing off an information
leaflet from the internet, but only after she had specifically requested information about her husband’s
medicine and how to use it. However, there were no other references to professionals using the
internet or signposting patients and FCGs to this as resource for information about their illness or
prescribed medication.
Language, culture and translation
The provision of effective and tailored care to patients from diverse social and cultural backgrounds is
a test of capacity and quality of systems of care. The study included two BFCGs and one patient case
from an Asian background. None of the three patients involved spoke fluent English. In addition, HCPs
spoke about working with patients and carers from ethnic minority backgrounds. They tended to focus
on issues around language and how this can act as a barrier to care. Although available, translation
services were not often used in practice, and reliance on a relative to translate was the more common
option in such circumstances:
I’ve never had to use LanguageLine Solutions for those discussions in general practice, to be fair, the
end-of-life discussions. In reality, it’s usually through a relative.
GP, HCP11
The potential impact of language difficulties is not confined to consultations that take place between
patients and HCPs. The labels on medicines and the instruction leaflets, re-order slips for requesting
prescriptions from the GP and instructions about how to use re-ordering services from both general
practices and pharmacies are in English, which can be problematic for any patients with limited literacy
and, especially, for older patients from ethnic minority communities who do not read English:
The person could speak really good English, but they had very poor, it was actually the writing of it, and
most surgeries, they request that you put something [controlled drugs] in writing to the surgery.
SPCN, HCP14
The fact that Mrs Choudhury, Mr Bhutan and Mr Bhatt’s mothers could speak little English did
not appear to be a significant issue. The general practices that the families used were staffed by
Gujarati-speaking doctors, who were their key professional contacts. FCGs mediated contacts with
other services. Mrs Chowdhury was frail and elderly and the GP made house calls to see her. Her
medicines came from the pharmacy in dosette boxes and were administered and monitored by her
daughter-in-law. Mrs Choudhury relied on a few key individuals within a small but effective informal
and local professional network. Her FCGs were able to advocate for her regarding issues arising,
for example in obtaining agreement for the DNs, rather than family members, to administer her
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daily insulin injections. Mr Bhuta described a very different experience in relation to his mother’s
interaction with secondary care services. The family had supported her decision to refuse dialysis;
however, during a hospital admission, Mr Bhuta reported the following:
I asked could I speak to them to see what had been discussed. And he [doctor] came back to me and
he said, ‘Oh yeah, I’ve managed to persuade your mum to have dialysis’. And I said,’ There’s actually no
way on earth mum has agreed to that’. And he goes, ‘Yeah. I had an interpreter here and she explained
everything to mum and she wants to have dialysis’. And I said, ‘I’m sorry. I just don’t buy it’. And it’s very
easy for mum to misunderstand things even if there’s an interpreter there. Very easy, I know, she’s my mum.
Mr Bhuta
Language issues clearly compound the difficulties of establishing the nature of patient preference and
the problems of translation. However, this case also illustrates the way that such preferences may be
subject to framing by family members as well as HCPs, regardless of ethnic and cultural background.
This is not to say, in this case, that Mr Bhuta was not representing his mother’s position as she would
have wished. However, her voice is effectively absent from the discussion.
Problems with prescribing and accessing medicines
A minority of patients and FCGs described an experience of GPs and pharmacists having systems in
place to make prescribing and accessing medications a smooth process. This seemed to involve a good
understanding of palliative care and shows what can be achieved when the system manages to produce
joined-up care:
They [pharmacy] was absolutely brilliant. And even some of the problems with some of the medications,
when they were prescribed, they would go and sort it out with the GP’s practice without me having to
get involved.
Mrs Brown
However, difficulties in accessing help and advice from their GP, and delay and confusion over
prescriptions, often attributed to ineffective communication between GPs and pharmacists, was widely
reported as a source of considerable frustration. Even when they expressed overall satisfaction with
care, all lay participants described at least one problematic incident that caused substantial difficulty
and distress:
So, it was kind of a backwards and forwards. And eventually I managed to get it sorted and I said to both
the sides, I said, ‘Look, don’t treat me like this because you are telling me to go there and these people are
telling me to go there. I’m caught in between. This is where we come and this is the pharmacy we use, so
why don’t you communicate between two of you and sort it out for us, then I don’t have this issue at all?’.
Eventually they got it, but that kind of a breakdown of communication.
Mr Bhatt
Home delivery of medicines was undoubtedly appreciated as a valuable and convenient service.
However, a downside is the extent to which it can undermine the extent and opportunity for personal
contact with pharmacists and their potential as a source of medicines advice for patients. Not all
pharmacists provided home delivery and controlled drugs had to be signed for and collected directly
from the pharmacy. In most cases, this was not experienced as a problem, at least in relation to
routine prescriptions. It became more of an issue when drugs were prescribed by different sources and
dispensed at different times. This could involve participants having to make quite lengthy journeys to
collect medicines from the different pharmacies or hospital dispensaries. Mr Crispin, for example,
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continued to receive a prescription from the MND clinic after his condition deteriorated to such an
extent that he could no longer attend as an outpatient. This meant that a member of his family had to
travel to the hospital to collect the prescription. This became difficult to manage in view of Mr Crispin’s
deteriorating health and the heightened level of care that he needed at home.
Difficulty in accessing medicines urgently, especially OOH, is a recurring theme in professional and
lay accounts. Professionals expressed concerns about timely anticipation of need and then effectively
planning for the supply of medicines in good time. The process could be complex. The first task was to
find someone who could and would prescribe the medicines, then there could be a search for an open
pharmacy that stocked the drugs and could dispense them. Mrs Bates described how she had to set
out in the middle of the night to obtain a prescription prescribed for her husband by an OOH doctor.
Fortunately, some friends who had come to provide support during her vigil for her husband’s death
were able to remain with him while she tried to find a pharmacy that both was open and could fill
the prescription:
I didn’t know where [OOH pharmacy] were and I had to drive, on my own, in a fairly distressed state,
leaving two people in the house, thinking, ‘Oh dear, well, I’ve got to go and get this’.
Mrs Bates
As described in Chapter 6, some nurses were aware of the practical difficulties that families could
experience in accessing medicines and were willing to help proactively in checking supplies with local
pharmacists or even going to collect the medicines to take directly to the home. However, others
considered that this task was part of the family responsibility, even in the case of families caring for a
dying relative and at a time when the demands of care in addition to responding to rapid changes in
prescribing could become intense:
There are times where the community nurse will say to the family, ‘We’re running short of this, will you
order it through the GP surgery?’. That’s quite difficult for a family member to actually do to be quite
honest. They’ve got enough to do at the end of life, to actually be supporting the patient, not to be having
to run around, to ring, wait on, because some surgeries have got like a call system where you’re actually
probably 17th on-line [sic] or something to actually do a prescription. You can’t order prescriptions over
the phone for many of my surgeries now, you have to physically go in. So that means leaving the patient
to actually go and do it.
SPCN, HCP17
Nurses commented that they preferred to work with smaller pharmacies, rather than big chains,
because they tended to be more responsive and there was greater continuity of staff. Nevertheless,
the spectre of not having adequate supplies of drugs, especially during the night or over weekends and
bank holidays, was frequently raised by professional respondents. Only one pharmacist in the study
reported having access to patient records, which he considered to contribute greatly to the quality
of the service that he could provide. This illustrates the scope that there may be for greater pharmacist
involvement in end-of-life care.
Navigating the system and maintaining vigilance
Lay participants described a process of growing awareness that a lot of help was available, but finding
out about what was on offer, and knowing how to access it, particularly at the right time, was a difficult
and protracted process, especially as needs changed. Many reported an experience of learning on the
job and figuring out how the system worked as they went along, with few professionals signposting
to resources. Lack of information and guidance about how to use medicines was a recurring concern.
Simple, direct information given at an appropriate time was a clear requirement that was rarely met.
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Some reported being told things at a time when they were not able to take it in or found that the
information was not delivered in a comprehensible way:
I had no help with chemo [chemotherapy], when he, he literally had chemo in hospital, and they sent him
home. And I said to the nurse, ‘Can I have a leaflet or something? [laughs] I don’t know what to do. What
do I do when I get him home?’. And she went on the internet and she printed off a leaflet which was off
the Macmillan website. That’s all I had.
Mrs Baker
Even relatively expert caregivers, such as Mrs Bates, reported finding out by chance, and late in the
day, that certain resources, such as home visits from psychiatrists or liquid formulations of medicines,
were available. Mrs Bates was very proactive in managing her husband’s care and liaising with services.
She was quite positive about their experience of care and broadly trusted services and professionals to
give her good advice. She was willing to take the initiative in making suggestions about discontinuing
medicines that her husband no longer needed. When his ability to swallow was impaired, she asked if it
was possible to have these made up in a liquid form to be administered by syringe rather than a tablet,
which made things much easier. This was her initiative and not a suggestion that had been made by
HCPs. Although acknowledging that she was carrying a heavy care load as her husband’s needs
intensified, Mrs Bates was confident in managing this, including his medicines, and was extremely
committed to doing so. She was determined that he should die at home. Mrs Bates was comfortable
with making decisions about stopping some drugs and when to administer anticipatory antibiotics, as
well as when to stop using these altogether. She was articulate and confident in her dealings with
HCPs, with whom she described having good relations. However, she also described the considerable
effort required to learn how the system worked and how to work the system, and how the process of
figuring this out unfolded in a piecemeal fashion.
Family caregivers often found themselves in an ambiguous position. On the one hand, they desperately
sought clarity and confidence in managing medicines, and ready access to help when critical situations
arose. On the other hand, they felt frustrated when professionals failed to acknowledge their expertise,
particularly their knowledge of the patient, the nature and severity of their symptoms and how they
responded to specific drugs:
Pain-wise, we had lots of different medications. Some made him delirious, so he was labelled with a label
of dementia, vascular dementia, which I, I still debate. Once them medications were changed, you’d got
the old person back. So, I had, every time, they had to do a change in pain medication along an opiate
route, I had to battle for them not to put him back on them.
Mrs Brown
In addition, FCGs had to negotiate a fragmented system in which they found that different services and
HCPs were never up to date and lacked understanding of the patient’s illness and treatment and the
input that other services were making to this. Consequently, many participants reported maintaining
constant vigilance regarding the patient’s care, for which they effectively took on the role of case
manager. Meticulous details were maintained about the patient’s medicines, what had been prescribed
and what had been taken. Often, it was the FCG who mediated the gaps in professional knowledge of
awareness of recent developments in their relative’s treatment:
If you get the call-out doctor at night, theirs [records] were never accurate. They were always out, so
I had to be on it, all the time, definitely. And it’s not their fault, it’s, you know, because you could be on
something on Monday, go and see the doctor on Tuesday and you’re on a different, you know, medication
on Wednesday, aren’t you? You know, the hospital, they’re not going to know that the doctor at [town]
is giving him an increased dose of gabapentin, say, for example, they won’t know. Not until I go back,
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and he has his meeting, and they have this chat with the consultant, and I’ll say, ‘By the way, I need to
tell you that he’s doing this, he’s taking this’. And, he used to call me administrator, the doctor.
Mrs Baker
At the same time, FCGs did not always feel that their testimony was accepted and struggled to find a
voice within the professional system:
I think they need to listen to people that have actually lived with these people for years and know exactly
what’s going to happen. She never listened to what I said.
Mrs Bristow
Relatives commented that HCPs who spent a few minutes visiting patients at home had no insight into
the wider picture or how the patient’s condition could change rapidly over the day and, especially, the
night. This was extremely frustrating if FCGs felt that drugs had been inappropriately prescribed or
mistakes had been made. Another cause of dissatisfaction was professionals or services that stuck to a
narrow task-based remit, unwilling or unable to see the bigger picture from the family’s point of view
or take ownership of a problem that remained unresolved.
The input of DNs was sometimes assessed in very positive terms. Some participants valued continuity
in establishing a relationship with an individual nurse. Others said that they did not mind being visited
by different nurses, provided that the care and communication they experienced was good:
No. They [DNs] were absolutely first class. And 24/7 [24 hours per day, 7 days per week] [laughs] you
know . . . Oh yeah . . . we were calling them sort of, probably every other night during the last 2 to 3 weeks.
Mr Butcher
However, other participants described the very limited and sometimes task-based focus of individual
nurses, attending to only a narrow brief, such as wound dressing, and being unresponsive to the bigger
picture and other issues and concerns that the family may have had. Mrs Brand described her frustration
when she called the DNs because her husband urgently needed pain relief, but they insisted on laboriously
checking how much had been used prior to administering this to her husband:
They would come in, and they would count all the medication which could take 20 minutes because there
was a lot of medication. And then they’d give him the medication. And I kept saying to the nurses, ‘Why
can’t you – ?’, ‘Well, we need to count it’. I says, ‘Well, what if it’s not there, what do you do?’ Says, ‘Well,
we’ll still give him it’, I says, ‘Why don’t you give it him now then?’ So, we did have a few heated arguments
because I could see him in so much pain. But it was their policy that they have to count before they give.
Mrs Brand
Exasperation at being referred on from one professional role to another was frequently expressed.
Several participants expressed their frustration when nurses had to contact the GP for a prescription,
given the delay that they often experienced in establishing contact with the surgery, followed by the
time taken for the prescription to be issued. In this connection, the wider ability of CNs to prescribe
could be helpful, especially in expediting the process of obtaining medicines.
Relatives who had been helping patients manage their medicines for years could find it difficult to hand
over responsibility to professionals, on whom they nevertheless depended for critical care. Even when
they felt annoyed that their expertise and knowledge was ignored, and when they felt that they were
not kept adequately informed about changes to the patient’s medicines, FCGs expressed awareness
of the need to position themselves appropriately in relation to the services on which they depended.
They tried to present as ‘good’ patients and as ‘reasonable’ relatives, to be not too demanding or
difficult, and to make sensible and considerate demands on a system of health care that they
recognised to be overstretched and under-resourced.
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The hazard of change
Families confronting the challenges of caring for a dying relative struggled to maintain a sense of order
and coherence in the face of dynamic instability. Alterations to prescribed medicines were common and
were usually made because symptoms, especially pain, had changed or because the patient was struggling
to take the medication in the form in which it had been prescribed. Sometimes medications were changed
multiple times to find the right drug or dose to control symptoms effectively and with minimal side effects
for the patient. Changes to routes of administration were helpful (e.g. syringes or liquid formulations to
support deteriorating swallow, or the move from tablets/liquids to pain relief patches or syringe driver).
However, in these circumstances, change was often experienced as a hazard. Delays in transferring details
of changed prescriptions between different services have been described above. Even very small changes
could have substantial consequences.
Patients and FCGs frequently found that the brand and, consequently, the shape and colour of
medicines were changed by the pharmacist without notice or explanation:
. . . because the prescription hasn’t changed, but obviously the thing the patient recognises is the tablet,
the colour, the shape . . . so there’s a disconnect there and we’re not involved with any of that . . . That’s
just whatever stock the pharmacy can get and that can change quite, speaking to B, our pharmacist,
because stuff, new producers come and go and things come and things still change, oh well, that new
producer can make things cheaper. So, there’s this continual chasing of cheaper meds for NHS costings.
GP group, HCP25
Lay participants understood that brand changes arose through issues with suppliers and from the
effort by GPs and pharmacies to contain costs through effective ‘shopping around’ for the cheapest
deal. However, this made it difficult for them to identify specific drugs or link tablets to function,
especially if they arrived made up in blister packs, potentially undermining agency in reducing
responsibility for self-management of care. For Mrs Creasy, a patient who had allergies to common
ingredients of many drugs, the consequences of changing brands could be onerous and distressing for
her and her FCGs.
Family caregivers had to adapt quickly to deal with new drugs and increased doses to control pain and
symptoms arising as the end of life approached. This was a period of great anxiety and concern, even
for FCGs who had reported being previously confident in managing care. The introduction of controlled
drugs, such as morphine, was often met with apprehension. These were issued on paper prescriptions,
rather than electronically, and had to be collected and signed for at the pharmacy:
I’d never done it before, and it’s a whole new rather scary . . . [laughs] way of administering things. It’s one
thing to give something, a tablet which we’re familiar with but, you know, measuring it out with a syringe
and everything.
Mrs Bates
This introduced a further task at a time when FCGs faced increasing care responsibilities and difficulty
in leaving patients unattended at home. In addition, it was often these drugs that were urgently
required, which caused problems of access and supply at local pharmacies, particularly when they
were prescribed OOH. Several participants expressed their discomfort, at least initially, at having
controlled drugs in the house. FCGs felt that they were left in charge of powerful medicines, often in
different formulations, which they lacked confidence in administering. This was quite apart from the
practical difficulties that could arise from a patient’s inability or unwillingness to take their medicines.
Responsibility for managing medicines, especially making decisions about p.r.n. doses of morphine or
other powerful drugs, was stressful. FCGs feared making mistakes, getting the dose wrong and making
bad judgements about what was required. The cascade of care that frequently characterised the last
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days of life could be particularly distressing for FCGs, as they struggled to keep up with rapid changes
in the patients’ condition, the medicines prescribed to relieve new and distressing symptoms, and the
personnel and services brought in to administer and monitor care:
But she did have quite a lot of side effects from quite a lot of the medication, so we did have to keep
changing it a lot. I think where it got really stressful was more when she was much more poorly, she
wasn’t as able to understand herself, obviously, at that, what she was taking, and we were also having to
have a lot more people come to the house. So, it might have been an on-call doctor, or the palliative care
nurse, or the nurses that just come to the home on-call. And, at that point, then, obviously, all of those
people were able to prescribe or change her medication, which is where it got quite difficult, I think, and
overwhelming, because she sort of, I, I think I know where I am, and then the next day, it was something
else would change.
Mrs Booth
Transitions to and from hospital
Many FCGs describe episodes of unscheduled hospitalisation of their relative. In some cases, these were
repeated or frequent. Hospitalisation was sometimes episodic for acute developments and relapses.
However, some admissions were subsequently realised to mark the divide between managing illness
and acknowledging the end of life. This heralded an escalation in the intensity of care and the responsibility
required from lay participants, as well as from health and social services. This abrupt transition could be
quite challenging, as FCGs struggled to cope with the practical as well as the emotional challenges involved.
Hospital admissions were usually described negatively by lay participants. They called for continuing
vigilance. Staff were described as lacking knowledge or understanding of the patient, ignoring family
advice or concerns, and sometimes as providing poor care in failing to check that the patient was actually
taking the medicines provided. Participants experienced confusion when the advice of hospital staff
contradicted what they had been told by community professionals, and when they became aware
that staff from different hospital specialties were giving conflicting opinions and advice. FCGs reported
difficulty in getting hospital staff to listen to their concerns or acknowledge their expertise and experience
in relation to the patient’s care. There are also accounts of poorly co-ordinated administration, including
discharging frail older patients late at night, of not checking that there was adequate support at home,
and of needless delays and protracted stays in hospital that were not necessary and effectively wasted
time that the patient and family could not afford.
Hospital admissions often involved difficult and risky transitions. Stable systems of managing medicines
that families had painstakingly developed over time could be dismantled in an instant and were difficult
to re-establish after the patient’s discharge home with a large bag of unfamiliar drugs:
And then he’d get discharged, and I bring him home, and I got that discharge sheet with what you’re
taking away and, you know, and, they weren’t always right, I learned in the end, to check those, they
weren’t always correct . . . There was an occasion when he was having chemotherapy, and I said to this
nurse, I was given these tablets to give him when he got home but I’ve never seen them before. And she
says, Oh, don’t have those if you’re having cyclizine, I mean, I don’t know, this is what they’re giving you,
they don’t tell you, you know, as well as they could.
Mrs Baker
Participants felt inadequately informed about changes that had been made or what new medicines
were for. Some reported feeling at a loss about what to do. As described above, hospital prescribing
was often problematic, as it did not tally with community records and was not always supported by
the GP, and so did not transfer smoothly into community care.
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Participants reported that some drugs needed to be prescribed by the hospital because they could not
be prescribed by GPs or covered by their budgets. This could involve FCGs needing special trips to the
hospital pharmacy. One pharmacist observed that hospitalisation could result in a review and reduction
in prescribed drugs. This could be a telling indication that the end of life was approaching (i.e. ‘the slide
downhill’). Pointing to an apparently rare example of good and effective practice, he said that in this
case the hospital would call him directly to advise him of the changes that had to be made to the
patient’s drugs and blister packs. However, more commonly, community HCPs, especially nurses, were
disparaging about the disruption caused by hospitalisation and discharge, after which families could be
left struggling to know how to manage new medicines and also how to integrate drugs prescribed by
the hospital with those they had been using before.
Getting help in a crisis
Most patients and FCGs shouldered the burden of illness and the responsibility for care with great
forbearance and resilience. They acknowledged the constraints of an overstretched system of health care
and were broadly positive in their assessment of the care that the patient had received. However, difficulty
in getting help, particularly in a crisis, was a frequently reported cause of frustration and distress. It was
precisely at the time when lay participants most valued the continuity of staff and consistency of service
that they found themselves confronting a bureaucratic and unresponsive system, in which the patient was
‘not known’. Participants reported difficulties in getting through to a general practice, of waiting for DNs to
arrive to administer pain relief, of summoning help OOH or of having to continually repeat the details of
the case to anonymous staff on the end of 111 calls:
I kept having, you know, to have to call the doctor quite a lot and be like, ‘Well, was I still supposed to
give her this one?’. Or not, and, you know, we were never quite sure. Or if we ran out of one, how much
of a problem is that? You know, and, so yeah, quite a lot to kind of do in that period of time when she
was really poorly. And I think the, the continuity of the help at that point was not very good, really.
Like it just, it was just sort of, and I completely understand why, but it was, you know, it’s whoever’s
available on the end of a phone, or, which meant I found myself phoning that 111 number quite a bit.
Mrs Booth
Home could be a very lonely place when FCGs found themselves struggling to cope with patients in
extreme pain or agitation, especially when this occurred at night:
You can ring [the hospital ward]. And I think I did actually ring them at one point and say, ‘Look, you’re
going to have to tell me what I can do because otherwise I’m putting him in the car and I’m bringing him
down’. Because I daren’t go to sleep because if I go to sleep – I mean I had to hide the drugs because
I had such a fear that he was just going to get hold of them and just take them himself.
Mrs Bailey
Having direct access to a 24-hour helpline of some kind was a critical resource. However, most families
did not have this or discovered it only late on. Some participants had access to a hospital ward or a
24-hour hospice helpline and a couple had been told or found out about a local SPA service. Regardless
of whether or not they needed to use it, the knowledge that accessible help was always available was
greatly reassuring. The general 111 service was the advice line most frequently mentioned. However,
participants commented on their frustration at having to start again with each contact and provide details
of the patient’s illness, as well as their sense of interacting with a formulaic and anonymous service:
And like I say, phoning all these different numbers. I was probably phoning three times a day at that
point, to get help on whatever it was, you know, new symptom or the thing you’ve just tried isn’t helping
so what else can we do? Or, you know, the syringe driver’s beeping and not working, can you come and
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change it? And, you know, it was just those sorts of things, constantly. For that period of time, and that,
yeah, we did say, just got to the point where we couldn’t have carried on.
Mrs Booth
Lay participants described difficult judgements involved in decisions about when and who to ask for
help, especially in what they felt to be a crisis. On the one hand, they desperately needed advice and
reassurance. On the other hand, they were reluctant to make unnecessary or inappropriate demands
on a system that they perceived to be overstretched and struggling to cope. Wrong judgements on
their part were taken to signify a lack of competence, which was strongly resisted. This could go either
way. FCGs could fail to call for help when it was needed or make needless demands on the system
when it was not:
Because, you say, ‘Is this serious enough to call the doctor, what do you think?’. I mean, luckily, throughout
the whole time I was caring for [patient] I got it right every time. And I, and I used to really beat myself up
about it, but I know, looking back, now, I was fortunate I’d got each decision right, because sometimes, it’s,
‘Do I give him some more medicine? Do I ring the doctor? Do I call the ambulance? Is it 111?’. You know,
you’re thinking, all the time, ‘Which one is it? Which one is it? Because you got so many options, got too
many options. Do I ring the Macmillan nurse? Do I ring the community nurse? Do I ring the consultant?’.
Mrs Baker
Deprescribing
Deprescribing of unnecessary medicines is widely advocated for clinical and cost-saving reasons.
Patients approaching the end of life are unlikely to benefit from continuing to take medicines previously
prescribed for the prevention of disease. Simplifying medication regimens is clearly desirable for FCGs,
especially when additional items to control pain and other symptoms arising during dying are likely
to be prescribed. Professional participants from a range of roles talked about their involvement in
deprescribing, but FCGs did not often refer to awareness of professional intervention of this kind. Some
professionals expressed discomfort about raising the issue of deprescribing with patients because of its
clear significance in intimating a limited prognosis. They anticipated that this would be distressing for
patients and found these conversations to be difficult encounters. Having spent many years encouraging
patients to continue taking drugs, such as statins or antihypertensives, to prevent or control illness to
protect the patient’s health and prolong life, it was difficult to subsequently suggest that these drugs
were no longer needed. Although such conversations would benefit from the application of good
communication skills, some HCPs described an approach that was quite direct:
So, we rationalised her medication so we would limit the stuff that she didn’t really need, down to the
minimal amount that she needed. I would go through all her medication saying, ‘If you don’t take this one,
then this could happen. Do you want to take it? No’.
Community nurse, HCP05
Some tablets she should have had because she had thyroid trouble, so she was on, technically, she was on a
125 mg of thyroxine. But the consultant said, ‘ What’s the point? Don’t bother taking it, it didn’t matter now’.
Mr Berger
Patients and their FCGs were often receptive to reducing the medicine load and discontinuing drugs
when it was appropriate to do so. They describe instances where they had themselves taken the
initiative in asking for a medicines review, querying why particular medicines were still being
prescribed or if they needed to be continued. For example, Mr Crispin described repeatedly asking his
GP to undertake a medicine use review for his father. One issue with deprescribing is that within a
complex system in which individual patient care was provided by many different services and
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professional roles, it was not clear which of these should be allocated responsibility for undertaking
specific tasks. Consequently, it was quite likely that no one did. Pharmacists were rarely referred to
in the context of deprescribing, although this is one area in which they could have a considerable
contribution to make.
Anticipatory medicines
Anticipatory medicines or just-in-case drugs are injectable medicines to treat commonly occurring
symptoms (e.g. pain, nausea, secretions and agitation) in the last days of life, which are prescribed in
advance of, and just in case of, future need (Box 8 gives a focus on AMs). Once prescribed, these drugs
are kept in the patient’s house to be immediately available for DNs or other HCPs to administer
BOX 8 Focus on AMs: BFCG perspectives
Bereaved family caregivers described their experience of the entire process of anticipatory prescribing,
from collection and storage to medicines use and disposal. Getting the medication in place so that they
could be used was not always straightforward. In one instance, it was reported that the authorisation had
not been correctly written and so the DN was unable to give the medications, despite them being available.
In another instance, the prescription was written by the GP just an hour before the patient died. Other
participants reported AMs being in place in good time and stored them out of sight to keep them safe so
that they were not reminded of their purpose:
I mean, basically, I picked up the bag of stuff, I looked in it, I thought, I hope we’re not going to need that . . .
we certainly didn’t need it at the time, this was months, months before, I rolled it up and put it in a lockable
cupboard, told the carers where it was, in case something happened when I wasn’t around . . . In fact, one of
the things in it went out of date before we needed it, and the carer . . . spotted this and she caused it to
be updated.
Mrs Butler
It was the emergency district nurse . . . ‘We’re going to come but we think, for the weekend, we ought to have
the grey box’ . . . I can remember having to go and get the prescription from the emergency place and then
finding a pharmacist who would do it late on a Friday night . . . that wasn’t easy actually. I had to get a friend
to come and stay here. And obviously, it was quite distressing. Because I knew . . . I knew what it meant.
Mrs Bates
But [he] didn’t want them on show. You know. Because he knew what they were. He says, ‘Yeah, just put them
in that bottom cupboard in the kitchen’, and we never really touched them again, until after he’d died, and
I took them back to the chemist again.
Mrs Becker
Although BFCGs eventually realised the purpose of AMs, this was rarely explained directly to them at
the point of prescribing. As Mrs Best describes, HCPs tended to be vague and avoided opportunities for
providing explicit information:
When they were picked up from the pharmacy there was no description by the pharmacy about this is
what they’re for or anything like that . . . There was never any written information. And then when the
nurses started coming in they said, ‘Oh have you got any of these medicines in the house?’. So, there’s no
communication with them either . . . We just, we knew what they were and we had them in a particular place.
Mrs Best
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should the need arise. Thirteen of the BFCGs reported that the patient had been prescribed AMs;
in six instances these had been used. Six of the case study participants also reported that AMs were in
place. In practice, professionals in the study tended to favour prescribing AMs quite well in advance of
anticipated need or, indeed, even when there was not a strong likelihood that they would be needed.
Mrs Crawford described asking the DNs to remove the drugs from her house 1 year after they had
been prescribed but not used. This was partly because she did not like having them in the house,
but also because she found the monthly visits made by the DNs to check the drugs to be irksome.
Mrs Bates described how her mother, whom she had also cared for, as well as her husband had been
prescribed AMs for over 1 year before they had been withdrawn by the nurses providing care. Prescribing
AMs so far in advance of the patient’s anticipated death is to ensure that they are available and to
pre-empt the anticipated delays in getting drugs prescribed and prescriptions filled when the need does
arise. This ‘just-in-case’ argument was reported by HCPs to be a way of softening the import of the
discussion about AMs:
One of the things that I always say to patients or to carers, to families, I always call them the just-in-case
meds [medications]. These are just in case, or we’re not asking you, on a Saturday or a Sunday, to go and
find a chemist to go and get these medicines in because we’ve got, relatives spend so much time trying to
find a chemist . . . And then getting to a chemist, then the chemist hasn’t got it. We get that scenario time
and time again . . .
Community nurse, HCP09
However, a consequence of there being a number of professional roles able to prescribe AMs, alongside
the tendency for these to be prescribed far in advance of need, meant that it could be difficult for
individuals to keep track of what had been prescribed previously. It might not be remembered that
AMs were already in the house or that they had been prescribed by another service:
I visited the gentleman and then I think he took quite a . . . sort of nosedive . . . he’d stopped swallowing.
And I hadn’t been in contact and by the time I’d noticed on his notes that the GP had been out and
recommended that he start on some subcut injections, which incidentally, [FCG] sort of forgot she’d got
in the house, because we put them in pre-emptively. Well, that can be, you know, could be a couple of
months before the person needs them. And I think sometimes people put them away very safely, and then
actually forget that they’ve got them, so, you know, that can be a tricky one.
SPCN, HCP14
The prescribing of AMs is a significant event for patients and their families, clearly signifying the
imminence of death. It calls for skilled and sensitive communication. This might be one reason why
However, BFCGs valued the availability of AMs when they were needed.
When we needed it, both with [my wife] and my mother, the district nurses were literally there, normally
within about 20 minutes.
Mr Butcher
There was a point when a couple of days before he passed away, his breathing was very laboured and . . .
the district nurse came and she put this butterfly in and she used something that was in the box, and . . .
it did calm him down.
Mrs Bates
BOX 8 Focus on AMs: BFCG perspectives (continued)
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prescribers avoid discussion or explanation of AMs and why they had been prescribed. Several FCGs
reported that they had been unaware that medicines taken home after hospital discharge included AMs.
Others reported AMs being prescribed without accompanying explanation or discussion:
And, I get a call . . . from the surgery, to say there’s a prescription for you . . . So, I went down, got this
prescription, and the nurse had left a message asking me to phone. So, I phoned back, ‘Oh, there’s these
drugs, and you must keep them on one side’ . . . And it still didn’t click. So I then went to get the
prescription, and I took it and got the medication, ‘You should have it on one side, you know, it shouldn’t
be touched, it’s got to be on one side’. So, I said, OK . . . [a different nurse who was doing a home visit]
said, ‘Oh, they call them anticipation, anticipatory drugs’. And then I thought, ‘Oh . . . it’s for if he gets
really agitated, and of course, it’s morphine, nobody had told me, I’d picked them up, not realising’.
Mrs Crawford
Our participants did not express overt concern about this issue, rather they were more anxious and
uncomfortable about the nature and status of the drugs. They felt vulnerable about having controlled
drugs stored in the house:
Having never handled any controlled drugs at all, it was actually quite scary when the chemist is making
you sign for things, and they talk about words like morphine, [laughs] and dangerous drugs. And you do
actually feel quite sort of, ‘OK, I’ve got these in the house, am I going to be burgled?’ [laughs]. And, you do
feel sort of rather reticent to ever use them.
Mr Butcher
Risk and responsibility
The limits to family responsibility
The experience of FCGs varied widely in terms of the duration and complexity of their role in
supporting medicines management. Individuals differed, also, in the resources of time, energy and
confidence that they brought to this task. Some embraced the responsibility, even for complex tasks
and administration of controlled drugs, keen to provide any support that they could and to enable the
patient to remain at home for as long as possible, even if this did not always extend to death. Others
described the burden of care to be difficult and were apprehensive about assuming responsibility that
they did not feel confident or competent in:
I think a lot of family members are very, very, very eager to kind of . . . It’s their way of feeling that
they can do something . . . and are very, very happy to administer medication and will contact us with
absolutely any concerns . . . We also need to kind of identify if it is too much of a responsibility for some
family members and being able to pick up on that and making sure that the carers aren’t feeling totally
overwhelmed and feeling that it’s expected of them and they are struggling to do it.
SPCN, HCP23
Especially as the patient’s condition deteriorated towards the end, home could be experienced as a
very vulnerable and lonely place when faced with the responsibility of having to make judgements
about care. In some cases, this was manifestly unwelcome:
The other thing I found was people would ask me, ‘Well, what do I want to do? Or What do you think?’.
And I’d feel like saying, ‘I don’t know, I’m not a doctor, why don’t you tell me?’. Like, ‘Do you think she
needs to go to the hospice now, or do you think she needs to be in hospital, or do you think that just a
doctor will be OK?’, ‘Well, that’s why I’m ringing you’. You know? I just don’t know. I’m in a panic and
I need help from somebody . . . Yeah, just ask you, just, yeah, felt like sometimes, you were being, you were
having to make all the calls?
Mrs Booth
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Participants who had previously worked out relatively stable regimens of managing medicines could
find themselves knocked off balance and overwhelmed by the escalation of care that commonly occurred
in the period prior to death. This could be the point at which the patient was admitted to the hospice or
hospital. The decision to abandon the goal of caring for the patient at home could be deeply felt as a
betrayal and failure, especially where families had started out with a strong commitment to do this:
It was horrible admitting that she’d have to go to the hospice and my brother and I were sort of feeling
guilty that we couldn’t keep, you know, keep her at home. But, it just did get to the point where I was like,
‘Oh, I can’t, I don’t think I can do this anymore’. I just felt so stressed and so panicked and so helpless.
Mrs Booth
Health-care practitioners and FCGs varied in their assessment of the safety and feasibility of technical
tasks that family carers could reasonably and appropriately to take on. For example, some FCGs gave
injections, managed dialysis and were willing to take on additional tasks, such as changing cartridges in
syringe drivers or calibrating doses of morphine. Mr Berger said that he would have been happy to
give his wife injections of morphine for breakthrough pain. He had been in the process of being trained
to do this prior to her death because it took so long for the DNs to arrive after a call-out. Some HCPs
were receptive to extending the role of FCGs, given appropriate support and training. They acknowledged
the advantages in enabling patients to receive faster and more tailored control of symptoms, cutting out
the wait for professionals to make home visits:
I think in terms of end-of-life medication, when somebody’s very end of life, I think managing that at
home is ad hoc to say the least. I think there ought to be some sort of scope for assessment with a
relative should they want to, to be able to administer something themselves. Because to sit and watch
somebody who can’t breathe or is in huge pain, or is so terminally agitated, and you ring up a nurse and
they can’t come for four hours, is just horrendous. And they have the injectable medicines there that they
cannot touch and they can’t give them, so I don’t see how, I mean it would be difficult but I don’t see.
You send people home with their dalteparin and you teach them how to give the dalteparin and the
insulin and injectable drugs, could we not have some way of assessing and empowering somebody to
be able to do that?
SPCN, HCP16
Professionals also recognised a trend towards increasing the range of tasks that FCGs could be
trained to do:
I think it’s something we need to explore, because we’re heading towards a lot of self-care models, aren’t
we? We’ve got to do something different. And we’ve got patients and carers who do numerous, bowel
care, continence care, their own leg dressings, [why can’t], if they’re geared up and they’ve got the right
support systems in place and the right knowledge and education, and support to say, ‘Do you know what,
they’re in pain, or, [. . .] [vomiting], and we can support them through that’, and we’re heading towards
self-care for every other thing, why not, because they can wait hours.
Community nurse, HCP09
The advantages of greater FCG input in relieving strain on an overburdened health service were
acknowledged. However, some HCPs and FCGs also recognised that family members may feel
intimidated and even overwhelmed by the prospect of taking on greater responsibility for care:
You also get, and I’ve always encouraged families to be open and honest, you’ve got a patient who wishes
to die at home, no matter what, and you’ve got a family member who’s very nervous about being
responsible for administering controlled drugs.
SPCN, HCP08
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Concerns were also expressed over safety issues resulting from the delegation of more care to FCGs,
especially around administration of controlled drugs and about the allocation of responsibility and
blame when mishaps occurred:
You end up making somebody [feel] responsible for killing their [relative] because they gave the last dose
of whatever, and they died 10 minutes later. And, what you need to balance that against is, waiting
2 hours for a harassed nurse who comes and then says, ‘Oh, I haven’t got the right bit of paperwork
and I can’t . . . ’, you know, which sometimes happens. And so, I think it’s about managing risk.
Consultant, HCP03
In addition to doubts about the commitment and competence of FCGs to shoulder the burden of care,
there is also the issue of capacity. As the population ages, the primary caregiver of dying patients is often
an elderly spouse, likely themselves to be affected by the limitations imposed by frailty and comorbidity:
If the person can’t manage themselves, it does fall onto the relatives and where, how can we expect them
to suddenly have the knowledge of when to give them [medicines]? I had a referral yesterday for a lady
who was in hospital but wants to come home to die very soon. Her husband’s 87. You know, how can we
expect this man to look after his wife? And be able to provide her with medication?
SPCN, HCP02
The proposal that some relatives could be trained and trusted to take on greater responsibilities for
care is strengthened by the number of FCGs who are also HCPs within the wider population, as well
as within the study. Several study participants were, or had been, HCPs. Their experience could give
confidence about managing care but could also bring additional difficulties. Personal and emotional
involvement could override professional detachment and judgement. Some found the system to be
bureaucratic and unresponsive and reported similar difficulties to those experienced by participants
with no professional training. Some participants described their uncertainty about how to present
themselves in dealing with professionals and services, including whether or not to reveal their expertise.
They also felt frustrated when, on occasion, professionals providing care did not acknowledge this.
Alternatively, it could be the case that other HCPs assumed too much, and participants with a dual role
as HCPs received less information and support than they felt other FCGs would have received.
Vulnerability and disadvantage
Risk management, especially of powerful medicines for pain relief, generated concern among both lay
and professional participants. These risks were compounded in patients who experienced one or more
kinds of additional disadvantage. It is important to know how the system responds to the needs of
terminally ill patients who experience homelessness, substance misuse or dependency and serious
mental illness. Although we were unable to recruit such patients directly, we gained some insight into
the issues arising in their care from the accounts of HCPs who took part in the study. Practitioners
spoke of their experience in working with people from diverse or disadvantaged backgrounds and the
ways in which they adapted their practice to provide good care.
Homelessness
Several HCP participants had experience of caring for homeless patients, including two who worked in
practices that specialised in the provision of services to this group. These included a GP who said of
this patient group that ‘the average age of death is 46 in our population’ and then went on to say that
‘when we do have a terminally ill patient, they tend to be an exception’ (HCP22_GP). However, the GP
felt that the homeless population is a vulnerable one:
When you ask, one standard question is would you be surprised if the person died in the next 6 months?
To tell the truth we wouldn’t be surprised if any of our population died in the next 6 months.
GP, HCP22
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Managing medicines and prescriptions could be difficult for homeless people and controlling pain posed
particular challenges. A CN who worked regularly with homeless people linked some of the difficulties
that she encountered in providing good care to this group of patients to their relative youth and the way
in which services did not want ‘to admit that it’s end of life’ (Community nurse, HCP24). Her preference
would always be to develop a care plan, although this was not straightforward:
I tend to do a care plan but there’s no like DNRs [do-not-resuscitate orders] and it’s very, there’s a lot of
pain issues and there’s a lot of fear because those people are young. So sometimes I find it very difficult
to manage their pain and to actually give them dignity sometimes.
Community nurse, HCP24
The lives of people who are homeless can be chaotic, making it difficult for them to keep track of
when and where appointments are scheduled. HCPs described management strategies for issuing
prescriptions and the need for responsive tailoring of services. For example, a palliative care specialist
nurse described one case in which a patient who was approaching the end of his life lived in a car.
She worked with the GP to schedule joint appointments to reduce the effort of making and keeping
appointments for the patient so that they could more easily co-ordinate his care. The GP was the only
person who prescribed in this case so that the professionals could keep track of what was going on
with his medicines. There was a perceived risk that prescriptions or medicines could be lost, stolen or
sold on to other users. These were consequently issued in small amounts:
I cover one of the homeless practices in [city] and that’s always a big challenge because obviously, they
don’t want to be walking [around], that’s when the local pharmacies come in . . . They’ll give it to them in
stages rather than give them a whole supply of one lot of medication at a time. Because they lose it, sell it.
SPCN, HCP14
Options available to homeless people who were dying were limited. Sometimes the local authority
could find accommodation, but not everyone would wish for this because ‘Some people haven’t got
anybody to support them out there and they’d feel very lonely’ (Community nurse, HCP24). Some
homeless people would opt to stay in a hostel as they were dying, which the team did their best to
facilitate, but often a hospital was the final place of care and death.
Substance misuse and dependency
Providing end-of-life care for people with substance misuse issues could also present challenges
for practitioners, particularly in relation to ensuring that pain is managed while keeping medicines
secure from misuse (Box 9). Issues could arise when it was not patients themselves, but another
family member, who had the problem. A GP spoke about a patient for whom she was caring who
had end-stage COPD and was experiencing pain that was increasingly difficult to manage. The patient
required ‘whopping doses, of morphine, midazolam for her symptoms to be controlled’ (GP, HCP10),
but there was a potential problem in that her son was a drug addict and, although he did not live with
his mother, he did visit her on a regular basis. The patient was keen to remain at home and the local
hospice at home service was brought in to support her in doing so. Her drugs were kept in a locked
cupboard and her son did not know where the key was kept. All HCPs involved in the patient’s care
were informed of the situation and the success of the procedure was helped by the fact the son
‘was very open about his abuse’ (GP, HCP10).
Balancing risks in relation to safety and potential misuse of controlled drugs with effective control of pain
and other symptoms called for fine judgement and innovative practice, based on the ability to establish
strong and trusting relationships with patients and their families. The case outlined in Box 9 illustrates
the potential for attentive and individualised care, and the importance of strong relationships in which
HCPs effectively act as keyworkers mediating the vagaries and complexities of the system and using
professional knowledge and expertise to adapt this flexibly to the singular needs of individual patients.
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The role of home health-care workers
The role of HCWs in supporting families to cope with care, including medicines management, and so
enabling patients to remain at home is not widely acknowledged. Home care was sourced from different
agencies and a mixture of social and hospice services and private care. There was considerable variation
in the tasks and responsibilities HCWs were reported to undertake and the intensity of care provided,
although this tended to increase as the patient neared the end of life. Accounts varied regarding the
extent to which HCWs could and should be involved in medicines management. At one extreme, HCWs
were described as being able to only oversee and prompt patients to take their medicines:
They can’t physically put the tablet in their mouth. They can get them out and they can put them in the
patient’s hand. But they can’t physically put it in their mouth, because then that’s administering it. So,
they can prompt it, but they can’t administer it. If the patient gets to the point where it needs putting in
their mouth for them, then the medication would have to be reviewed.
CNS, HCP18
BOX 9 Managing pain relief in a patient with substance abuse
Focus on substance abuse: SPCN perspective
A SPCN described a patient who was approaching the end of life and was experiencing increasing pain.
He was a heroin addict, as was his partner, and their house was frequented by other drug users:
At the moment, because of his heroin addiction and his partner’s heroin addiction, and there’s frequent other
users going in and out of the property, we have to have restricted the amount of medication that’s actually in
the house. So, the majority of his medication is kept here [hospice], and he just has a very small supply of
Oramorph, at the property at one time . . . His pain is changing and his pain is increasing, so we’ve had to
increase the amount of visits . . . he’s also started on a patch. Because, obviously, people coming in and out
can’t see that, hopefully. And can manage it better.
SPCN, HCP07
The patient’s medicine was collected from the pharmacy by the HCP, rather than the FCG, and taken in
small quantities to the house, where the patient’s partner undertook to keep his medication out of sight of
visitors. The HCP was aware that the patient continued to take non-prescribed drugs that had an impact on
the effectiveness of his prescribed medicines and increased the difficulty of appropriately calibrating the
required dose:
It’s about managing the relationship with him, because if you, you know, he’s going to buy things anyway, he’s
going to continue to use heroin . . . at the beginning I said to him, ‘I’m not here to tell you what to do, but if
you tell me what you’re buying, it helps me to manage your symptoms better.’
SPCN, HCP07
The HCP believed that the patient was honest with her about what else he was taking besides the
prescription medicines because she was open with him and had taken time to build up a relationship
effectively as the keyworker involved in his case. She remained non-judgemental about the patient’s
lifestyle or addiction and expressed a strong commitment to supporting his autonomy and choices for
end-of-life care (i.e. to remain at home), despite the additional demands and difficulties this imposed.
However, she was also aware that her colleagues took a very different view and some were not willing
to undertake home visits where they felt vulnerable and at risk.
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In other cases the HCWs’ input was more proactive, although their training in medicines management
varied widely and seemed sometimes to be ad hoc. The HCW who provided regular support for
both Mr and Mrs Cole described the training that she had received on starting work for the company
that employed her: ‘It’s 4 days, your first lot of training when you first start with the company, and
1 day is specifically medication’. Mrs Cole received her medicines and food through a PEG tube, which
were both administered by the HCW, who said that she received on-site training for this from the
company nurse who ‘has to sign us off to say that we’re competent. So, she has to watch us get the
medications ready, put the medications in, put the pump on’. The HCW found this ‘quite a daunting
thing’ to undertake. For Mr Cole, the HCW put the medicines he needed to take into a small cup and
handed it to him so that he could take them himself. She did, however, change his fentanyl patches for
pain relief.
Home health-care workers who were involved in supporting patients with their medicines spoke of
receiving some training. The HCW who worked with Mr Crispin, for example, said ‘We do have specific
medication training. So, we have the induction. It touches on every subject but then there’s alternate
training for medications’. However, it was not clear what the training covered nor how extensive it
was. The HCW went on to describe being able to handle controlled drugs, such as morphine, but not
being permitted to use needles to administer medicines.
The HCW supporting Mr Cooper described being able to place pills into a patient’s mouth, but in
certain circumstances only, such as when the patient consented, as Mr Cooper had:
We actually place it in his mouth and then he takes water via a straw . . . His consent – like his tablet and
then it’s, B, OK to have them, and he says, yeah, go ahead.
Mr Cooper, HCP02
The role that HCWs took in supporting the people under their care in relation to the management of
medicines varied, as did the training they received to do so. It seemed clear, however, that they played
a key role in helping people to remain at home:
One gentleman who has passed away, now, and that kept him at home for a long time. When I first got
involved, he was bouncing back and forward to hospital, and actually, when we got that medication in
place, we trained all of the carers in how to use it, they were using it really well, at the appropriate times
and it meant that patient, for his last 6 months, was at home.
CNS, HCP06
As this case illustrates, HCWs could have an important role in supporting medicines management,
which enabled patients to remain and to die at home.
A few patients with very complex and severe health problems received intensive packages of care.
Mrs Brown’s husband had undergone bilateral amputation below the knee as a result of poorly
controlled diabetes. He required daily home peritoneal dialysis for renal failure. Towards the end of
his life, two HCWs came 24 hours per day and supported his wife to manage his medicines and
dialysis. This enabled Mr Brown to remain at home and his wife to continue to work outside the home.
In this case, HCWs took an active role in monitoring and administering medicines. When patient needs
were less intense, even a modest amount of HCW input could be critical to the patient and FCG’s
ability to cope at home. Other patients would clearly have benefited from some HCW input, especially
those, such as Mrs Carter, who lived alone and lacked the dexterity to open packets or pick up tablets
and transfer these to her mouth. The system seemed to respond to patients with self-evidently intense
care needs, including escalation at the end of life. However, those with less intense or clearly visible
impairments, or whose difficulties gradually intensified over time, were more likely to slip below the
radar of professional surveillance and intervention.
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After the death
Despite the security measures put in place for access and storage of controlled drugs while the patient
was alive, following his death, family members were surprised to find that they were handed the
responsibility of returning these and other unused medicines to the pharmacist. This was an additional
and unwelcome task occurring at a difficult time:
When a patient has passed away, we give the responsibility to the family to take the medication back to
the pharmacy.
SPCN group, HCP01
It was not clear what happened in most cases, as the disposal of medicines after a patient’s death
seems to be unmonitored. However, FCGs were not comfortable with the responsibility for managing
this risk. Some families described how they responded quickly and were glad to get rid of the
controlled drugs as soon as they could:
One of the first things we did [laughs] was to get all the end-of-life meds [medications] out of the house.
Because we just thought, I mean, they’re, you know, they’re obviously very potent things and we just
wanted to get, we just took them up to the pharmacy that morning . . . I mean, presumably, one of the
things about them is they’re the kind of medications that people want to get hold of for less desirable
reasons . . . So, we just, we wanted to get them out, for all sorts of reasons really.
Mrs Butler
I had all sorts of stuff like bottles of morphine, and I kind of just felt a bit uncomfortable that I’d been left
with all this stuff . . . You know, and, kind of thought, Well, luckily, I, didn’t feel in any way suicidal, and
I’ve got my family but I thought, ‘[Gosh], some people must feel like that, in those situations’. And, and
then you got a houseful of drugs, and I thought that point was a bit, it was left to us to dispose of that . . .
But again, it was left to us to work out.
Mrs Booth
The enormous waste of unused medicines was sharply exposed after the patient’s death, as boxes of
unused drugs were gathered together. This was a subject of regret on the part of HCPs and FCGs:
And the sad thing is that all the medications we had, many were not opened. They all had to be rubbished
and scrapped. What a waste. You know, if they’re still sealed, why did they have to be destroyed?
Mr Butcher
Several HCPs observed that the waste of medicines might continue after the patient’s death in the
case of automated repeat prescriptions. If the patient’s family did not let them know directly, there
was no mechanism within the system to alert the pharmacist to the need to stop delivering supplies.
What could have been better
Participants were asked how their experience of care could have been improved and put forward a
range of suggestions. These were often accompanied by statements acknowledging that HCPs were
very busy and that services were overstretched. Indeed, concerns about making inappropriate use of
these services and struggling to decide whether or not in fact a request for urgent help was justified
recurred throughout the data. Nevertheless, participants described the anxiety and distress that they
experienced when finding themselves unable to access effective help in a crisis and the frustration
caused by their experience of a system that could be unresponsive and bureaucratic. A more
responsive service was considered important, both in picking up on the fact that families were
struggling and needed more proactive professional engagement and, particularly, in enabling rapid
access to help in a crisis. The idea that dying patients merited recognition and special consideration
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from services throughout the system was strongly expressed. A dedicated telephone line and systems
for better communication of this status throughout the services and professionals involved in care
were frequently suggested. The perceived unresponsiveness of some general practice staff was
underlined by the suggestion of several participants that the medical records of dying patients should
be clearly flagged so that the need for a sensitive and rapid response would be immediately apparent:
I would have, it would have been really helpful if the district nurse, or someone, had recognised the fact
that we were starting to struggle.
Mrs Becker
One thing, I think GP surgeries should do is, anyone caring for a terminally ill person, it should be noted
on their record.
Mrs Blakemore
Being given more appropriate and timely information about medicines, their purpose, their side effects
and how they should be used, especially when they were first prescribed, was also considered to be
important. The provision, without having to ask, of simple reference information about the drugs was
one of the most frequent responses:
It could have been a lot better. I do think that the GP practice actually lacks the knowledge on how best
to prescribe palliative care medications, well, for the ones we’ve got anyway . . . I think they could have
explained things better to me. About the medications.
Mrs Brown
Having access to a quick and reliable source of help and information about medicines was one of the
most important things:
Just one point of contact, where I could say, ‘I’m not sure about these tablets, I’m not sure about this,
that and the other’.
Mrs Baker
The scope for greater pharmacist involvement in providing advice and help with medicines was rarely
recognised by lay or professional participants, including pharmacists.
Conclusion
This chapter has considered how patients and family caregivers experienced interactions with HCPs
and services within a complex system of care in relation to medicine-related issues. Frustration with
the experience of a fragmented and bureaucratic system was frequently reported. Poor communication
with and between HCPs and services and a lack of adequate information and support to families were
recurring themes. Many FCGs assumed a pivotal role in patient case management, including undertaking
surveillance of professional care and monitoring of medicines management. Even small changes in
medicines or relationships with key staff could have far-reaching consequences for families working
to maintain a stable network of care. These were particularly likely to rupture during crises occurring
in the last weeks or days of the patient’s life. Problems with prescribing and accessing medicines
were common, especially of controlled drugs and when required OOH. Pharmacists were considered
primarily as suppliers of medicines, and there was little recognition of the scope for extending their
role in medicines optimisation and support. Variation in family resources and responses to extending
responsibility for administration of medicines in the home raise questions about the limits of what FCGs
could and should be asked to do, and how professional support can be tailored to individual preferences
and circumstances. In this context, the largely unacknowledged role of HCWs in supporting medicines
management at home, especially for patients living alone, will become increasingly critical in future.
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Chapter 8 Findings: stakeholder workshops
In June 2019, we held two dissemination and discussion stakeholder workshops. Both events werestructured in a similar way, starting with lunch and an opportunity for informal discussion. After a
welcome and an introduction, the research team presented data based on three key themes identified
from the study findings: (1) the work of managing medications, (2) diversity and disadvantage, and
(3) system and complexity. All participants were then allocated to a table of approximately four to six
people to discuss one of these selected themes using the prompt questions provided in Boxes 10–12.
With permission, discussions were recorded and facilitated by a research team member. We had
pre-assigned participants to groups to ensure that each group was interprofessional and had a PPI
representative. This worked well, and the groups engaged in conversations not only about their allocated
theme, but also about the other themes and wider issues raised by the study findings. Forty-five minutes
were allocated for each group discussion, after which we asked participants to anonymously make a note
of three key issues relating to their primary discussion topic. Many identified more than three and some
responded to more than one topic.We received 52 sets of notes across the three topic themes. The group
recordings were not transcribed in full, but listened to repeatedly by the researchers, who made detailed
notes and verbatim transcripts of selected extracts. These notes were compared with the written notes
made by participants and amalgamated. The final part of the workshop sessions was a presentation from
a team at Southampton who are undertaking a National Institute for Health Research-funded study,
‘Accessing Medicines at End-of-life (ActMed)’ [URL: www.journalslibrary.nihr.ac.uk/programmes/hsdr/
165223/#/ (accessed 19 March 2021)].
A total of 48 stakeholders attended the two workshops (Nottingham, n = 29; Leicester, n = 19]. A wide
range of professional and PPI representatives with interests in SPC, community service provision,
pharmacy, research and education were included. Table 7 shows the breakdown of attendees by
professional grouping. The largest overall group of stakeholders was the 10 people engaged through
PPI. We also had representation from 11 nurses working either in hospices or working in the community
as CNSs in palliative care. Alongside two consultants in palliative medicine and a further two hospice
community liaison personnel, we had considerable engagement from SPC services. We were also pleased
to see participants from our university education teams who were keen to incorporate the findings into
evidence-based teaching, particularly for the non-medical prescribing course.
Participants were provided with three questions to consider within their allocated theme. These provided a
degree of uniformity between the groups and acted as a starting point for discussion (Box 10). Participant
identifiers have not been added to the direct quotations included in this chapter. Some are example of
written feedback on notes that participants left anonymously at the end of workshops. Others are taken
from recorded round-table discussions in which it was not possible to identify individual speakers.
System and complexity
Participants acknowledged that health and social care systems were complex and that the different
parts did not always intersect well:
The system does not support people dying at home, especially re [regarding] availability of medicines
when needed suddenly, despite policy push for death at home.
Some also recognised that constant changes to services and their titles, based on funding availability,
meant that even as HCPs they were not always knowledgeable about what was available for patients
in their area. Reflecting the findings from the HCP interviews in workstream 1, it became apparent
that, although interdisciplinary discussions were considered important, most of the HCPs attending
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expressed limited understanding of roles outside their own. The system and complexity discussions
focused on issues around communication, information and advice, and the difficulties for different
HCPs and sectors in responding to patient need.
Participants noted communication as a core issue within all systems, citing the need for better
communication between HCPs and families and between different HCPs, especially GPs and pharmacists.
Issues around the sharing of patients’ medical records were raised several times. Sharing these between
HCPs was considered to facilitate communication, but it was often not considered possible to share
records, such as across primary and secondary care and with community pharmacy. ‘360-degree patient-
held records’ in the home along with the promotion and implementation of ACP were suggested as ways
to support improved communication between HCPs and between HCPs and families.
Participants felt that it was important that patients and families should be given numbers to call for
ready access to help and advice, including OOH:
I think the problem with when you’ve got a lot of people involved is that it does end up going back to
the relatives or carers or the patient themselves and that’s where it does tend to fall down . . . it’s very
disjointed and unfortunately it’s the patient and carer who get left to deal with it.
TABLE 7 Workshop attendees
Role Nottingham (n= 29) Leicester (n= 19) Total (n= 48)
SPCNs 4 7 11
Consultant in palliative medicine 1 1 2
Community hospice teams 1 1 2
Community clinical nurse
specialists (HF and PD)
1 2 3
Research nurses 1 1 2
Pharmacy 5 1 6
PPI 7 3 10
Academic: lecturers 3 1 4
PhD students 2 0 2
Researchers 4 2 6
Dual roles 1 (PhDa student and nurse)
1 (PPIa and PhD student)
1 (pharmacista and lecturer)
HF, heart failure; PD, Parkinson’s disease; PhD, Doctor of Philosophy.
a Counted above by this initial title.
BOX 10 Prompt questions for group discussions: system and complexity
l How should we balance the issues of risk and responsibility for patients and FCGs managing medicines
in the home at the end of life?
l How can we set up better processes to enable patients and FCGs to access responsive help in a crisis?
l What could and should be the role of the pharmacist in supporting patients and FCGs to achieve
optimal medicines management at the end of life?
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However, they acknowledged that our data demonstrated that this clearly did not always happen.
Who should be responsible for giving out this information was less clear, particularly when services,
such as district nursing or SPC teams, were not in place. Key/case workers who could function as
a central point of contact and care co-ordination were considered beneficial for patients. However,
there was no agreement about who might take on this role or how this could be accommodated
within current health or social care systems. Participants voiced the need to empower patients
to self-manage and have strategies in place to avoid and respond to crises. They also acknowledged
the difficulties involved when patients lacked necessary information or knowledge of where to seek
advice and support. SPA lines that offer a 24 hours per day, 7 days per week (24/7), telephone helpline
were considered a good resource. Again, it was acknowledged that knowledge of this service was not
widespread and most workshop participants felt that they did not cater for medication-specific queries.
Participants recognised that, in relation to medications, the complexity of the system and its multiple
parts could mean that there were many points at which things could go wrong:
System of medicines’ management is flawed, there’s overprescribing, stockpiling, waste, etc., sometimes
you lose sight of that actual person.
Participating HCPs reported considerable issues with lack of staffing, increased caseloads and systemic
problems leading to staff burnout. Some also felt that systems and policies had made HCPs overly
risk averse, with too few taking the time to assess individual risk against the level of responsibility that
families were willing and able to take on. Discussion led participants to agree that systems at the end
of life needed to be streamlined, with fewer professionals involved and an emphasis on simplifying
medications. Again, a designated key worker or case manager was considered an asset in ensuring
that systems were updated and communication between professionals was optimised.
Pharmacists were judged to be underutilised, particularly in reviewing medications usage and
potentially expanding their role in the removal of medications from a patient’s home after death:
Pharmacists well placed – given increasing placement alongside GPs.
. . . pharmacists going to be key moving forward for managing medicines for all patients, but particularly
for patients that are disadvantaged or struggling.
However, with representation from a pharmacy in most groups, the limitations of the role of
pharmacists were clarified. Participants emphasised that pharmacists’ lack of access to shared
information and reduced budgets would hinder them taking on additional roles:
Pharmacists ‘are completely blind’: don’t have access to patient records, nor to other pharmacists’ records,
so only know of the prescriptions a patient has dispensed from their pharmacy. Summary record meant to
address some of the issues, but doesn’t, it’s ‘just a snapshot in time’ and pharmacists are not part of a
joined-up system.
Some participants also felt that pharmacists had an ‘image problem’ in that patients and families and,
indeed, HCPs were not aware of the roles that they could play in advising medication use. HCPs expressed
concerns that even if pharmacists did take on this wider role, patients may prioritise information from
their GP over advice given by a pharmacist, particularly in relation to stopping unnecessary medications
at the end of life. Deprescribing or rationalising medications could be a more active role for pharmacists.
However, some discussion was had about how this may lead to ‘difficult conversations’ about why
preventative medications, such as statins, were no longer necessary and whether or not pharmacists
would have the necessary skills to undertake, and potentially initiate, such end-of-life conversations.
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The work of managing medicines
The importance of the methodological design of the workshops to provide both dissemination of
findings and interdisciplinary conversations was confirmed when one group discussion was started by a
nurse who characterised the comments of many of the HCPs across the 2 days:
I work as a nurse in the community and I didn’t realise the responsibility we put on the patients’ relatives,
on medication, until this workshop. I didn’t realise we put a lot of responsibility on them and some of
things we expect them to know . . . [this patient] was taking the medication the wrong way, because of her
condition she got confused, every visit I had to go and explain, no you should be taking this at that time,
this at that time. I ended up writing a simple format . . . for them to understand it, [to] do it correctly and
today I just realised we just put so much on them.
As part of exploring how the ‘work’ being undertaken by patients and families could be reduced,
discussions centred on communication, co-ordination, information and prescribing medications (Box 11).
As noted in System and complexity, good-quality communication between HCPs, between HCPs and
families, between primary and secondary care, and between HCPs and pharmacists was considered the
foundation of delivering good end-of-life care. One PPI participant suggested that the default starting
point should be to ‘assume patient and family know nothing’. Again, a key co-ordinator or key worker
was noted as important, but there was debate about whose responsibility that could and should be,
and acknowledgement that ultimately this often fell to the family caregiver. Consequently, family
caregivers need to be included in discussions about medication and care and should have their insights,
knowledge, reports and concerns listened to:
Listen to patients/carers about what they have noticed. Often key information is overlooked because we
think we have the answers [as clinicians] without knowing full context of situation.
Increasing the number of regular home visits was also considered to improve rapport, understanding of
the patients’ needs and to avert crises.
Clearer, tailored information was considered essential in not only reducing workload but also anxiety
and stress for families. Although all considered verbal information to be essential, backing this up with
written information and ways to support families to instigate their own medication charts was featured
as a central issue. As the nurse quoted above demonstrates, reiterating information verbally over and
over may not work. As shown in Chapter 6, listening and retaining complex information is extremely
difficult for patients and FCGs during a time of considerable strain and exhaustion. This was also
considered important when regimens were changed, such as when patients were discharged from
hospital. PPI participants emphasised the need for clearer information about who families could
contact for help and support. Echoing findings from the case studies and BFCG interviews, participants
acknowledged that information and training about the use of medication and equipment often fell
through the gaps, with no one taking responsibility for this.
BOX 11 Prompt questions for group discussions: work
l How can HCPs reduce the ‘work’ for patients and families?
l What do you find works well in practice?
l What do you find to be the biggest challenge?
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Discussions about prescribing and medicines use centred on ways to simplify regimens and to make
medicine-taking easier. It was suggested that a simple planner could be provided to include the dose,
time that it should be taken and what the medication looks like. Medication no longer needed should
be removed, both from repeat prescriptions and physically from the home. Patients should not have to
wait for their medicines to be ready when they were discharged from hospital, and a member of staff
should go through the medications with the patient and FCG before the patient leaves. Pre-emptive
prescribing of AMs was reported to be essential and reassuring for HCP and families.
Within the groups, some of the biggest challenges were reported to be not just a lack of co-ordination
but uncertainty about who should assume responsibility for undertaking this role (i.e. ‘there are a
number of fingers in the pie with only the FCG, a rookie, trying to co-ordinate’). Many HCPs felt that
delays were often caused by a lack of access to records and the limitations of written records owing to
time constraints. Nurses highlighted an issue with delays in their ability to administer prescribed AMs
when there was a lack of written authorisation for them to do so:
Use of electronic records can be problematic, in that there is nothing in the patient’s home to indicate
what is happening/why; number of patients live alone and depend upon HCWs coming in and all they
have is the MAR [medicines administration record] charts; need paper, patient-held record in home.
A lack of paper records in the home was also seen as problematic by CNs, as it restricts their
knowledge of who is coming into the home and what they might be doing or prescribing.
Alongside the problems, some participants identified things that worked well:
What works well in practice? Every aspect – somewhere – but not consistently everywhere,
e.g. 24-hour line.
These included systems that enabled effective sharing of electronic records, medication reviews being
undertaken and electronic repeat prescriptions. Good communication, especially between key HCPs,
was thought to be facilitated by involvement of palliative care services and GSF registers that
promoted interdisciplinary discussion. Patient-held records or communication books in the home were
simple but effective ways of co-ordinating care. The importance of HCWs as a source of support for
FCGs as well as patients was emphasised, particularly as a means of enabling patients to remain at
home despite intensive care needs.
Diversity and disadvantage
Discussion groups that focused on the diversity and disadvantage theme deliberated a number of the
same issues raised in the other two themes, but with greater emphasis on advocacy, holistic care
planning, capacity issues and a system that facilitates a joint health and social care approach (Box 12).
BOX 12 Prompt questions for group discussions: diversity and disadvantage
l In your experience, what are the key issues in medicines management for patients from culturally
diverse and/or socially disadvantaged groups?
l What measures do you put in place to support patients in these groups?
l How could support for managing medicines in these groups be improved:
¢ at an immediate and practical level
¢ at a policy or health services level?
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A dedicated person or advocate was considered key to supporting people with additional needs. This
person built a relationship of trust and was able to co-ordinate care by providing a case management
approach. For ethnic minority communities, this would be a person who could mediate cultural
differences and potentially provide support through translation. Language barriers were recognised to
be a specific issue for medicines management when patients and FCGs did not read or write English:
When there is a language barrier we quite often get people to write on the [medicines] box in their
own language.
There was a call for care planning that addresses needs more holistically to include mental and physical
health, as well as end-of-life care wishes. A disconnect between physical and mental health services,
as well as between health and social care services, often left gaps in provision and responsibility for
patient welfare:
The care available [informal/formal] is much more vulnerable to being inadequate to provide the help the
person needs. E.g. if someone is seen as being ‘inappropriate’ or there are ‘safety risks’, care is reduced/
removed to protect the carers. Then the person who needed the help with meds is even more vulnerable.
General practitioner registration was reported as a barrier for some (e.g. the homeless). In general, the
discussion groups recognised the need to ‘look at the individual’ and ‘stop trying to fit people into groups’.
Participants in the discussion groups cited a range of experiences, identifying key issues from culturally
diverse and disadvantaged groups:
At point of discharge home from hospital – takes some time to set up an [interpreter] and we have them
for an hour, so we have to get everyone within that hour; complexity can be disincentive, but good service
to have; having interpreter can take the anxiety out of the situation, knowing patient understands;
resource limited, and where does it go from there.
In particular, some individuals had experience of patients and family members with mental health
issues, illustrating issues around risk assessment in the home being based on the assessor standards
and how advance statements of patients’ wishes can be useful if professionals are confident in carrying
them out:
In mental health [we] have a lot of advance statements, saying these are the people I want to deal with if
I lose capacity, I give you permission to talk to them and like that, so . . . they’re more and more common;
professionals need to be confident that they hold legal weight if they are to follow them, and this
probably includes at the end of life.
A particular example of the intersection, or its lack, between mental and physical health was
highlighted by one professional as they recounted a recent patient’s circumstances. The professional
explains how both the patient and the FCG had mental health issues, with the patient having an
additional diagnosis of advanced cancer:
Two individuals who were being managed by psychiatric services who said well we don’t know anything
about cancer and then when you try to, we got support from specialist services in palliative care but
not a bed because her behaviour was very chaotic . . . so we tried to manage it as best we could, but . . .
the carer was giving not only her medication to the patient but the patient’s medication and the dog’s
tablets. It resulted in the GP going out at 8 o’clock in the morning, the Macmillan nurse out at 7.30 in the
morning to give medication to sort things out and then we had to safeguard the whole situation because
the patient was vulnerable . . . it was almost like they had been invisible and unseen until this happened,
they had been muddling along . . . until this physical manifestation of illness came into play . . . it kind of
showed the cracks.
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Conclusion
The workshops were an important way of disseminating the study findings and creating a wider
interdisciplinary discussion about the issues these raised. These were very well-attended events and
attracted a wide range of professionals, students, teaching staff and PPI representatives, although
the absence of GPs was unfortunate. We tailored the group discussions to narrow the focus within
the time constraints of the day, and this has helped to consolidate our analysis of the data from the
previous two workstreams and to shape the chapters of this report. The themes clearly resonated with
participants and they engaged extremely well with each of them, providing detailed discussions and
comprehensive written notes.
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The study findings have documented the considerable effort required by patients and their FCGs in
carrying out the complex work of medicines management for serious illness. This tended to intensify as
the patient’s illness progressed, especially in the last months and weeks of life. This progression was
depicted in the BFCG interviews and two patient case bereavement interviews in which participants
looked back and reflected on the death of their relative. Families varied in terms of their circumstances
and composition and in relation to the resources that they could mobilise through their informal and
professional networks. Patients gradually relinquished responsibility for managing medicines to FCGs,
usually to one key individual, with some tasks delegated to others (e.g. collecting prescriptions from
the pharmacy). The key FCG was usually a spouse, in the case of couples, and an adult son or daughter,
in the case of patients who lived alone. Where the patient was affected by progressive, long-term
chronic illness, FCGs had gradually adopted the role of carer. Where onset was unexpected and
deterioration rapid, FCGs could find themselves making a much more hurried transition to the role.
Primary FCGs who were spouses tended themselves to be old and affected by frailty and poor health.
Problems with prescribing and accessing medicines were frequently reported, by lay and professional
participants, especially in critical situations and those arising OOH.
Families developed more or less elaborate and personally effective systems for managing medicines
and recording use. The onus was on the patient and FCG to find out how to navigate a complex system
of care. This could take a great deal of time and involved a considerable amount of luck, as well as
effort. Patients and FCGs varied in the extent to which they felt supported by the professionals and
services with which they interacted. The development of a strong relationship with a key professional
was an important (but not sufficient) determinant of a positive experience of care.15 Lay participants
remained vulnerable to changes in a system over which they had little understanding or control.
Although broadly appreciative of the care that they received from an NHS that they perceived to be
under-resourced and under strain, lay participants described an experience of services that were
often bureaucratic, task focused and poorly co-ordinated. Patients and FCGs described taking on
the role of care co-ordinator, maintaining vigilance in their dealings with professional services and
the medicines that could be prescribed, and changed, by different HCPs. They maintained and
communicated up-to-date information about the patient’s medicines and tried to fill in the gaps in
interprofessional co-ordination and communication. FCGs were frustrated when professionals failed to
recognise their expertise and lived experiences, on the one hand, and their concerns and apprehension
about managing complex and potent medication regimens, on the other.15,152 Lay participants were
overburdened with responsibility and did not feel that enough information had been provided to
give them confidence, especially in relation to administering controlled drugs. FCGs described feeling
that they were left alone to work things out for themselves. They came to realise that information
and resources were available within the system, but these were effectively hidden because they were
not made aware of their existence and often discovered only by chance.
Lay participants appreciated and worked to establish stable systems of care within informal and
professional networks. Patients and FCGs valued continuity, particularly if they had established good
relationships with individual HCPs. However, consistency of service rather than individual staff
members was generally accepted. Problems and delays in accessing services, and problems of
communication between and with professionals and services, were frequently encountered and
criticised. Changes to personnel – either because of arbitrary shifts in the system or because of
changes in the patient’s illness and circumstances – were out of participants’ control, but could have
significant consequences for their well-being. Discharge from or transfer between services could
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rupture established relationships and routines and disrupt carefully established regimens of medicines
management. Families could be overwhelmed by rapid changes in the patient’s condition and in the
medicines prescribed to control distressing symptoms in the last stage of life, especially when a
cascade of care and different prescribers entered the fray, as well as new and different services.
In the intensely charged period during which the patient was dying, families could find themselves
dealing with professionals who had no knowledge of the person, but assumed responsibility for
making very significant decisions about their care. This applied particularly to urgent home visits,
especially made during OOH, and contacts to emergency services and helplines. BFCGs described
widely different experiences of their relative’s death and the period leading up to it. In some cases,
symptoms were well controlled. Others described the experience of their relative dying as intensely
distressing, with poorly controlled symptoms, especially pain, and lack of access to prompt or effective
professional input.
Health-care practitioners acknowledged the work of patients and FCGs in managing medicines and
sometimes expressed awareness of the demands and burdens that this could impose. However, they
tended to assume the willingness of FCGs to shoulder the responsibility for home care and do whatever
they could to support their relative, particularly to remain at home, without being fully aware of what this
personally entailed for the individual within the domestic setting.152,153 Professional participants, particularly
nurses, described giving patients and FCGs explanations about how to use their medicines and sometimes
undertook a review of what had been prescribed. Beyond that, they did not often follow this up and
enquire about how these were being managed or proactively investigate whether or not any practical
problems were arising. The pharmacist’s role was usually confined to supplying prescribed medicines and
participants found their home delivery service valuable. However, both professional and lay participants
identified problems of supply and access to medicines, especially controlled drugs and OOH.
The burden of treatment
May et al.7,74,154,155 have called attention to the excessive burden that health-care services impose
on patients and FCGs in complying with complex treatment regimens, and the need for these to
be streamlined and simplified to realise the goal of ‘minimally disruptive medicine’. Co-opted family
caregivers have become an essential resource that underpin the system of professional health care,
as the boundaries between private and professional spaces become increasingly blurred.2,4,5,8,33,131,156,157
Patients and FCGs are being asked to undertake tasks formerly carried out by professionals, but with
little, if any, training or supervision.14,31,60,158 The shift in cost and responsibility for care from institutional
to domestic settings is spearheaded by an ideology of ‘responsible citizenship’, a consumerist model of
health care that valorises personal autonomy and patient ‘choice’ and the expectation that most people
wish to age and die at home.9 However, little attention has been paid to the experience of patients
and FCGs confronting death at home or the challenges involved in providing intensive care.157,159–162
The Managing Medicines study has highlighted that dying at home is difficult and that FCGs require a
degree of professional accessibility and support, which is not always forthcoming.15 Failure to control
pain and other symptoms caused great anxiety and distress for patients and FCGs.8,33,42,46,163–165 HCPs
in the present study rarely conveyed a high level of awareness or insight into the difficulties families
confronted in handling either the responsibility or the sheer work of managing medicines, and the
amount of scarce time and energy that had to be expended on basic tasks. These included ordering,
obtaining, calibrating, administering, recording and storing medicines in the home, and liaising with
professionals about changes, errors and problems with prescribed medication.41,42,60,165 Patients and
FCGs often took on the role of care co-ordinator, maintaining ‘hypervigilance’39 in their dealings with
services and HCPs and filling in gaps in information and co-ordination between these. O’Hara et al.166
refer to the proactive work of patients and FCGs as ‘reaching in’ to create a ‘scaffold’ to support the
quality and safety of care and compensate for system complexity. HCPs did not often attend proactively
to the details of how patients and FCGs felt about managing medicines in the home, as well as the
practical difficulties and concerns they confronted while doing so and the tensions and conflicting
DISCUSSION
NIHR Journals Library www.journalslibrary.nihr.ac.uk
90
interests arising between patients and family members.14,19,167 The challenges involved in managing
medicines in the home can be intense, if not overwhelming, especially in the last weeks and days of
life.7,14,16,39,74 However, the realities of care remain overlooked in the policy and public166 perpetuation of
an idealised depiction of care at home as a prerequisite for accomplishing ‘a good death’.3,4,9
Navigating care in a complex and fragmented system
It is disappointing that patients and FCGs continue to report an experience of fragmented and poorly
co-ordinated care,19,39,126,131,155,157,159,168,169 especially in view of policy goals of seamless service delivery
following the End-of-Life Care Strategy in 200827 and resulting tools and processes such as the
GSF and End-of-life Care Pathway.170 More recently, there has been a great emphasis on the work of
Sustainability and Transformation Partnerships as a means of integrating and simplifying care.171 However,
the National Audit Office reports limited progress172 and a lack of robust evidence that these schemes
have delivered the expected benefits in reducing costs and hospital admissions and in improving patient
experience of care.173 Many local initiatives and commissioning bodies focus on horizontal rather than
vertical integration of services, especially in relation to social care. Expectations of the benefits to be
achieved through integrated care tend to outstrip evidence of their effectiveness, particularly in relation to
patient experience of treatment, possibly because the service developments involved appeal more to the
goals and values of professionals rather than the public.173,174 Notably, moves to achieve greater integration
of care have not yet succeeded in reducing the trend towards increased hospitalisation, particularly of frail
and terminally ill patients.175 Going forward, the NHS Long Term Plan176 aims to improve the efficiency and
convenience for patients by putting an even greater focus on integrated care systems, including increased
use of digital technologies and the creation of primary care networks to achieve greater integration of
services at a local level.,177 Whatever benefits the NHS Long Term Plan176 may deliver, it contains virtually no
reference to palliative and end-of-life care. Rather, it perpetuates a rhetoric of patient empowerment,
responsible citizenship and ‘transformation’, which has questionable relevance to the reality of dying,
particularly following the prolonged experience of comorbidity and frailty, which characterises the
epidemiological transition of the current century.1
Participant experience reported in the Managing Medicines study showed that current levels of
integration between the primary and the secondary care interface was largely insufficient during
transfer to and from home to hospital. Families’ experience of care was shaped not just by the
relationships established with individual HCPs, but by how these professionals inter-related with each
other.15,98,99,178,179 Consequently, the lack of timely and effective communication between hospital and
community HCPs resulted in confusion and delays for patients’ access to medicines. Patient and FCGs
described the considerable time and effort required to resolve these issues.The dysfunctional consequences
of complex, bureaucratic and poorly co-ordinated systems of health care affect HCPs as well as patients and
FCGs. For example, DNs described being subject to the same difficulties as patients in telephoning through
to GPs or practice receptionists when seeking advice about changes to use or prescribing of medicines.
Professionals, as well as lay participants, found the health-care system hard to navigate, having access to only
a partial knowledge of its component elements. HCPs tended to have little knowledge or understanding of
the functions and roles of specialist services and professionals with whom they did not regularly interact.
The hospital–community divide was a case in point. In our construction of patient case ecograms, it became
quickly apparent that much of an individual’s network (lay or professional) is invisible to others. Keeping
track of rapidly changing developments involving different services and personnel was challenging, especially
when information sharing was impeded by use of different electronic systems. Professionals who had no
knowledge of the patient could be charged with making significant decisions about care and treatment.
Patients’ and FCGs’ partial understanding of how the health-care system worked, alongside its lack of
responsiveness, was one reason for making direct use of hospital accident and emergency services.180
However, this could also result from familiarity, as participants had worked out the most effective ways
of accessing the help that they needed. A cluster of patients affected by COPD bypassed community
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staff and their GP and called an ambulance directly to take them straight to hospital when they
realised a relapse in their condition was imminent.180 These individuals had a good understanding
of their illness and felt confident about managing this within a simple network with few active
professional links. There is not necessarily a direct connection between complexity and a negative
experience of uncoordinated care, although this is suggested by our analysis and is a question worth
exploring in further research. Moreover, patients with complex networks tended to engage directly
with a small number of professional contacts, with many other links being episodic, marginal or
negative. For example, in contrast to the simple networks of the patients with COPD, the patient cases
with the most complex ecograms tended to the least functional. For example, although aware that he
was included in the PRISM (Pathway and Referral Implementation SysteM) scheme, an integrated care
system or ‘professional hub’, Mr Crispin had no idea what this involved and did not perceive any
benefit. His GP, in contrast, was enthusiastic about a scheme that he felt had potential for linking-up
multiple services and sources of professional expertise on which he could draw. However, it is precisely
this multiplicity that can prove problematic for patients. It is possible that schemes, such as PRISM,
may be more attractive as a resource for professionals than for patients and their families who value
consistency and simplicity, rather than change and diversity in their dealings with the health-care
system.154 An alternative model is based on the development of self-governing Buurtzorg nursing
teams developed in the Netherlands and trialled elsewhere, including in the UK. Rather than work on
mechanisms to integrate a complex array of specialist professional services, this model is based on
‘integrating simplicity’. Small teams of CNs work together within a flat organisational structure to
provide all aspects of health and social care and organise referral to additional specialist services
as required.181–184
Feeling supported by the system: the role of the key professional
The availability of a HCP who took on the role of a key professional (or key worker) was highly valued
by the families who had managed to establish such a relationship. In a few cases, participants
characterised staff at a particular clinic or hospice day service collectively as their key contacts.
A key professional relationship helped participants to feel safe and, also, to ‘feel known’ within
the system.39,153 This was the ‘go-to’ person when problems or queries arose, who had an in-depth
knowledge and understanding of their case and could proactively help in navigating the system.
The benefit of a single point of contact has been reported in other studies.39,131,185,186 In the Managing
Medicines study, key professional relationships were established with HCPs from community, hospital
and hospice settings, and tended to be with someone in a nursing role, occasionally a GP or consultant.
These relationships seemed to develop serendipitously from an elective affinity between the parties
involved (agency), rather than the result of deliberate allocation or organisational properties of the
system (structure). There is considerable scope for this role to be routinely formalised and developed
further. The role of the key professional could be flexible and wide ranging, including, for example,
co-ordinating and liaising with services and other HCPs to simplify and streamline care and mitigate
the negative impact of change. It could include providing and sourcing information about medicines,
reviewing and optimising medicines prescribed and used, identifying and explaining changes that
needed to be made, as well as providing training and support to FCGs in taking on the responsibility
for more challenging aspects of medicines management, such as administering subcutaneous injections
and judging dose and frequency of pain relief. The key professional could play an important role in
liaising directly with prescribers regarding medicines-related issues, regardless of whether or not
they were themselves prescribers.126 Key professionals could also help families make appropriate
judgements about when and where to access help – reportedly a widespread concern – and support
FCGs to achieve credibility and a voice within the wider system of professional health care.8,39,180
Although the role of the key professional or key worker has been widely advocated as a quality marker
and means of co-ordinating end-of-life care,185,187 these did not feature in cases reported in the study.
The one participant who mentioned having specifically been allocated a key worker had never met or
had any contact with the individual concerned.
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One of the most frequently expressed shortcomings of patient and FCG experience of the health-care
system was that, from their perspective, the system was insufficiently responsive to the needs of
patients when they were dying. Participants felt that this circumstance merited special consideration
and that there should be a co-ordinated way for the system to acknowledge and share information
to expedite effective help. It may well be that professional recognition of the patient’s prognosis had
been logged and shared, for example, through general practice GSF meetings, but this information,
and subsequent decisions about care, was not communicated to families.188 Families who had been
coping well could quickly feel out of their depth as the patient’s symptoms changed or worsened in
the days or weeks prior to death. At this point, having rapid access to responsive sources of help
that are available 24/7 was critical to their capacity to cope. This was another point at which ‘being
known’ within the system was significant. Having repeatedly to tell and retell one’s story to different
and frequently anonymous 111 telephone service staff was alienating and frustrating. Only a few
participants had access to a SPA telephone number. This was helpful, particularly in providing a sense
of security, regardless of whether or not the service was used. However, it was likely to have been
discovered by a chance encounter, rather than a systemic process of information provision. Contact
with helpline services was frequently medicines related. At the time of the study, neither 111 nor
the SPA services were specifically equipped to deal with medication-related issues. The introduction
(November 2019) of an NHS Community Pharmacist Consultation Service within the 111 service is
welcome. However, it is not clear from the current specification that this service could resolve many
of the urgent queries and concerns reported by participants in the study, particularly around use and
access to controlled drugs for patients receiving palliative care. Moreover, access is through referral
from a GP or the 111 service, rather than direct. Cancer patients were more likely than others to
have access to 24/7 helplines provided by local palliative care and hospice services, but this was by
no means always the case. Provision appeared to be idiosyncratic and patchy. Nationally, the provision
of specialist 24/7 helplines for patients approaching the end of life is reported to be available in a
relatively small number of areas,189 despite being recognised as a priority.23,168,190
Communication and complexity
Poor communication between patients and HCPs is a frequently cited source of dissatisfaction and
experience of poor end-of-life care.168,191 The nature and function of small-world networks seemed to
be a key determinant of the quality of experience of communication and care by patients and families,
including whether or not the GP and pharmacist had an efficient system of co-ordinating medicine
prescriptions and supply (and ironing out problems arising from these), and whether or not the GP
had confidence in the judgement of DNs about use of AMs.124 The efficiency of transfer of information
between staff and services was crucial. HCPs greatly appreciated the efficiency of communication
when the same information technology system was used by different services and enabled full access
to patient records. Where this was not the case, bottlenecks were described, including delays in
specialist clinicians communicating with GPs, lack of integration between systems of electronic records
(e.g. EMIS and SystmOne) used by different parts of the system and lack of information available to
OOH clinicians and CPs.192 Lack of access to patient medical records has been cited as a particular
barrier to effective medicines management,19 including use of AMs,99 and greater engagement of
pharmacists within palliative and end-of-life care.22,55,57,97
Specialist versus generalist care
We were interested to see if there was a discernible difference between the care experiences of
patients affected by cancer as a primary diagnosis compared with those with diagnoses other than
cancer, and among patients who had received SPC and those who had not. All patient cases and the
deceased relatives of BFCGs who had been affected by cancer had been referred for SPC, as had
most of the others, although cancer patients evidently had more extended input. Some participants
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who had not received SPC input had long-term support from disease-specific CNSs who were
experienced at caring for patients at the end of life. However, too many individual factors relating
to the type and stage of illness, the point at which referral was made and the extent and duration of
SPC input made it difficult to systematically compare this aspect of care across the relatively small
number of participants included in the study. The same applies to patient and FCG experience of
hospice care. Most participants were positive about this, especially those who had long, established
relations with staff and services. However, participants who were not referred to hospice did not
report less satisfactory care. It should be noted, in either case, that there was no clear correlation
between participants’ assessment of the care they had received and whether they felt that good
symptom control had been maintained or ‘a good death’ achieved. Participant experiences – and
their assessment of these – were variable and complex.
Diversity and disadvantage
The intrinsic disadvantage affecting all patients experiencing terminal illness is compounded through
additional sources of vulnerability, such as living alone, having physical or sensory impairment, or
experiencing social or economic disadvantage.189,193–195 The study sought to incorporate diversity in
participant experience and to include patients and FCGs from minority and hard-to-reach groups that
are medically underserved and not well represented in mainstream research.79,82,83 In this context,
diversity referred to patients affected by conditions other than cancer, from ethnic minority groups, or
to patients who were affected by the often interlinked factors of socioeconomic disadvantage, sensory
or physical impairment, severe mental illness, living alone, homelessness or substance abuse. The small
amount of research into end-of-life care for disadvantaged groups has focused primarily on issues
relating to inequality and access to services, rather than the challenges of symptom control and
medicines management.82,196–199
We achieved inclusion of diversity in illness condition, particularly in the patient cases, and in
incorporating the experience of patients with additional disadvantage, such as living alone, being
affected by sensory or physical impairment, dementia and learning difficulties. The sample included
limited representation of the experience of ethnic minority participants, all three of whom were from
Asian backgrounds. We were not able to directly recruit participants affected by serious mental illness,
homelessness or substance dependency. Recruitment of all participants to the Managing Medicines
study was challenging, particularly those from diverse or particularly vulnerable groups. We depended
on clinical gatekeepers to identify eligible participants and provide them with information and an
invitation to take part in the study. Understandably, clinicians were protective of patients whom they
perceived to be particularly vulnerable and with whom they felt it was not appropriate to broach
participation in the study. However, we did obtain some insight into the particular issues of medicines
management with patients affected by serious mental illness, substance dependency and homelessness
from the detailed accounts of specific cases given in the HCP interviews. The key issues reported
related to problems with prescribing, safe storage and disposal of controlled drugs, problems in
symptom control, especially pain, when medicines were not easily accessible, and maintaining contact
with individuals, particularly those without safe accommodation or access to FCG support.199
Several HCPs described their proactive and innovative responses to such problems and the considerable
effort they were willing to make to support patients and FCGs affected by homelessness or substance
dependency, particularly their commitment to respecting individual preferences, even when these were
very much at odds with the mainstream. Overall, however, HCP accounts did not strongly feature care
of patients from diverse or minority disadvantaged groups as a significant aspect of their work. The
need for, or use of, translation services was not common. The Asian patients included in the study
described being enclosed within small but effective networks of family and community services, within
which their relationship with the GP who could converse in their native language was particularly
significant. Older patients may still rely on younger members of their family to communicate with HCPs
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and for knowledge and understanding of their medicines and options available for health care. Lack of
awareness of services, including hospice and palliative care, has been widely attributed as a cause of
reduced use among ethnic minority groups.84 It may be significant that none of the three Asian patients
had been referred to SPC. Their experience highlights issues of communication and literacy, which affect
more than individuals from ethnically and linguistically diverse groups. Beyond the domain of community
care, their FCGs reported similar problems in dealing with a complex and poorly co-ordinated system to
those described by other participants, and more widely in the literature.193,196
Reduced and late access to SPC is widely reported in the literature for all patients with diagnoses
other than cancer.193,194 However, patients from marginalised and vulnerable groups are less likely to
receive palliative care, and when they do this is likely to happen at a late stage of their illness.79,198,200
People who are homeless and/or affected by additional difficulties, such as serious mental illness or
substance dependency, die at a considerably younger age than the rest of the population.197 HCPs are
less likely to recognise that younger people are approaching the end of life.189,196 Accessing effective
pain and symptom management is difficult, particularly when professionals lack experience with
addiction or if patients are unwilling to disclose their drug use.201 Vulnerability on the streets, substance
misuse and limited access to pharmacy makes the management of medications an additional complexity
when someone is terminally ill. The storage and administration of medications in hostels is also reported
to be problematic, as staff have no training in this area.196,202 The challenges resulting from system
complexity and poorly co-ordinated services affect all patients, but are compounded for those who are
vulnerable and marginalised within mainstream health care.189,196 The results of this study support wider
calls for the need for further research among diverse vulnerable and disadvantaged patient groups,
specifically with reference to how medicines management is undertaken as individuals approach the
end of life. The experience of patients experiencing severe mental illness should be a priority, as these
have been a particularly neglected group.198
Risk and responsibility
The challenges of meeting the increased demands of home care, including medicines management,
have not been adequately acknowledged. The strongly promoted policy preference for dying at home
has created normative expectations of FCG support for dying relatives. Many families may be strongly
committed to this outcome, but by no means all.203 Patients may lack available family members or
other sources of informal support, especially those who have outlived their spouses and are living
alone. Notwithstanding the desire, families may lack the resources or capacity to provide home care,
particularly if FCGs are themselves old and in poor health or living far away.3 Lay and professional
attitudes to risk involved in medicines management, including use of controlled drugs in the home,
vary widely. Some families felt that they were handed more responsibility than they felt comfortable
with managing. They felt intimidated by the task of storing and administering controlled drugs, which
outstripped their capacity to cope.3,8,42,126 Participants in the Managing Medicines study, as in others,
have commented on concerns about causing harm by giving relatives the wrong dose of medicine,
particularly pain relief, and about making the wrong judgement about when and how much medicine
to give.42,61 Their anxiety is compounded if support and advice is not readily available round the clock.
Other participants were willing – sometimes keen – to extend their role in managing medicines and
learn techniques of administration, such as giving injections, administering AMs, replacing syringe
driver cartridges or managing dialysis.112,133 Taking a proactive role could be valued as a means of
providing rapid pain relief and reducing dependence on HCPs. FCGs could be frustrated when
professionals did not acknowledge their competence and expertise.131
Professionals varied, also, in their personal thresholds of risk acceptance or aversion and how they
assess the competence of families and the suitability of the home environment. Some families were
willing to assume greater responsibility for patient care than HCPs are willing to delegate.131 The
question is how should considerations of risk and responsibility be balanced, and in such a way as to
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take account of the consequences of changes in the patient’s illness trajectory? This applies especially
when the work involved in medicines management is conflated with intense emotional engagement
and distress arising from deterioration in the patient’s condition and the anticipation of death being
imminent. In the Managing Medicines study, we found that some FCGs who had developed confidence
in managing medicines regimens during relatively stable stages of the patient’s illness found their
equilibrium disintegrated with the changes in symptoms and prescribing occurring in the last weeks
or days of the patient’s life.
These findings raise issues about what it is reasonable to ask families to do, and how the limits to
family engagement can be acknowledged and tailored to individual resources and situations and the
changes occurring over time.131 Schemes extending family involvement in managing medicines for
dying relatives have proved successful, especially in Australia, where the logistics of distance and
geography prompt innovative solutions regarding access to professional help.57,129,131 Local schemes or
research projects have been undertaken in the UK, but are not widespread.133 Regardless of the role
that patients and families wish to take in medicines management, it is important that this should be
explicitly discussed, agreed and kept under review throughout different stages of the patient’s illness.
All patients and FCGs should have round-the-clock access to responsive, expert help and advice about
medicines management and symptom control.23,61 There is considerable scope for use of telemedicine-
related technologies to facilitate this access, and it is likely that these will remain more widely used
following the COVID-19 pandemic.204–208
The widespread practice of anticipatory prescribing has increased the amount of controlled drugs stored
in patients’ homes, often for an extended period of time.68,124,209,210 Many of these are not used, raising
concerns about the risk of misuse or criminal diversion and waste.99,126,211 Beyond the observation that
relatives should be informed that they should return controlled drugs and other unused medicines
to the pharmacy after the patient’s death, there do not seem to be any procedures for monitoring
how such drugs are disposed of in the home.212 HCP participants monitored the supply, storage and
use of controlled drugs while the patient was alive, but appeared to pay little attention to their fate
afterwards. FCGs expressed concern about storage of controlled drugs in the house and about their
role in administering these to patients. They were keen to remove them from the house following the
patient’s death, and several expressed concern and resistance to being allocated responsibility to return
them to the pharmacy (see Chapter 7). It seems that little is known about the disposal of AMs in the
community and that it would be helpful to have clearer procedures for these. However, FCGs and some
HCPs felt strongly that family members should not be handed responsibility for this task.
The role of the community pharmacist
Historically, the CP role has been marginalised from the mainstream MDT, with a focus limited largely to
medicines dispensing and supply.101,213 More recently, professional and policy initiatives have provided
opportunities for CPs to substantially extend their role and to engage directly in patient care. This
includes services such as new medicines reviews and providing vaccinations, blood pressure checks and
non-medical prescribing.102,214–218 The public are encouraged to consult CPs for advice about treatment
of minor ailments as a means of reducing the load on general practice and community health-care
services.216 This is in the context of a continuing anticipated decrease in the number of GPs, DNs and
community matrons.219,220 The recently introduced NHS Community Pharmacist Consultation Service
provides access to pharmacists through referrals from GPs and the NHS 111 telephone service. This is
intended to reduce the pressure on acute emergency services.177
To date, however, CPs have played little part in supporting medicines management at home for
patients receiving palliative and end-of-life care.221 In the Managing Medicines study, CPs were
considered primarily suppliers of medicine, with little acknowledgement of potential for greater
involvement. Pharmacists and other HCPs, including GPs, rarely reported that other HCPs asked
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CPs for advice about drug choice and prescribing issues. Where discussion occurred, it tended to
be about what the CP could/did stock and possibly alternative brands/products if a prescribed drug
was not in stock. There were no references to CP involvement in non-medical prescribing by any
participants within the study. This is in accordance with wider findings that the practice of non-medical
prescribing among CPs and other HCPs who have completed training is low, especially in palliative and
end-of-life care.102,109
Patients and FCGs preferred independently owned or smaller-branch community pharmacies, as
well as those attached to general practices, which were more convenient. Home deliveries were
valued by most participants who received these, particularly when access would otherwise have been
difficult. However, one consequence of this service was the reduced face-to-face contact with patients
and FCGs, hindering the scope for more direct involvement in care. Indeed, when the process of
prescription and supply was running smoothly, the pharmacist’s input to the process tended to go
largely unnoticed and unremarked. Several patients or FCG participants observed that they preferred
to collect their prescriptions directly because they welcomed the personal contact with pharmacy staff
and the opportunity to discuss their medicines and ask questions. This also contributed to the sense of
‘being known’ by staff and services within the system, which was an important component of a positive
experience of care. The study findings illustrated the impact that a more proactive stance on the part
of pharmacists could have in optimising patients’ experience of using medicines. Examples include
pharmacists taking the initiative to streamline or automate the process of accessing medicines, in
contacting the GP to resolve prescribing issues and in suggesting alternative formulations (e.g. liquids
rather than tablets) that would be easier for patients to take.
In relation to end-of-life care, CPs remain an underused resource.55,101,221 Recent initiatives within
the UK have shown the potential contribution that pharmacists could make in supporting medicines
management for palliative care patients in the community, but these remain episodic, limited in
scope or disease specific.104 A number of barriers to greater integration of CPs within palliative and
end-of-life care remain hard to resolve.222–224 This is despite the long-standing commitment of greater
integration of community services within the NHS.219 This was most recently set out in the NHS Five
Year Forward View and subsequent initiatives,171,225–227 alongside the development and increased used of
digital technologies to improve access and communication between patients, HCPs and services within
the community and across the primary–secondary care interface. However, it is acknowledged that
progress has been slow. Most patients are not feeling the benefits of better co-ordinated care.181,226
The nature of the relationship between GPs and pharmacists was an important determinant of patients’
and FCGs’ experience of medicines access and supply. Where communication and organisation were
good, and a well-worked-out collaboration established, the process of medicines supply went smoothly
and problems that did arise could be promptly resolved. When it was not, participants described
experiencing delays or errors in their prescription and having themselves to make the effort to
intervene and get the issue sorted out. Although access to summary care records is now established,
lack of access to full patient medical records has been frequently cited as a major barrier to greater
CP involvement in patient care.178,192,228 This contrasts with the situation in other European countries
where shared access has been long established.228 Pharmacists reported that without knowledge of the
patient’s medical record, they had no way of knowing that he or she had been flagged as end of life,
although eventually they may deduce this from the drugs prescribed. It is not just CPs who are affected
by problems of information sharing, separate information technology systems also make it hard for
HCPs from different services to communicate and co-ordinate care.227
The Royal Pharmaceutical Society (London, UK) has estimated that CPs could prevent 10% of GP
consultations and 5% of accident and emergency attendances.104 However, barriers to greater
involvement of CPs in patient care are long-standing. Apart from issues of professional hierarchy
and marginalisation, there are problems of cost, payment time and other resources. Some local
schemes have enabled CP access to patient medical records. However, as was evident in the Managing
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Medicines study, patients receive prescriptions from different prescribing sources and may have to
access them from more than one pharmacy, which makes access to records more difficult. It also
remains to be established whether many CPs actively wish to engage in end-of-life care or prefer
other forms of service development and diversification.229
The contribution of domiciliary home health-care workers
The study findings highlight the important and hitherto neglected contribution made by domiciliary
HCWs in supporting dying patients at home, including managing and administering medicines. This
support is particularly important for older people living alone who wish to remain at home.36 Some
patients in the study had long-term support and intensive packages of care. In other cases, domiciliary
care was in place only to cover a critical period of days or weeks prior to death. HCWs undertake
a wide range of tasks, not least of which is providing companionship and emotional support for
patients and their FCGs.230 In relation to medicines management, a wide variation was reported in
the tasks and responsibility undertaken by HCWs, from prompting patients to take medicines to
directly administering controlled drugs. This reflected diversity in provider organisations and training.231
However, families reported the very significant contribution HCWs made to their ability to cope
with care at home. The scope for greater training and involvement of HCWs in supporting medicines
management in end-of-life care for patients dying at home is an important area for further research.
Strengths and limitations of the study
The substantial body of qualitative data collected by the Managing Medicines study enabled a very
detailed account and comparison of the experience and perspectives of patients, FCGs and HCPs
about the work of managing medicines for seriously ill patients being cared for and dying at home.
The interviews with BFCGs provided complete narratives of the experience of illness and process of
care through the last months of life and the patient’s death. The professional interviews provided
comparative perspectives from a wide range of different roles and highlighted the limited understanding
of the difficulties and demands of medicines management frequently experienced by patients and family
caregivers, as well as concerns about the difficulties of giving as well as receiving care in a complex
system, within which communication and co-ordination of services was often difficult and inefficient.
The patient case studies gave insight into how patients and FCGs adjusted to the process of care, as
symptoms and medicines changed over a period of several months and enabled us to triangulate data
from a range of different sources (i.e. patients, FCGs, HCPs, photographs, observations and review of
medical records). A longer period of follow-up would have deepened our understanding of families’
experience of managing medicines in end-of-life care, but was beyond the resources available to the
project. The cases included patients with very different conditions and circumstances. Alongside the
singularity and diversity of individual experience, our analysis also identified recurring themes relating
to the two broad issues of the work of medicines management and the impact of a complex system of
care on patient experience, resilience and access to resources. It was not the aim that the study findings
be directly generalised to other settings, but rather to provide in-depth insight into patients’ experience
and practice. However, they are supported by findings from the limited number of previous studies from
the UK and wider international literature.
It is the nature of qualitative research that the focus of investigation develops in its own terms as the
study progresses. Lines of enquiry and topics of interest that were not initially envisaged may become
apparent, as do the practical limits of realising original objectives in complex real-world settings. We
had intended to recruit a substantial number of participants from diverse patient groups and minority,
underserved and disadvantaged communities; however, we found recruitment of these participants to
be particularly challenging. In part, this was likely due to issues such as language barriers and cultural
differences around talking about death and dying. We were, however, successful in recruiting patients
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with conditions other than cancer, those with disabilities or dementia and those from a range of rural
and urban, affluent and economically disadvantaged areas. The three ethnic minority families recruited
to the study were Gujarati, and we did not manage to include participants from a wider range of ethnic
backgrounds. Nor did we succeed in directly recruiting patients affected by substance dependency,
serious mental illness, homelessness or other forms of social disadvantage. Some insight into the
particular difficulties of managing medicines in end-of-life care for patients as well as HCPs was
provided by the accounts of professional participants who had experience of supporting individuals
experiencing different forms of disadvantage.
Diversity of diagnosis was achieved in the sample by recruiting through different services that were
sometimes approached directly or on other occasions through referral from someone with whom the
research team already had a working relationship. The latter process was most productive. Recruiting
diversity in terms of ethnic minority participants was harder to achieve. The research team did not
start with established connections within relevant communities, which take time to build. This reflects
the fact that this aspect of the study was a late addition, requested by the funders, rather than an
integral part of the study design. The team made efforts to recruit through five different community
groups operating in Nottingham and Leicester. However, this resulted in recruitment of only one BFCG.
It was not appropriate to attempt to recruit patients to take part in case studies through community
groups, given the sensitive nature of the research. For this, we were dependent on our clinical gatekeepers,
who reported that patients from diverse and underserved groups made up a small part of their caseload.
At the outset, we were interested to see if there was a discernible difference in the care experiences
of patients affected by cancer as a primary diagnosis compared with those who were not, and among
patients who had received SPC and those who had not. This distinction turned out not to be relevant,
however. All patients affected by cancer and some of those who were not had received input from
palliative care services. Most patients who had not been referred to SPC had long-term support from
disease-specific specialist CNs who were themselves experienced at caring for patients at the end of
life. In addition, it was not feasible to compare the experience of patients at different stages of their
illness in relation to the extent and duration of palliative care. Too many individual factors made it
difficult to systematically compare this aspect of care across the cases. A comparative focus on groups
of patients affected by specific conditions would be required to explore this question.
A further intention, at the start of the study, was to undertake a simple qualitative analysis of how
the work of medicines management was distributed across patients’ social networks, including both
informal and professional sources of care. The process of completing the ecograms provided a prompt
for participants to think through and reflect on the nature and significance of the different kinds
and sources of support they received, including those that were negative or absent. However, the
elusive nature of the social network and their representation quickly became apparent. Participants
approached the task of drawing an ecogram with widely different perspectives and commitment.
Ecograms drawn by different participants in each case varied in the links identified and how these
were assessed. They were often very selective and contained many omissions. The study revealed the
extent to which individual ecograms are a construction, or artefact, of the interview and setting in
which they are produced. As we wished to gain an idea of the range of individual networks and the
resources to which participants had access, we opted to draw on all relevant information available
throughout the case. Consequently, the ecograms reproduced in Appendix 1 are quite deliberately a
composite, or construction of the researchers rather than the individual participants. We have been
careful not to overinterpret the comprehensiveness or significance of an interpretive exercise in
reconstruction. However, taken together with the wider data we have about each case, the ecograms
have enabled us to easily visualise and compare the network of care, including informal and professional
links and the range and nature of contacts, as a way of aiding analysis of each case. They also provide a
simple way of exploring the range and distribution of informal and formal contacts and their significance
within each case, particularly the importance of relationships and communication between HCPs and
professional services, as well as between patients and professionals.
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Finally, we have omitted consideration of the fifth objective as stated in the study protocol. This
referred to the formulation of empirically founded recommendations for service development and
effective commissioning to improve the care and experience of patients dying at home, and that of
their FCGs. However, it is a condition of Health Service and Delivery Research programme funding
that project reports should not make recommendations for policy or practice. Consequently, we have
framed our implications for practice in terms of topics and priorities for future research.
Conclusion
The Managing Medicines study has documented the work involved in managing medicines at home
for patients approaching the end of life as a core part of a considerable burden of care. In this respect,
it adds considerably to the available literature on this topic, particularly through the case study
triangulation of professional, patient and FCG perspectives, and the narratives of BFCG’s experiences
of the period leading up to the patient’s death. The findings reveal the resourcefulness of many
participants in developing routines and schedules of medicines management and the process of
gradually working things out as they grappled with the confusion and impenetrability of a complex,
fragmented and bureaucratic system of care. They also highlight the extent to which families struggled
with different tasks and stages of illness, particularly in the weeks and days prior to the patient’s
death. The difficulties caused by complexity, the need for 24/7 SPC help for dying patients and
their families, and the value of a key professional to help families navigate the system have been
widely reported over a considerable time. NHS policy has been directed towards developing effective
solutions and a clear vision of streamlined, supportive and co-ordinated care. Integrated care remains
a long-term goal and the commitment to providing 24/7 access to support for terminally ill patients is
well established. Translating this vision into reality remains elusive, but must surely be based on an
understanding of patient and FCG experiences and perspectives of illness and what is most valued in
the provision of excellent health care.
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Chapter 10 Conclusions
The Managing Medicines study identified two key and inter-related areas in which patient and FCGexperience of managing medicines at home in end-of-life care could be improved: (1) reducing the
work of medicines management and (2) improving co-ordination and communication in health care.
The complexity of the health-care system and requirements for patients to access multiple parts
meant that there were many points at which things could go wrong. The burden of treatment theory
proposes that improvements to patient and FCG experience of care require an understanding and
modification of the structurally dysfunctional elements of health-care systems, rather than focus
entirely on intervening at the level of individual practices, such as improving communication skills.
Access to support, resilience and coping capacity is mediated through the resources available to
patients, the relationships that they have with people in their personal and professional networks, and
beyond that through the wider connections – or disconnections – that these links have with others.
The NHS has struggled to achieve systems of user-friendly integrated care that centre on the patient.
NHS costs and unscheduled hospital admissions continue to rise despite ongoing efforts to reduce them.
Despite a rhetoric of patient choice and patient-centred care, there is little evidence that such initiatives
start from an understanding and receptiveness to patient and FCG experience or perspectives about
care, and the changes required to improve this. The Managing Medicines study collected a detailed body
of qualitative evidence that we hope will increase professional awareness and understanding of the
substantial challenges faced by patients and FCGs managing medicines in the home at the end of life
and how they may be better supported in this endeavour.
The detail and complexity of the case study data provide a sense of the everyday work that families
undertake in managing medicines and the associated demands incurred over time. The BFCG
interviews provide accounts of the process of caring for a dying relative in its entirety, in which
participants reflected on their experiences throughout a process that was usually very challenging
and intrinsically distressing. The triangulation of professional, patient and FCG perspectives in the
longitudinal case studies provided insights into the problems confronting different stakeholders over
time and how they attempt to resolve these. The quality of the connections between HCPs and
services have a direct impact on patient and FCG experience of prescribing and access to medicines.
They also affect if and when the patient is recognised to be dying and the treatment and prescribing
decisions that follow. The patient case studies and BFCG interviews enabled an analysis of what
patients and FCGs valued in their dealings with health services and professionals and how they worked
to navigate a complex, bureaucratic system of care. They also expose areas of concern, including lack of
access to rapid and effective support when problems arose, especially in the weeks and days prior to
the patient’s death. The professional interviews revealed the considerable efforts and resourcefulness
that HCPs could bring to bear in addressing issues of medicines management for terminally ill patients,
especially those affected by disadvantage. They also reveal the extent to which professionals often
had a limited awareness of the burden of treatment confronting families and the difficulties that they
encountered, particularly in accessing help during a crisis.
The study aimed to explore the different perspectives of key stakeholders in the context of medicines
management as a collaborative effort between families and professionals. Within a complex system of
care, which many participants (professional as well as lay) experienced as fragmented and uncoordinated,
effective collaboration was often lacking. Where many professionals and services were involved in
an individual case, lack of communication and joined-up care increased the burden of treatment, as
everyone ‘gave’ but no one ‘took away’ accumulating tasks and medicines for the patient and their
family to deal with. The scope for improving patient and FCG experience of care is considerable, as was
illustrated by participants’ accounts of positive experiences. These included effective sharing of medical
records and information about the patient, the scheduling of pharmacist medication reviews, efficient
systems of electronic prescriptions, good communication between key professionals (particularly
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between hospital consultants and GPs, and between GPs and CPs) and active management of GSF
registers. The role of the key professional (or key worker) could include supporting and co-ordinating
the patient’s care, checking understanding and use of medicines, calibrating capacity and preferences for
undertaking specialist tasks relating to medicines administration, and judgement about administering
pain relief to dying patients. However, these examples of good practice were patchy, operating at a local
level and dependent largely on interpersonal relations between agents, rather than being an outcome of
the wider integrated or co-ordinated system.
It was often the patient or, especially as illness progressed, the FCG who assumed the role of
care manager, trying to co-ordinate care and maintaining ‘hypervigilance’ about the impact of
professional input, especially to prescribing changes. Initiatives to develop integrated care tend
towards proliferation of services and linking professionals from different specialist areas and expertise.
However, families can find the resulting increase in inputs and visits bewildering and demanding.
Moreover, it was evident from the patient case ecograms that complex networks usually contain
obsolete, vestigial and negative links. Families valued simplicity and a reduction in the number of
services, people and visits to contend with. Those who had established a relationship with a key
professional benefited from their ability to act as intermediary between a wide range of additional
services, reducing the need for patients and FCGs to maintain vigilance and themselves take on the
role of care co-ordinator. An important aspect of the key professional role was to promote transitivity
to ensure that different parts of the system were connected and communicating effectively with each
other. It also engendered a feeling for patients and FCGs of ‘being known’, buffering the impersonality
of the system and offering protection against the hazard of change, especially during the cascade of
care occurring often in the period prior to the patient’s death.
The involvement of a key professional was highly valued by families, but was not in itself enough to
optimise the experience of care. Key professional roles developed in an ad hoc manner during contact
with families and the personal relationships that developed as a result of this. However, the evidence
of this study indicates the need for a reorientation of palliative and end-of-life care services to more
closely correspond with the needs and lived experience of the patients and FCGs providing care at
home, including medicines management. The availability of key professionals and necessary information
should not be left to ad hoc, chance discovery. With increasing specialisation, service delivery has
developed in such a way as to fragment care and contribute to a complex system. However, patients
and FCGs, especially when they are old, severely ill and frail, find it difficult to understand or navigate
and are unable to cope with the demands of this complexity. Current policy aims to resolve the problem
of complexity through the strategy of integration of services and the development of professional
‘hubs’ that will bring together practitioners from a wide range of different services and specialties.
However, although this may improve efficiency for professionals, it does not engage directly with
patient perspectives and needs, nor does it necessarily reduce complexity for the patient. By contrast,
the Buurtzorg model aims explicitly to achieve simplicity through small teams of community nursing
teams undertaking all aspects of health and social care and co-ordinating involvement of additional
services as and when these may be required. This model incorporates a vision of the organisation of
end-of-life care as a community or public enterprise. However, the goal of integrated care or of health
care as a genuinely collective endeavour will not be realised until the patient perspective is placed truly
at the starting point of health-care organisation.
We complete this report of the Managing Medicines project at a time when the world is struggling
to overcome the effects of the COVID-19 pandemic. Rapid guidance from the National Institute for
Health and Care Excellence has already been issued, prompting changes in how AMs are prescribed
and used. To cope with the pressures of rising demand for end-of-life care drugs, and on professional
time, it is suggested that prescribers use long-acting formulations that can be administered by
subcutaneous injection, buccally, sublingually or rectally, and that these may need to be administered
by family members. This proposal will likely result in extending the role and responsibility of FCGs,
where they may take on extra responsibility in administering end-of-life care medicines in relation to
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the type of drug and method of delivery. It is unclear how the pandemic will change the experience
and practice of palliative and end-of-life care. However, it is likely that changes to practices that have
been made will not be easily be undone and that increased FCG involvement in administering AMs
may become the norm. This is asking a great deal of FCGs at a time of great anxiety and distress. It
highlights the urgent need for research into family experience of medicines management for seriously
ill patients during the pandemic, especially in relation to how AMs were prescribed and used, as well as
after. It is important to be mindful of the need for transparency and open discussion about the extent
to which patients and FCGs can and should be co-opted as proto-professionals in the technically and
emotionally demanding tasks of managing medicines at the end of life.
Implications for future research
The study findings indicate the following priority areas for future research:
l Studies should explore the role of the key professional as a means of (1) integrating and
co-ordinating care and prescribing, (2) supporting the family in optimising medicines management,
(3) acting as patient advocate in negotiating a complex system, particularly the interface between
primary and secondary care, and (4) negotiating the role that individual patients and FCGs are
willing and able to accept in managing medicines at home at the end of life.
l Studies should evaluate current initiatives to integrate care, including the extent to which these
(1) improve the communication nexus and incorporate a genuine understanding of and insight into
patient experience and perspectives of medicines management, especially at the end of life, and
(2) overcome traditional barriers to interprofessional working, particularly those preventing the
integration of CPs as members of the health-care team.
l Studies should explore the scope for extending the role of the CP into supporting patients and
FCGs with managing medicines in the home at the end of life. Research is needed into patient,
public and professional attitudes towards greater CP involvement and the kinds of support that
would be most useful.
l Studies should explore the effectiveness and value of radically different models of community care
that aim specifically at ‘integrating simplification’ rather than complexity (e.g. the Buurtzorg model).
l Studies should explore the current role of domiciliary HCWs in supporting medicines management
for seriously ill patients in the home, the scope for expanding this role in future and the training
and support needed to enable HCWs to undertake extended responsibility with confidence
and competence.
l Studies should explore the understanding, experience and attitudes of patients and FCGs towards
the prescribing and use of AMs, their preferred and actual role in decision-making relating to
prescribing and use, and how professionals initiate and conduct discussions about AMs with patients
and FCGs.
l Studies should investigate the experience of medicines management during terminal illness among
diverse vulnerable and disadvantaged patient groups, including ethnic minority groups, the homeless
and those with serious mental illness and/or substance dependency. The experience of patients
affected by serious mental illness should be a priority.
l Studies should explore the feasibility and effectiveness of a patient-held prescribing record and
medicines chart available for all prescribers to review and record changes made during
consultations and in the patient’s home.
l Studies should develop and evaluate use of digital technologies as a means of supporting palliative
care patients with medicines management at home, including access to help 24/7.
l Studies should investigate the COVID-19 legacy, how this affected anticipatory prescribing during
and after the pandemic, and changes in the way families engage in, and respond to, discussions and
decisions about, and administration of, end-of-life care drugs.
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Appendix 1 Case summaries
Code key for case summaries
Case summary: Mrs Clark
Family and living arrangements
Mrs Clark was a woman in her 40s, married and living at home with her husband and teenage
daughter. She retained responsibility for managing her medication during the period of interview data
collection, with support from her informal network (Table 8).
Background
Mrs Clark had been diagnosed with stage 4 ovarian cancer and within 9 months she had been told
that her condition was terminal and referred to hospice for SPC. In the last few weeks of life, she
had considerable pain that became increasingly difficult to manage and she subsequently died in the
hospice < 2 years after her diagnosis.
Managing medications
Mrs Clark took responsibility for ordering prescriptions using an application on her telephone, which
she also used to show her hospice consultant her GP record. She also organised the storage and taking
FIGURE 20 Ecogram code key.
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of her medicines at home. A weekly dosette box was used to organise her pills and an alarm was set
on her telephone to remind her of the times at which she should be taking medication. She also had a
file for letters and information regarding treatment and appointments, plus a notebook that she used
to keep track of the five oral medicines that she was taking at the time of interview (i.e. when she had
taken them and what kind of effects they had). Mrs Carter’s husband sometimes reminded her to take
her medication and had also learned to give injections. Her friend, who also took part in a research
interview, had provided extensive practical and emotional support, administered a daily anticoagulation
injection over an extended period, attended consultations and surgery with Mrs Clark and her
husband, helped her to organise and document her medicines and her reactions to them, and provided
moral support. Her sister collected her medication, including morphine, from the local pharmacy.
Mrs Clark felt well supported by the palliative care consultant at the hospice and regarded him as her
main point of contact (i.e. key professional) should she have any queries or worries.
Last days of life
Record reviews from her general practice and the hospice recorded Mrs Clark’s preferred place of
death as the hospice. Two weeks prior to her death, Mrs Clark was admitted to hospital after suffering
with increased nausea and vomiting, and several days later she was discharged directly to the hospice
for symptom management and end-of-life care. The hospice records indicate that symptom control
continued to be difficult. However, the GP records that Mrs Clark died 'fairly peacefully’.
Ecogram
Mrs Clark’s active network is quite compact and effective (Figure 21). She remained in charge of
ordering and administering her medications, even when she sometimes needed physical help to
do so (e.g. injections administered by her friend). Her key informal links were her husband and her
friend, who had had an unusual amount of involvement over an extended period of time. She had
been actively involved with an internet forum and made contact with another contributor whom she
corresponded with directly. The GP is a marginal figure in this network. The hospice consultant was her
key professional and she was also close to the SPC nurse and DNs, who had been regular attenders to
change her syringe driver earlier in her illness. Overall, Mrs Clark remained in charge of managing her
medications and was content with a system she experienced as being quite flexible and supportive
through her experience of rapidly progressing illness and ongoing issues with drug administration and
symptom control. There was no reported change in her network between interviews and no additional
services recorded in the period prior to death, rather an intensification of input.
TABLE 8 Case data: Mrs Clark
Participant Data collection
Patient stage 4 ovarian cancer Two interviews
Friend (FCG) One interview
Palliative care consultant (HCP) One interview
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Case summary: Mrs Carter
Family and living status
Mrs Carter was a widow in her late 70s who lived alone. She had a daughter and granddaughter who
did not live locally, plus siblings and their spouses who lived nearby. She retained responsibility for
managing her medication during the period of interview data collection, with support from her informal
network (Table 9).
Background
Mrs Carter was diagnosed with metastatic breast cancer and was affected by lymphoedema, which
made her left arm unusable while mobility in her right arm was decreasing. This made handling
medicines difficult as she struggled to undo bottles, pick up small pills or co-ordinate the pouring of
TABLE 9 Case data: Mrs Carter
Participant Data collection
Patient metastatic breast cancer, type 2 diabetes,
impaired kidney function
Two interviews
Sister-in-law (FCG) One interview
Palliative care consultant (HCP) One interview
Patient, sister-in-law Three ecograms
Three photographs
Medicines list
FIGURE 21 Ecogram: Mrs Clark.
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liquid medicines. Mrs Carter was under SPC from the hospice and enjoyed attending for day care.
The main issue in terms of medicines for Mrs Carter was to manage her pain while taking account
of her diabetes and impaired kidney function.
Managing medications
Mrs Carter took responsibility for ordering prescriptions by ringing the general practice when she
needed a refill. She organised the storage and taking of her medicines at home. This was difficult at
times because of her lack of manual dexterity. She used plastic containers to store her pills, which
remained in their packaging. Mrs Carter was able to remember what she should take and when, saying
that she placed the medicines in the box in a certain order, which aided her memory. She understood
what her medicines were for, although she struggled with the physical processes necessary for taking
her pills and to co-ordinate pouring medicine on a spoon. She managed small pills by licking her finger
to pick them up and transfer to her mouth. She had discussed this difficulty with her palliative care
consultant and they had agreed that they would leave things as they were for the time being.
Mrs Carter’s sister-in-law collected her medicines from the local pharmacy. As she was taking a
controlled drug, the prescription had to be on paper and signed for on collection from the pharmacy.
Mrs Clark felt well supported by the staff at the hospice, particularly the consultant who oversaw her
care and the PCN. She regarded the hospice as her main point of contact should she have any queries
or worries.
Issues with medicines
Pain was an ongoing problem for Mrs Carter and the pills that she was prescribed made her drowsy so
that she would fall asleep during the daytime. Her consultant had considered a bisphosphonate drip,
but a blood test had revealed that Mrs Carter’s kidney function was too poor to make this a safe
option. Instead, Mrs Carter was given a patch for pain relief and found that she was more alert than
when she was taking the pain relief pills.
A further issue for Mrs Carter was that her diabetes was not well controlled, as she was not physically
able to test her blood sugar levels herself. It appeared that no one was able to do this for her on a
regular basis and the DNs could not visit for this purpose. Staff at the hospice checked her blood sugar
levels when she went to the day hospice. Her consultant acknowledged this as a gap in care.
Ecogram
Mrs Carter had a relatively compact and simple network, which seemed not to be densely
interconnected (Figure 22). Key informal contacts were her daughter and her sister-in-law who did
quite a lot for her, including collecting her medicines. Several other family members and neighbours
provided at least social support. Mrs Carter had eight informal links (two of which were core) and
12 professional links (eight of which were active). One of these links (a hospice bereavement counsellor)
was added in between interviews. Four professional links were episodic, including the GP who features
in the sister-in-law’s ecogram, but not Mrs Carter’s. Her most significant professional contacts were
through the interconnected links of hospice day care, PCN and consultant.
Case summary: Mr Crump
Family and living arrangements
Mr Crump, the patient, was in his 80s and lived with his wife, his main carer, who was in her 60s. Both
Mr and Mrs Crump have adult children from previous relationships and Mrs Crump has a sister and
two friends who offer some support (Table 10).
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Background
Mr Crump had a kidney transplant some years previously and was still taking medication to support
his immune system. He also had vascular dementia, for which he was not taking medication, and type 2
diabetes. Until about 4 years before the couple joined the study, Mr Crump had managed his own
medicines. Gradually, his wife had taken over responsibility for these as her husband’s dementia had
got worse.
The couple had reduced their social activities over recent years and Mrs Crump was building up a
new support network through a dementia carers’ group of which she was a member. At the time that
Mr and Mrs Crump took part in the research, Mrs Crump still felt that it was safe to leave her husband
alone for a few hours, but believed that this was likely to change in the near future. The implications of
this worried her. Mrs Crump accompanied her husband to all his clinic appointments, GP consultations
and for any blood tests he needed to have. Mrs Crump found her GP very supportive.
TABLE 10 Case data: Mr Crump
Participant Data collection
Renal failure, dementia, type 2 diabetes
Patient’s wife (FCG, key respondent) Two interviews
Patient, patient’s wife, renal specialist nurse Observation of outpatient appointment
Patient’s wife Ecogram
Medicines list
FIGURE 22 Ecogram: Mrs Carter.
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Managing medications
Most of Mr Crump’s medicines were provided in two separate blister packs: one put together by
the GP and the other, which contained his immunosuppressant drugs, by the hospital pharmacist.
Mrs Crump managed this by combining the medicines into a weekly dosette box and adding in the
additional medicines that did not form part of either blister pack. Mrs Crump appeared to have a good
understanding of her husband’s medicines and what they were for. However, she acknowledged that if
there were a change and she needed to remove one of the tablets from the dosette box she would
struggle to identify it away from its packaging.
Issues with medicines
In addition to the two blister packs provided through the GP and the renal clinic, Mr Crump was taking
some drugs with variable doses, such as warfarin, which the pharmacist was unable to include in the
blister packs. This combined to make the process of managing her husband’s medicines challenging for
Mrs Crump. She set an alert on her telephone as a reminder of when he was due to take his medication,
but if she was occupied when the alarm went off she would defer giving him his pills and would sometimes
forget. Mrs Crump was then presented with the quandary as to whether or not to give him the missed
dose when the next dose was almost due. She also sometimes woke in the night to the sudden memory
that she had not given her husband his evening tablets. The schedule of medicine-taking was difficult to fit
within the schedule of their other activities and commitments, such as being ready for the ambulance to
take Mr Crump to a day centre on several days each week.
Ecogram
Mr Crump depended on his wife for all aspects of medicines management and administration, and
to remind and encourage him to take his medicines or he would ignore/forget them. This was quite
a committment, which, although shouldered resolutely, she nevertheless experienced as a burden.
Mrs Crump tried to retain some time for her own activities and interests, but expressed concern
that this would become increasingly difficult as her husband’s condition deteriorated. Mrs Crump was
very outgoing and enterprising in many ways, in engaging both with the system (social services and
benefits) and with informal support services, such as a local dementia support group, through which
she extended her social contacts and network (Figure 23). However, her main source of informal
support was one of her sisters, to whom she was becoming increasingly close, and also two friends.
Her sister and friends came to stay and they would go out on jaunts. Her husband went to a respite
home when she was away. For shorter stays, her sister and a friend had come to stay at the house
to look after her husband and give him his medicines. Mrs Crump’s key HCP was their GP whom she
described as being emotionally supportive and understanding. Mrs Crump had quite a wide informal
network, although most links seemed fairly weak. Despite moral and practical support from her friend
and sister, on a day-to-day basis Mrs Crump felt rather isolated and on her own. No SPC referral had
been made.
Case summary: Mr Crawford
Family and living status
Mr Crawford was a retired man who lived with his wife, who was his main carer, and his
daughter (Table 11).
Background
About 7 years before Mrs Crawford joined the study, her husband became unwell, initially becoming
forgetful and struggling to find the right words to use. It took 4–5 years and disagreements between
HCPs to obtain a diagnosis. One possible diagnosis was dementia and treatment was prescribed for
that. PSP was then mooted as a possibility, as Mr Crawford had a number of falls in addition to
memory difficulties. However, consultants disagreed and no specific diagnosis was offered, although
the focus was on PSP, and Mr Crawford was referred to a specialist Parkinson's disease nurse.
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Mr Crawford attended a day hospice, and for some time they had support from night sitters, carers
and occasional respite care.
Managing medications
Mr Crawford was prescribed different drugs by different HCPs at different times. Mrs Crawford took full
responsibility for the management and administration of these, although she found it difficult to keep on
top of the changing drug regimen. Initially, they had received blister packs from the pharmacist, but the
constant changes created waste, which was unacceptable to Mrs Crawford. She, therefore, moved to a
system whereby she filled a weekly dosette box, which she purchased herself, and created a written
record of the drugs her husband was taking. Their general practice had moved to an online system for
ordering repeat prescriptions, which Mrs Crawford did not like, although this was not possible for
controlled drugs. If Mrs Crawford had any queries she would contact the specialist Parkinson’s nurse.
TABLE 11 Case data: Mr Crawford
Participant Data collection
Patient: PSP No formal participation in study
Wife (FCG, key respondent) One interview
Specialist Parkinson’s nurse (HCP) One interview
Wife Ecogram
Medicines list
FIGURE 23 Ecogram: Mr Crump.
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Issues with medicines
Mrs Crawford worked hard to manage her husband’s care and medicines. She reported poor communication
with HCPs, exacerbated by the uncertainty created by the lack of diagnosis and disagreement between
professionals. On one occasion, Mrs Crawford received a telephone call from the general practice asking
her to pick up a prescription for medicines, which she later realised were AMs. The specialist Parkinson’s
nurse had discussed placing her husband on fast track, but no one had discussed AMs with either her or her
husband. Mrs Crawford felt that it was a matter of trial and error in relation to her husband’s medicines.
She also reported some errors that had been made, such as night sitters calling a DN to give Mr Crawford
morphine, when she had already given him Oramorph. She described maintaining vigilance over her
husband’s medicines and the prescribing decisions made by different professionals.
Last days of life
The specialist Parkinson’s nurse was interviewed after Mr Crawford’s death. He died at home, with
a syringe driver having been installed 2 days earlier. The nurse was uncertain whether or not any
of Mr Crawford’s medicines had been withdrawn as he was dying because she was unable to access
GP records.
Ecogram
Mr Crawford’s network was complicated (Figure 24), reflecting a large number of contacts over about
7 years, which was difficult in terms of working the system and coping with the increasing severity of
his illness, an unusual form of Parkinson’s disease. Perhaps the difficulties of diagnosis and treatment
set the scene for the family’s struggle and dissatisfaction with a number of elements of the system.
Mrs Crawford, her husband’s carer, was relatively isolated, with only a little help from her sister,
but no other informal links of help or support. There was a very complex array of professional links,
FIGURE 24 Ecogram: Mr Crawford.
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a significant number of which she expressed dissatisfaction with, including their GP and even elements
of the hospice and associated services. The ecogram had 28 links, including four informal links (one was
the PSP association), 24 professionals, no key informal supporter and nine negative links. There was no
key HCP. Mrs Crawford reported that caring for her husband and managing his medicines was an
ongoing struggle, in which they both felt all at sea.
Case summary: Mr Cole
Family and living status
Mr Cole, a man in his late 60s, lived with his wife who was in her late 50s. Mr Cole had a brother, a sister
and a niece living locally, and Mrs Cole had a son who was not local. They had a supportive neighbour who
would call to see them regularly and sometimes bring a meal for Mr Cole (Table 12).
Background
Mr Cole had multiple comorbidities for which he was taking a large number of medicines in different
forms, including tablets, patches and liquids. He had limited mobility and occasional confusion, perhaps
caused by the pain medication that he took. Pain was a big issue for Mr Cole. He was under the care
of a hospice and had experienced more than one admission in an attempt to manage his pain. He
had been discharged from hospice on a previous occasion on fast track, which had subsequently
been removed.
Mrs Cole had become blind as a complication of diabetes and was unable to eat or drink, being fed
through a PEG tube, with her medicines also being administered in this way, except for her insulin.
Mr and Mrs Cole described themselves as supporting each other.
Managing medications
Mr Cole, in particular, was on a complex drug regimen (daily), involving several different modes of
administration, which were handled by a HCW who came four times per day. The HCW also set up
Mrs Cole’s PEG. Mr Cole’s medicines were delivered routinely by the pharmacy in a blister pack,
without him needing to make a request or contact the GP. The pharmacy also sometimes rang to
check that everything was OK. Mrs Cole was impressed that after changes to her husband’s medicines
the system still worked well. The HCW put Mr Cole’s pills in a plastic cup and handed them to him to
take, applied/changed his fentanyl patch and handed him the insulin pen for him to inject himself.
TABLE 12 Case data: Mr Cole
Participant Data collection
Patient: complex co-morbidities including heart disease,
type 2 diabetes, kidney failure and prostate cancer
Three interviews (joint with wife)
Wife: blind, type 1 diabetes, PEG fed Three interviews (joint with husband)





Wife, HCW Observation of administration of PEG feed
Patient Medical record review
DVT, deep-vein thrombosis.
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Mrs Cole was able to manage checking her blood sugar levels with a talking device and injected herself
with insulin. In the early evening, a HCW administered Mrs Cole’s medicines through the PEG tube,
before connecting it to the food, which was administered overnight.
Mr Cole was well supported by the hospice and his PCN was the first point of contact in case of any
concern about medicines. Mr and Mrs Cole described their relationship with one of the HCWs who
came regularly to visit them as being ‘more of a friend’ than a professional.
Issues with medicines
The system by which Mr and Mrs Cole both received their medicines seemed to work efficiently on
the whole. However, Mr Cole was sent home from the hospice with a bag of AMs, although he was
not told that this was what they were. On at least one occasion, Mrs Cole’s GP prescribed medication
that could not be fully dissolved, which was unsuitable for her. It is notable that the couple were
completely dependent on the support of professionals in their day-to-day management of their
medicines and were in receipt of an extensive package of care.
Ecogram
Mr and Mrs Cole had complex health problems requiring intensive input from health and social
services (Figure 25). They reported having a good relationship with the HCW and the SPCN from
the hospice, who was their key contact. Different parts of their care system seemed to communicate
quite well: the SPCN and GP communicated to sort out issues, the GP and pharmacist liaised with
each other and Mr and Mrs Cole could communicate with the pharmacist about any problems with
prescriptions, which the pharmacist sorted out directly. Ordering and supply of medicines was handled
smoothly by the pharmacy. The couple did not have to put in a request for repeat prescriptions.
FIGURE 25 Ecogram: Mr Cole.
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The system even worked when Mr Cole was discharged from hospice with a new drug regimen,
although they later discovered that this included AMs, which they had not been told about. The SPCN
reported being ‘disgusted’ about this. The couple had one close and supportive neighbour. Mr Cole’s
brother-in-law and also Mrs Cole’s son who lived at some distance were accessible and involved if and
when necessary. However, the couple maintained a stance of independence and self-sufficiency, despite
increasing involvement of active help with the organisation and administration of their medicines.
The HCW had sorted out the considerable muddle in which their medicines were kept and set up a
good system of storage and administration. The HCW had considerable responsibility for supporting
medicines management, and also a very good relationship with the couple.
Case summary: Mr Collins
Family and living status
Mr Collins was in his 60s and lived with his wife, also in her 60s, who was his main carer. Adult
children and other family members lived locally (Table 13).
Background
Mr Collins had been ill for about 8 years, although was diagnosed with PSP only 2.5 years before joining
the study. It was originally thought that he had Parkinson’s disease and the diagnosis of PSP was made
following a brain scan. Although professionals were aware of this diagnosis, Mr and Mrs Collins were not
aware of this and discovered it only when Mr Collins was assessed by a surgeon for a hip replacement
operation and informed that the surgery could not take place because of the PSP.
Mr Collins attended hospice day care twice per week. Mrs Collins said that her husband experienced
incontinence, a level of confusion and restricted vision. He was also increasingly weak, to the degree
that his mobility was affected and he used a walking frame indoors and a wheelchair outside. He had
difficulty controlling his saliva, although a Botox (botulinum toxin) injection had helped. Mrs Collins
provided most of his care, believing that she knew him best and could understand his speech.
Managing medications
Mrs Collins managed her husband’s medicines effectively, although pain in her hands made physically
managing bottles and pill packets difficult. She kept a list of medicines and stored them in a tin, which
was kept in a cupboard with a list on it. Once per week, Mrs Collins made up a dosette box containing
the week’s medicines. Both Mr and Mrs Collins had an alarm on their telephones that was set to go off
when Mr Collins needed to take the next dose of medicine. Mr Collins carried his day’s pills with him
and knew that the alarm signalled when it was time to take his pills. Family members were aware of
this, as were the nurses at hospice day care.
TABLE 13 Case data: Mr Collins
Participant Data collection
Patient: PSP No formal study participation
Wife (FCG, key respondent) Two interviews




Observation of medication storage
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Mr Collins experienced a number of infections and had prophylactic antibiotics on hand, in case of
recurrence. However, Mrs Collins took an active role in deciding how to handle a developing infection
and believed that sometimes the key was to ensure that he drank plenty of fluids. Mr Collins’ medication
regimen was stable over the course of Mrs Collins’ study participation, although he had experienced one
hospital admission and received two courses of antibiotics.
The specialist Parkinson’s disease nurse was a key professional and the person to whom Mrs Collins
would go with any queries about medicines.
Issues with medicines
Mrs Collins reported that they had few issues with medicines. She found it difficult that she needed
to tell their story every time they met a HCP, particularly early on in the disease experience. The
main difficulty that they experienced was related to Mr Collins’ incontinence and the infections that
developed because of this. In addition, Mrs Collins was concerned about the impact of her husband’s
deteriorating swallow on his ability to take his (currently 14) medicines in future.
Ecogram
Mrs and Mrs Collins received good support from informal and professional members of their network
(Figure 26). Their key professional contact was a Parkinson’s disease specialist care nurse and they
also positioned the GP in a strong position in the chart, as well as the nurses at the hospice day centre.
In addition to available local family and community support, the couple was in touch with support
organisations such as the Carers Trust (Essex, UK) and PSP Association (Milton Keynes, UK). Mrs Collins
reported experiencing a marked improvement in care following the Parkinson’s disease specialist care
nurse’s suggestion that they agree to sharing their electronic medical records between HCPs involved
in Mr Collins’s care. This removed the need to continually retell their story.
FIGURE 26 Ecogram: Mr Collins.
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Case summary: Mrs Creasy
Family and living status
Mrs Creasy was a woman in her 80s who lived with her husband, who was her main carer. Mr Creasy
also had complex health problems (including cancer, diabetes and deafness). One of her daughters,
Ms Creasy, who lived nearby, also took an active role in caring for her mother, spending 1 day per
week with her parents. Her siblings, a sister and three brothers, were less actively involved in
providing support (Table 14).
Background
Mrs Creasy had a heart attack in her 30s, which was misdiagnosed and untreated. A second heart
attack in her 70s left her with heart failure, for which she was treated. Mrs Creasy was attending a
12-week course at the hospice, which she enjoyed. She had been taught some techniques by the
hospice to help her manage anxiety when she was feeling unwell and could not catch her breath.
She also used a fan to help her with her breathing.
Managing medications
Mr Creasy took responsibility for administering his wife’s medicines on a day-to-day basis, and the
couple’s daughter took charge of collecting the medicines and liaising with HCPs. Most medicines were
received from the pharmacy in a blister pack, which the family collected. Ms Creasy reported that she
felt alone and unsupported by services and that she had been unable to get social services support
for her parents. She also reported that her parents’ relationship was deteriorating and that her own
relationship with her mother was under strain.
Issues with medicines
Mrs Creasy had an allergy to a substance present in a number of medicines, and it was very difficult
to maintain a supply of medicines that did not contain this. Her daughter spent quite a lot of time on
the internet searching for information about medications and liaising with services and HCPs. Despite
her hard work, Ms Creasy had little satisfaction from her dealings with professional services. She
reported having to be quite vocal in her protests that medicines needed to be free from this allergen.
Her mother always needed to keep loratadine to counteract the allergy. Pharmacies tended to change
brands according to cost and manufacturing deals, which played havoc with their system, as new
medicines were likely to contain the allergen and apparently no one gave the family any warning.
Ms Creasy worked hard at reading the information sheets and trying to track down pharmacies that
stocked appropriate medicines, with variable success. Her father had to periodically make a trip to a
distant pharmacy to get one medicine. Other medicines were supplied by the practice pharmacy and
also other pharmacies according to supply and availability, which kept changing.
Ms Creasy also reported that her mother did not take her medicines as they were prescribed. Her husband
would take them out of the pack and hand them to her, but Mrs Creasy had told them that she did not
wish to continue taking some of her medicines and her husband had seen her throwing them away.
TABLE 14 Case data: Mrs Creasy
Participant Data collection (March)
Patient: heart failure, husband (FCG 2), daughter (FCG 1) Two interviews (joint)
Daughter (FCG 1) One interview
Daughter (FCG 1) Ecogram
Medicines list
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Ecogram
Mrs Creasy had an extensive network of professional contacts, but reported no supportive contact
or relationships with any individual or service. The family liked one GP at their local practice, but did
not see him often and he did not seem to be proactive in managing Mrs Creasy’s health issues. Care
seemed to be distributed across a disparate and rather ad hoc network (Figure 27), frequently involving
OOH calls and paramedics, resulting in several past hospital admissions. Different professionals tended
to change/add to Mrs Creasy’s prescriptions, which caused difficulties in getting these entered on
the system and in locating a source of medicines without allergens. There are a number of grey cells
in the network because of the struggle to get medicines and also services that were started and then
stopped. There are no real key professional contacts, which may be part of the problem. Despite
Ms Creasy being very proactive and engaged, she did not seem to have got the system to work for
them. There was a hospice day care referral, but it seems no active specialist nursing care (although a
heart failure nurse was included in the chart).
Case summary: Mr Cooper
Family and living status
Mr Cooper lived with his partner and both were in their 70s. They each had adult children from
previous relationships. Mr Cooper’s children lived at some distance and visited rarely. Mrs Cooper’s
children lived locally and visited quite often (Table 15).
FIGURE 27 Ecogram: Mrs Creasy.
APPENDIX 1
NIHR Journals Library www.journalslibrary.nihr.ac.uk
136
Background
Mr Cooper’s main health issues were MND and type 2 diabetes. He was confined to a wheelchair and
had only a little movement in his hands, although he had devised his own technologies that enabled
him to steer his wheelchair and hold his tablet. Mr Cooper received 24-hour non-invasive ventilation.
He felt that his voice and swallow had deteriorated between the first and the second interviews,
although he was still able to eat and take oral medications if he timed this well with his ventilator.
Mr Cooper had an extensive package of care from a private agency, with HCWs in attendance most
of the day. The care agency had a nurse whom they could contact in case of queries. A DN visited
twice per month, but was perceived by Mr Cooper to be able to offer little help. He was in contact
with an occupational therapist, attended the lung function clinic and saw a MND nurse during hospital
visits. Mr Cooper attended hospice day care and felt supported by the nurses who worked there.
He appreciated the equipment that the British Red Cross (London, UK) had provided.
Managing medications
Mrs Cooper took responsibility for keeping track of medicine supplies, ordering prescriptions online
and collecting medicines. Mr Cooper was prescribed nine oral medicines to take each day, one spray
and two others p.r.n. These were administered by HCWs and recorded on a medicines administration
record. Medicines were stored in plastic boxes on a work surface in the kitchen. This was not ideal, but
there was no other place that they could be kept. Mr Cooper felt that his GP would be his first port of
call in case of queries, including emergencies relating to medicines.
Issues with medicines
Mr Cooper’s partner had originally ordered prescriptions by ringing the general practice, but moved to
ordering medicines online and collecting them from the pharmacy. She preferred this system, which
she felt gave her more control over what was ordered. She did not wish to use the pharmacy delivery
service as she considered this to be unreliable. Mr Cooper was critical of his contact with and poor
support from the orthotics department and the supply and maintenance of his ventilation equipment.
This was critical because Mr Cooper depended on his ventilation machine to support his breathing.
Last days of life
Mr Cooper was given rescue medicines when he experienced breathing difficulties, but these did not
help. When Mrs Cooper called for an ambulance, the operator suggested moving her husband to the
floor to start cardiopulmonary resuscitation (CPR). When the ambulance crew arrived they enquired
about a DNACPR, which Mrs Cooper found and so the resuscitation attempt was stopped. GP notes
state that the patient died peacefully at home.
TABLE 15 Case data: Mr Cooper
Participant Data collection
Patient, MND, partner (FCG) and HCW (HCP 1) One interview
Patient and partner (FCG) One interview
HCW (HCP 2) One interview




Observation of medication storage,
NIV and tablet use
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Ecogram
Mrs Cooper was her husband’s key carer. Despite Mr Cooper’s disabilities and her own health
problems, they seemed to be quite a self-sufficient couple in the sense of being emotionally contained.
Some family members lived nearby, but they did not seem to be involved. They also had contact with
their neighbours, although these neighbours do not feature in the interviews. Some support was
provided by non-statutory agencies and services (Figure 28). Mr Cooper seemed quite proactive in
finding and using information. He had a moderate-sized professional network, but about one-third
were specified as free-standing rather than interconnected. No key professional was identified,
although the GP was specified as their first port of call. The intensive personal support provided by the
HCWs was the nearest to a key resource. Although they were positive about the staff and what they
did, neither Mr Cooper nor his partner seemed to engage with these individuals on a personal level.
Case summary: Mrs Crane
Family and living status
Mrs Crane was a widow in her 60s who lived alone in what had been the family home. She had two
daughters who visited but were not involved in the management of her medicines, and a friend who
visited 6 days per week and was a valuable source of support. A couple of neighbours also provided
support (Table 16).
FIGURE 28 Ecogram: Mr Cooper.
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Background
Mrs Crane had heart failure as well as arthritis in her knees, which caused her considerable pain and
sleep apnoea. She struggled to get upstairs in her home and had a lift installed to facilitate access to
the bathroom. She had a hospital bed in her living room, leaving just enough space for two armchairs
and a small television. She was visited twice per week by a HCW whom she considered a friend.
Her friend who visited regularly cooked meals for her and reminded her to take her evening
medicines, which sometimes Mrs Crane would forget when she was tired. Pain was a big issue
for Mrs Crane, as was tiredness because of her apnoea. At the time of taking part in the research,
she recognised that she was starting to need more support and was trying to secure further visits
from the HCW.
Mrs Crane attended day care at the hospice, which she enjoyed very much. When her time there
came to an end she was matched up with a hospice home visitor instead. Her HCW was a key
professional contact, as was the heart failure nurse whom she contacted via the SPA in case of
concerns about medicines or her health. Mrs Crane also regarded the hospice as an important
place for support. She had a DNACPR in place, which she had initiated herself about 1 year prior
to the interview.
Managing medications
Mrs Crane managed her own medicines. She received a blister pack from the pharmacist, as well as
several other medicines and inhalers. She was organised and knew what each of the medicines were,
if not their names, so that she could identify if something was missing or had changed, although she
found it frustrating that the pharmacist would change the brand without informing her. Mrs Crane had
attended the sleep clinic where she was given a continuous positive airway pressure machine that she
wore overnight, which helped her to breathe while asleep. This had improved the quality of her sleep
so that she was less tired.
Ecogram
Mrs Crane lived alone and was mainly housebound. She received a good deal of help from one friend
and a couple of neighbours. She also had some home help and extensive support from the hospice
(Figure 29). Mrs Crane took a lot of medicines (quite a complex regimen), which she was absolutely on
top of in terms of ordering arranging and sorting (some come in blister pack from pharmacy). However,
she relied on her friend, who visited every evening and prompted her to take these when she was
tired. She acknowledged feeling apprehensive about needing more organised help soon. Mrs Crane
disliked the pharmacist changing the brand of her medicines without giving notification. However, she
was willing to contact the pharmacy and her GP directly regarding any problems arising and other staff
through the SPA, if necessary.
TABLE 16 Case data: Mrs Crane
Participant Data collection
Patient: heart failure, arthritis, asthma, depression,
sleep apnoea
Two interviews
Patient and consultant in anaesthesiology and
pain management (HCP)
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Case summary: Mrs Choudhury
Family and living status
Mrs Choudhury was a widow in her 80s who lived with her son and daughter-in-law and one of their
three adult children. The family were originally from India and spoke Guajarati. Mrs Choudhury spoke
very little English, although younger generations of the family spoke this fluently (Table 17).
Background
Mrs Choudhury had angina, diabetes, arthritis and vertigo. She was unable to stand for very long and
required someone to be with her at all times. Her daughter-in-law was her main carer and the person
who undertook all of the household tasks. She also took part in the research interviews. Mrs Choudhury
was present during the interviews, but she did not contribute.
TABLE 17 Case data: Mrs Choudhury
Participant Data collection
Patient: angina, diabetes, arthritis, vertigo No formal study participation
Daughter-in-law (FCG, main respondent) Two interviews
Two photographs
Medicines list
FIGURE 29 Ecogram: Mrs Crane.
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In the past, Mrs Choudhury had a number of previous hospital admissions, but she was no longer
under hospital care. The family were told to come back to clinic if they needed to. The main source
of HCP support was the general practice at which there were two Guajarati-speaking GPs who were
considered by Mrs Choudhury’s daughter-in-law to provide excellent care.
Managing medications
Mrs Choudhury’s daughter-in-law took responsibility for administering medicines at the right time
and for monitoring her mother-in-law’s blood sugar levels. The medicines came automatically from
the pharmacy on a 4-weekly basis in blister packs. On occasion, Mrs Choudhury would have difficulty
breathing or experience a tight chest from the angina. She had a spray to use for this, but her daughter-
in-law reported that often it would be caused by something such as the room being overheated, and this
was easily remedied without recourse to medication. Mrs Choudhury’s daughter-in-law’s first port of call
in case of queries about medicines or her mother-in-law’s health was always the general practice. The GPs
were willing to do home visits, and when there was any need to make changes to her mother-in-law’s
medicines they would ensure that her daughter-in-law knew about it and understood what it was for.
Ecogram
Mrs Choudhury’s daughter-in-law provided intensive support for her and managed all aspects of her
medicines, which she was confident about and happy to do. The family had good relations with two
Gujarati GPs at their local practice, who liaised efficiently with the pharmacy if any drugs needed
changing. The network was small and self-contained (Figure 30). No other services were mentioned,
although Mrs Choudhury had had contact with the hospital in past. Staff there told her to come back
if she needed further attention, which seems not to have been the case.
FIGURE 30 Ecogram: Mrs Choudhury.
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Case summary: Mr Connor
Family and living status
Mr Connor was in his late 70s and lived at home with his wife. They had adult children but appeared
not to rely on them for support (Table 18).
Background
The couple had known that Mr Connor had kidney disease, but discovered that it was stage 4 only
when Mr Connor was told that he could not have a CT scan for his diverticulitis because it would
kill him. Mr and Mrs Connor had visited the renal dialysis unit, but Mr Connor had decided against
undergoing kidney dialysis. In addition, Mr Connor had type 2 diabetes and had experienced a stroke.
Mrs Connor also had health problems, including a heart condition and a problem with one of her legs,
which made walking difficult.
Managing medications
Mr Connor was discharged from hospital after his stroke, with his medicines in a dosette box. At
Mrs Connor’s request, their local pharmacy continued to supply his medicines in a dosette box and
also delivered them to the house. The couple found this helpful, although it did mean that they did
not necessarily know which tablet was which. It could also cause complications if the consultant made
changes to the medicines during a clinic appointment. On one occasion, for example, Mrs Connor went
backwards and forwards to the general practice and pharmacy five times to sort out an increase in the
dose of Mr Connor’s tablets. Mrs Connor supported her husband to take his medicines by putting the
pills into a small cup for him to take, morning and evening. She had also been trained to give her
husband erythropoietin injections into his stomach once per week.
If Mr and Mrs Connor thought that something was missing from the dosette box or prescription then
they would talk to either the pharmacist or the general practice. If they had a problem, however, they
would talk to the renal nurse specialist (CNS), although they said that they encountered very few
difficulties that they could not handle themselves. They both found the renal CNS approachable.
Last days of life
Records review from the general practice indicated that there appeared to be good support during the
last month of Mr Connor’s life, when the GP visited regularly without being asked. Mr Connor was on
the GSF register. He had a DNACPR order in place, giving his preferred place of death as the hospice.
This DNACPR could not be found and a new one was signed in the last week of Mr Connor’s life, giving
his preferred place of death as home. Mr Connor was visited by a palliative care CNS and DNs as
required. Approximately 1 week before Mr Connor died, his GP stopped most of his medication, and
4 days before his death a hospital bed was delivered to the family home and a syringe driver set up.
Marie Curie sitters were in place the night before Mr Connor died and the intention had been to allow
TABLE 18 Case data: Mr Connor
Participant Data collection
Patient: end-stage kidney disease,
stroke, diverticulitis, type 2 diabetes
Two interviews (joint with wife)
Wife (FCG) Three interviews (two joint with husband)
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Mrs Connor to sleep without being disturbed. Mr Connor died in the morning, with his wife and the
Marie Curie sitter present. Two DNs visited and called the GP to visit and verify death. Mrs Connor
asked to be left alone with her husband to wait for their son to arrive.
Ecogram
Mr Connor and Mrs Connor were an unusually self-contained couple. They did not include any informal
links in a very sparse ecogram (Figure 31) and referred only in passing to having obtained information
about the SPA from a friend. They had not used this, but appreciated knowing that it was available.
After Mr Connor’s death, his wife opted to wait for their son to arrive to help and this was the first
reference to their children’s involvement in the entire data set. They said that they did not have
any sources of support and would not have liked to ask anyone for help. This was in spite of quite
a large range of professional services and contacts being mentioned throughout the interviews. The only
significant links, from the couple’s perspective, were the renal CNS and the GP, who became increasingly
important as time went by, making several home visits, which were appreciated by the couple. They had
some past and episodic links and contacts, and good ongoing relations with the pharmacy, the renal
clinic and the consultant. There was an escalation in home services and equipment in the last days of
Mr Connor’s life. He died at home with his wife and Marie Curie sitters present. They had 23 links
(three weak informal links and 20 professional links, including the GSF register) and two close links with
the GP (increasingly towards end of life) and the renal CNS.
Case summary: Mrs Cramer
Family and living status
Mrs Cramer was in her 70s and lived at home with her husband (Table 19).
FIGURE 31 Ecogram: Mr Connor.
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Background
Mrs Cramer was diagnosed with a rare form of cancer. She had been admitted to the hospice in an
effort to bring her pain under control. This was successful and she was discharged home, as she
wished, for the last days of her life. Mr Cramer assessed his wife as being too ill to take part in the
research, but did so himself as he knew this was her wish. Mrs Cramer was discharged with a care
package, which included HCW visits four times per day to assist with her personal care.
Managing medications
On discharge from the hospice, Mrs Cramer and her husband were given a chart listing all of her
medicines, what they were for and when they were to be given. Mr Cramer found this very helpful.
By this stage, as his wife was unable to take charge of her own medicines, Mr Cramer took on this
role. Mrs Cramer was set up with a syringe driver and a DN visited every day to replenish this and
to keep an eye on how she was. Mrs Cramer had liquid medicine for pain relief, extra to the syringe
driver, in case of breakthrough pain and her husband would administer this if needed. The DN
monitored supplies of medication for the driver and reordered if necessary. They were also willing to
reorder other medicines if Mr Cramer asked them to. Prescriptions were generally delivered by the
pharmacy, but it was not a problem for Mr Cramer to collect them if necessary. Mr Cramer felt well
supported by professionals. He had a telephone number for the district nursing service and was also
able to ring the hospice in the event of any problems. He believed that his wife was given good care
and was pleased with this and the organisation of her medicines.
Last days of life
Mrs Cramer’s preferred place of death was her home and this was achieved as she died a few days
after her husband took part in the research interview.
Ecogram
At the end of her life, Mrs Cramer (and Mr Cramer) were supported by small informal and professional
networks that worked well (Figure 32). Their professional network was set up and co-ordinated by the
hospice. The DNs came daily to manage the syringe driver and Mr Cramer managed other medicines.
DNs were key contacts for medicines management. Mrs Cramer had an intensive care package of
HCWs who came daily but took no part in managing her medicines. The GP was the other significant
contact. Care was simplified after Mrs Cramer’s hospice admission and prior to her discharge home to
die. This put an end to aggressive treatments and confusing and effortful journeys to hospital. Over
half of the professional links mentioned in Mr Cramer’s account were no longer active.
Case summary: Mr Crispin
Family and living status
Mr Crispin was in his 70s and lived with his wife. One of their sons, who lived some distance away, was
active in supporting his parents, whereas his siblings lived further away and were less involved (Table 20).
TABLE 19 Case data: Mrs Cramer
Participant Data collection
Patient: cholangiocarcinoma (bile duct cancer) No formal study participation
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Background
Mr Crispin received a diagnosis of MND and experienced a rapid deterioration in his condition,
such that he died 6 months later. He retained full mental capacity, but by the time he participated
in the study he was severely disabled and unable to use his limbs, or to drink, eat or use the
toilet independently.
TABLE 20 Case data: Mr Crispin
Participant Data collection
Patient: MND, son (FCG1),
wife (FCG2)
One interview (joint)
HCW (HCP 1) One interview
Son (FCG 1) One interview
Three e-mails
GP (HCP 2) One interview
Two photographs
Medicines list
Observation of medication storage
and equipment
FIGURE 32 Ecogram: Mrs Cramer.
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Managing medications
Mrs Crispin obtained, stored and administered her husband’s medicines as required. These were stored all
over the house in a system that made sense to Mrs Crispin. Although she occasionally became confused
about his medicines, Mr Crispin monitored what he was taking and was able to help her sort it out. One of
their sons visited often and provided regular support. He was very proactive in managing his father’s
medicines and chasing up the system to get the best that he could for his father, especially with the GP.
He had a power of attorney for each of his parents. Mr Crispin’s diagnosis was made privately, and the
consultant had prescribed riluzole. Mr Crispin experienced a delay in obtaining subsequent prescriptions
and his care through the NHS. Mr Crispin had two carers, who attended four times per day, and a night
sitter. The family had AMs in the house ready, with pain relief and injections, in case Mr Crispin became
unable to swallow his medicines.
Mr Crispin’s son took an active approach to managing his father’s medicines and dealing with HCPs.
More than once, he initiated a review of his father’s medicines, which led to the stopping of something
non-essential. He believed that there was poor co-ordination and inconsistency between professionals
and services and felt the need to monitor his father’s situation. He felt that there was little communication
between professionals and little co-ordination of medicines prescribed. On one occasion, for example, a GP
added a drug to control secretions but did not remove the existing one, and it was the DN who noticed
that these two drugs should not be taken together.
A wide range of professionals and services were involved in Mr Crispin’s care. However, it was
difficult for both the family and the system to respond appropriately, given the rapidity of his physical
deterioration. The family felt, overall, that they had been left very much on their own to ensure timely
access to medicines and to work out a regimen of organising and administering these. A hospice
referral was made for Mr Crispin and he was visited three or four times by hospice staff.
Last days of life
Mr Crispin died a few days after he lost the ability to swallow. He asked for the DNs to be called out
to give him pain relief and then died peacefully later that same evening, with his wife by his side and
the HCWs present.
Ecogram
Mr Crispin’s large network included 25 contacts with people and services [four core family members,
23 professional and two ‘schemes’ (i.e. PRISM and Electronic Palliative Care Coordination Systems)]
(Figure 33). Of these, nine were significant/ongoing relationships with individuals or services, but three
(the GP, general practice and pharmacy services) were considered as unsatisfactory. HCWs were a core
resource. Other contacts were individuals or services that were used regularly but infrequently and/or
to supply equipment, specialist appraisal and assessment, such as the British Red Cross or speech and
language therapists. Specialist services, including the hospice/SPC nurse, MND nurse and community
matron, formed a cluster and the GP and DNs were connected, but not always positively. As Mr Crispin
became quickly and progressively more ill, a cascade of interventions seemed to have been directed to
his care. His son was particularly critical of the GP–pharmacy axis, which he felt lacked organisation and
continuity. There was no single key professional contact, although the HCWs were a very important source
of support as the illness progressed. The family maintained good enough working relationships with a lot of
regular services, including the MND nurse, community matron, hospice staff, DN and continence nurse.
However, they did not seem to have established close relationships with any of these. A confusing cascade
of care occurred close to the end of Mr Crispin’s life, including prescribing from different HCPs, which the
family found difficult to cope with.
Case summary: Mrs Chambers
Family and living status
Mrs Chambers was a woman in her 70s who lived alone. She had a daughter and son-in-law and a son
living locally, plus five grandchildren (Table 21).
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Background
Mrs Chambers experienced a range of health problems. Both her legs were amputated below the knee
and she was vulnerable to falls. She also suffered from phantom limb pain and had vascular disease,
diabetes, hypertension and cardiac cirrhosis. Pain was a big issue, which she tried to address with the
use of oxycodone hydrochloride (OxyNorm®, Napp Pharmaceuticals Ltd) taken as needed.
Managing medications
Mrs Chambers appeared to have a difficult relationship with her medicines. She received blister packs
that contained paracetamol from the pharmacy, but she said that she removed these because she had
no wish to take any more paracetamol. Mrs Chambers said that she had been told that she should
take her medicines on time, but also said that she had decided for herself what that time would be.
Although she received her pills in a blister pack, she then placed them in a dosette box on a daily basis.
She did not find the blister packs helpful because she struggled to get the pills out of them and
sometimes dropped the pills on the floor because her hands shook. This worried her because her
grandchildren visited and she did not want them finding and eating her pills. Mrs Chambers did not
ask for her medicines to be dispensed in this way, but thought that her GP and her daughter between
them came up with the idea.
TABLE 21 Case data: Mrs Chambers
Participant Data collection
Patient: vascular disease, diabetes, hypertension, cardiac cirrhosis,
bilateral amputation below knee (phantom limb pain)
Four interviews
FIGURE 33 Ecogram: Mr Crispin.
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Mrs Chambers was determined to retain her independence and was concerned that she would come
under pressure to move to supported living. However, she acknowledged that she sometimes got
confused over her medicines and it was not clear how reliably she took them. Although her GP had
provided her with a chart, it seemed that Mrs Chambers stuck to her own regimen of medicine-taking,
which involved splitting her tablets into morning and evening batches, with liquid morphine as needed
in between, quite a lot of this with variable effects.
Mrs Chambers’ daughter collected the medicines from the pharmacy. At the first interview, Mrs Chambers
expressed herself as content with the support that she received from her GP, who had gone through her
medicines with her and written out a list of them and when they should be taken. Mrs Chambers had also
had a consultation with a pain specialist at the local hospice. She said they had considered putting her on
ketamine, but had decided against it because she lived on her own.
Ecogram
Mrs Chambers’ complex health conditions and limited mobility left her in a very vulnerable position,
although she was adamant in wishing to maintain her independence and to continue living alone at
home. She received support from her family, particularly her daughter and son-in-law, and probably
more than she acknowledged. Her daughter fetched her prescriptions and it seems also liaised, to
some extent, with her GP and possibly others. A small professional network was described, with the
main contacts being her GP and the pain specialist whom she saw at the hospice (Figure 34). A few
other HCPs were involved on a regular basis (e.g. DN), but Mrs Chambers did not seem to have a close
relationship with these HCPs. On a day-to-day basis, there was no one to help her monitor or manage
her medicine-taking, which seemed fairly erratic.
FIGURE 34 Ecogram: Mrs Chambers.
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Case summary: Mr Church
Family and living status
Mr Church was in his 70s and lived with his wife in the family home in a small rural village. The couple
had made adaptations to their house to make it easier for Mr Church to maintain his independence.
They had two adult children and a grandchild living locally (Table 22).
Background
Mr Church was diagnosed with MND 2 years before joining the research study. Despite severely
restricted mobility, he still drove an adapted car and ran his own business. He also had asthma and
high blood pressure, and had previously experienced a transient ischaemic attack.
Managing medications
Mr Church was affected by complex comorbidities, including severe pain from arthritis. He assumed
overall management of his medicines, although his wife helped with organisation, fetching and storage.
His two children and a business employee sometimes collected his prescriptions. Mr Church had a lot
of trouble finding medicines without bad side effects, but was willing to experiment with different
drugs and dosage, apparently with his GP’s agreement. He was determined to maintain his independence
despite very restricted mobility and attempted to maintain work and normal activities as far as possible
while keeping health-care staff and services at a distance. His GP liaised with the hospice on his behalf
for advice on how to manage his pain and had tried most of the standard options. Mr Church’s GP had
also referred him to the hospice for day care and consultant input. He had declined this option, but his
wife made use of some of the services for carers.
Mr Church had been referred to a specialist MND nurse, but did not find this particularly helpful.
Referrals had also been made to occupational therapy and physiotherapy services, but he did not feel
that they could meet his needs. Mr Church’s relationship with HCPs was not always an easy one.
It appeared from the records review that Mrs Church was finding her husband’s physical deterioration
difficult to manage and that she felt tied to the house looking after him. Mr Church’s key health
professional was his GP, who rang him every 3 or 4 weeks and made occasional home visits. Both
Mr and Mrs Church felt that they could approach their GP with any issues about medicines or health.
Mrs Church also reported a good relationship with their local pharmacist. At the time of the research,
Mr Church did not have any AMs in place nor a DNACPR order. He was, however, flagged as being on
the GSF and as being at risk of dementia.
TABLE 22 Case data: Mr Church
Participant Data collection
Patient: MND, asthma, high blood pressure,
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Ecogram
Mr and Mrs Church were well integrated into a rural village community. He had a supportive informal
network that involved family and neighbours. Their informal network was of greater significance than his
contact with quite a complex network of professional services, from which he deliberately maintained
a distance (Figure 35). Mr Church was particularly resistant to hospice day care involvement, although
his wife found some of their alternative therapies useful. He had a good relationship with his GP, with
whom he maintained regular contact, but considered most other services and HCPs as not helpful.
Many professional services are greyed out on his ecogram as being either declined or unsatisfactory.
Case summary: Mr Campbell
Family and living status
Mr Campbell was in his mid-60s and lived with his younger sister, having lost his previous home through
inability to pay the rent. Mr Campbell also had two older sisters, but had no contact with them (Table 23).
FIGURE 35 Ecogram: Mr Church.
TABLE 23 Case data: Mr Campbell
Participant Data collection
Patient: emphysema, pulmonary hypertension One interview
Two photographs
Medicines list
Ecogram compiled from interview data
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Background
Mr Campbell was severely affected by long-standing emphysema and pulmonary hypertension. He was
oxygen dependent and struggled to go out, as exhaustion made it difficult for him to walk up and down
the stairs to the flat and there was no lift. Mr Campbell felt socially isolated because he could not go
out, although he had some friends who visited him occasionally. Mr Campbell was aware that he was
terminally ill and spoke about this during the research interview. He had a good understanding of his
illness and how it affected his body.
Managing medications
Mr Campbell experienced some difficulties with his prescriptions, either being given the wrong things
or being given too much of something. He viewed this as an unnecessary cost to the NHS. It appeared
that the general practice and the pharmacy blamed each other for this. Mr Campbell was keen to take
as little medication as possible. He was proactive in managing his medicines and tried to keep on top of
what he was taking, what supplies he had, what they were for and how effective they were. This was
an ongoing job, particularly given that his prescription included controlled drugs. Mr Campbell had
effectively deprescribed some of his medicines himself by deciding not to take them. He was on
continuous oxygen and used a nebuliser.
Mr Campbell was frustrated by the continuing inability of the hospital, GP and pharmacy to co-ordinate
his medicines. They often got this wrong, gave him the wrong medicines or failed to respond to his
notification that he did not need/want specific drugs. As a result, he had stockpiled morphine. He
preferred to keep medicine-taking to a minimum and initially was inclined to ‘tough it out’ and keep
morphine at bay, but he later decided that he had too little time left to spend it in pain.
Mr Campbell said that he rarely saw the same HCP twice on clinic visits, which meant that he had
to repeat his story every time he attended. They gave him advice about how to take his medicines,
but he believed that often it is a case of finding out how they can be most effective through personal
experience.
Mr Campbell found the best HCPs to be the palliative care team at the hospital. He felt that the consultant
there saw the whole picture and pulled things together for him. She recommended antidepressants, but he
was cautious about taking these. Overall, the palliative care professional was the key HCP for Mr Campbell.
His sister, with whom he lived, usually drove him to appointments at the hospice.
Ecogram
Mr Campbell had become homeless as a result of his inability to pay rent and moved to live with
his younger sister. He continued to do so after his financial situation improved. Mr Campbell was very
aware that he was dying and reflected a lot on this. His struggle to cope with his symptoms left him
pretty much housebound and socially isolated. A significant professional was his hospital palliative care
consultant and the team (Figure 36). More recently, he had been referred to hospice day care unit and
as an inpatient. He liked the hospice because everyone was in the same boat, but he did not seem to
have established significant relationships with staff there.
Case summary: Mr Cormack
Family and living status
Mr Cormack was in his 40s and lived in a flat in an assisted living complex, with residential support
workers. He had a learning disability and had lived for 4 years in the complex. He had regular contact
with his mother and sister (Table 24).
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Background
Mr Cormack had oesophageal cancer, which, he had been told, was terminal. His sister had always
considered his learning disability to be a mild one, but she found that he did not understand the nature
of his diagnosis and its implications and that it took weeks before he was able to grasp the fact that he
was dying. Support workers in the complex in which Mr Cormack lived provided help with daily living
activities and a member of staff slept in overnight in case of need. Mr Cormack often visited his
mother, who lived nearby.
FIGURE 36 Ecogram: Mr Campbell.
TABLE 24 Case data: Mr Cormack
Participant Data collection




Support worker (HCP 2) One interview
Medicines list
Ecogram
Observation of medicines administration
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Managing medications
Prior to his cancer diagnosis, Mr Cormack managed all aspects of his medicines with some support,
including a dosette box. Since a crisis admission to hospital and then hospice, he had gradually handed
over this responsibility to the support staff, who ordered and collected his medicines and stored and
administered his controlled drugs. They said that he asked them to do this. During these admissions,
his medicines were rationalised, with the focus on pain management and the reduction in the number
of tablets he needed to take, as swallowing was becoming increasingly difficult. His medication
administration at the time of participation in the study consisted of a patch, liquids and soluble tablets.
Support workers were key to supporting Mr Cormack in managing his medicines. Another key
professional was the PCN, who provided advice and information to both Mr Cormack and the support
workers. AMs had been prescribed and these were kept in a locked cupboard in a locked office in the
supported living complex office. Should the time come when these were needed, the DN would be
called to come and administer them.
Mr Cormack’s sister took a key role in advocating and supporting her brother, and placed herself as
the one who asked questions and challenged the HCPs when necessary.
Issues with medicines
Mr Cormack had liquid morphine for pain. This was kept in a locked cupboard in his kitchen and was
administered by a member of support staff at predefined times. This made it harder for Mr Cormack to
access breakthrough pain relief. He was reluctant to ask and would have to make a specific trip to the
staff office to do so. His sister felt that the support staff were not good at recognising the signs that he
was in pain. This situation improved once a SPCN prescribed patches.
Ecogram
One of Mr Cormack’s sisters played a key role in advocating for her brother and monitoring all aspects
of his care, liaising with staff and services. He also had a close relationship with his mother and one of
his sister’s friends. On a day-to-day basis, Mr Cormack’s support workers assumed responsibility for
all aspects of managing and administering his medicines (Figure 37). His key professional was a SPCN
from the hospice who was very proactive in managing his care and liaising with support staff and other
services, including hospice resources. Mr Cormack’s sister appreciated this input, but commented that
the SPCN was not experienced in dealing with patients with learning disabilities.
Case summary: Mr Carpenter
Family and living status
Mr Carpenter was in his 70s and lived at home with his wife (Table 25).
Background
Mr Carpenter had COPD and a non-virulent strain of tuberculosis for 10–14 years, with increasing
oxygen use for the last 9 years. At the time of interview, he was oxygen dependent, using it for about
20 hours per day. Mr Carpenter died after the first research interview and his widow later took part in
a bereavement interview. She had a small group of friends and a sister who offered mutual support.
Managing medications
Mr Carpenter managed his own medicines, reordering prescriptions online and collecting the medicines
from the pharmacy himself. He kept an emergency kit of antibiotics upstairs in the house in case
of exacerbations. His 14 daily medicines were kept in the kitchen. His wife was not involved at all
and said that she was confused by his medicines. Although his medicines could have been delivered,
Mr Carpenter preferred to collect them directly. This was partly because he liked the human contact
with the pharmacist, with whom he had a good relationship and who was happy to help with any queries.
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The couple also had a good relationship with their GP, whom they found accessible and willing to do
home visits. Their other key resource was the hospital respiratory ward and outpatient clinic and the
consultant and nurses there (Figure 38). The consultant’s receptionist was also a key figure as they
could telephone her any time and she would liaise with the consultant and call them back directly.
Mr Carpenter had been using oxygen for a number of years and found the system whereby tanks
were delivered and renewed to be straightforward.
Mr Carpenter required little support in the management of his medicines. He described one instance
when antibiotics made him feel very ill and so he stopped taking them. The hospital consultant
reintroduced them more slowly along with antisickness medicines, which were effective. Mr Carpenter
had attended the same respiratory clinic at the hospital for a number of years, and experienced good
continuity of care. He also reported a good relationship with the general practice and the pharmacy.
He had been seen by a COPD specialist nurse at the general practice and a respiratory specialist nurse
TABLE 25 Case data: Mr Carpenter
Participant Data collection
Patient: COPD/tuberculosis, wife (FCG) One interview (joint with wife)




FIGURE 37 Ecogram: Mr Cormack.
APPENDIX 1
NIHR Journals Library www.journalslibrary.nihr.ac.uk
154
from the hospital, but did not feel that he needed to receive regular visits from either of them. If he
needed advice or had a query, Mr Carpenter would contact the respiratory clinic at the hospital.
Last days of life
Mr Carpenter died 2 months after the first interview. The day before this happened, his wife had
called the GP for a home visit. She was aware that her husband probably needed hospital admission,
but was wary of the ambulance men taking him to the accident and emergency department and
possible admission to a hospital other than his usual one. The GP agreed that he needed to go to
hospital and arranged through the Bed Bureau for the ambulance to take Mr Carpenter directly to
his usual respiratory unit, where he died the next day. This was their preferred place of death, although
it was not recorded anywhere (and neither was a DNACPR). He and his wife had been quite clear
that he did not wish to die at home, as she was worried about waking up to find him dead beside her.
Overall, despite very poor health, Mr Carpenter and his wife took a very pragmatic and independent
approach to his problems and their management of them. They just got on with things but were
confident and appreciative of the professional support they had available.
Ecogram
Mr Carpenter’s professional network was relatively compact, with interlinked clusters characterised
by a few key services and considerable continuity of staff and place. Mr Carpenter felt known by the
people in the network and had confidence in them, despite his poor health. Two specialist nurses for
respiratory conditions and COPD are on the periphery and were felt not to be needed. Mr Carpenter’s
ecogram (see Figure 38) is unusual in that it contains no reference to informal links, and neither did
his interview. However, during the bereavement interview, Mrs Carpenter mentioned that she has
FIGURE 38 Ecogram: Mr Carpenter.
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support from friends and family members and mentioned a few individuals in particular; however,
these individuals relate to her rather than her husband, apart from one reference to their son, who
was present at the hospital when her husband died.
Case summary: Mr Clunes
Family and living status
Mr Clunes was in his 70s and lived at home with his wife. This was a second marriage for them
both and they each had adult children from previous relationships, plus grandchildren and great
grandchildren (Table 26).
Background
Mr Clunes had emphysema, which restricted his mobility quite severely, although he was still able to
drive. He had a number of health problems, including type 2 diabetes, angina, an enlarged prostate
and arthritis. His wife was in her 80s and also had complex health problems that restricted the physical
activities that she could undertake.
Managing medications
Mr Clunes was prescribed a large number of medicines that he managed himself with some prompting
from his wife. He was able to keep track of a complex regimen, he said, because he had been on most
of the medicines for a long time. He was a little concerned about the effects that the medicines might
have on each other, but took them anyway.
Mr Clunes had an annual review of his medicines at the pharmacy, but only if he asked for it, and his
GP occasionally called him in to review his medicines. The pharmacy the couple used did not deliver,
but this was not a problem as they preferred not to have to wait in for the medicines to be delivered.
Mr Clunes’ son would take the repeat prescription request to the pharmacy and then collect the
medicines a couple of days later. If he was unable to do so, Mrs Clunes would collect the medicines.
Mr Clunes had monthly visits from the COPD specialist nurse and he could ring her if he had any
problems. He also attended the COPD clinic at the hospital. DNs would visit if required, and during
general practice opening hours Mr Clunes felt he could always contact the GP. However, if he needed
help it was likely to be necessary to call an ambulance, which he would do.
TABLE 26 Case data: Mr Clunes
Participant Data collection
Patient: COPD/emphysema, type 2 diabetes,
angina, arthritis






Observation of medication storage
and equipment
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Ecogram
Initially, the couple both said that they had no support. It emerged, however, that Mr Clunes received
considerable support from members of his extended local family and friends/neighbours (Figure 39).
This was more extensive and significant than that received from professional services, from which
Mr Clunes seemed slightly distant. No key professional was identified. His son fetched his prescriptions
and helped with shopping and gardening, and a granddaughter helped him with personal care a couple
of times per week. One good friend assisted with the housework and another with the (small) garden.
Mrs Clunes also had health problems that limited her activity a lot, and so they both needed practical
help in the house. However, the couple did not want HCWs from social services because they did not
want to be tied to someone else’s agenda in terms of what time people arrive and what they think
should be carried out. A COPD nurse visited once per month and Mr Clunes felt that he could ring her
if he needed to. The DNs called if needed. His GP would be his first contact if he needed help, but they
felt that this did not happen often. Mr Clunes related mainly to the hospital and if help was needed it
would be to call an ambulance to take him there, although it was not clear if he had actually done this.
Case summary: Mr Corner
Family and living status
Mr Corner was in his 70s and lived with his daughter and her family (Table 27).
FIGURE 39 Ecogram: Mr Clunes.
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Background
At the start of his study participation, Mr Corner was just out of hospital after an admission for
pneumonia and a heart attack. He was on oxygen 24 hours per day and found it very difficult to go
out. By the time of the second interview, he was looking much better and, although still requiring
oxygen, he was able to get out and about a bit more using an oxygen cylinder.
Managing medications
Mr Corner described himself as self-sufficient in managing his own medicines and oxygen, and
as understanding what they were all for. When discharged from hospital he had 11 items on his
prescription, with medicines to be taken in different forms, including pills, inhalers, liquid Oramorph,
sublingual and oxygen. His medicines were re-issued automatically and, when able, he collected them
himself from the pharmacy. When he was unable to do this, his daughter collected them for him.
Each week either Mr Corner or his daughter would dispense his medicines into a dosette box, which
he found a useful tool as it simplified the process of taking his medicines. Mr Corner’s oxygen
machines were serviced twice per year by an external company and in between times he cleaned
the filters himself.
Issues with medicines
Mr Corner did not feel that he had any issues with his medicines nor with his oxygen. Although stating
at the first interview that he knew what his medicines were for, he acknowledged during the second
interview that he did not know what all of the medicines were for or why he was taking them. He
noted that the pharmacist would write on the medicine packet how many tablets he needed to take
and when. He had never needed to make any enquiries about his medicines from either the GP or the
pharmacist. He attended outpatient appointments with the respiratory team every 3–6 months and
rarely saw his GP. If necessary, he would ring the GP and request ‘rescue antibiotics’ and a prescription
would be issued without the need for an appointment.
Ecogram
Overall, Mr Corner had quite a small network, which worked reasonably well (Figure 40). Despite
being in poor health, Mr Corner wished to maintain his independence, including control of managing
medicines. He received some help from his daughter and her family. When he felt that he was becoming
ill from an acute attack of COPD, his preferred response was to call 111 and get an ambulance to
take him directly to hospital, bypassing his daughter and his GP. He saw no point in involving the GP
who would, he felt, simply call the ambulance, resulting in an unnecessary delay. Mr Corner said that
the paramedics and the hospital were familiar with his case and he kept a card to show them his details,
of which they were aware. Thinking to the future, Mr Corner said that he wanted to train both his
granddaughter and his nephew in making up his dosette boxes so that he will have additional back up.
He was happy that his daughter was able to do this and felt that he had resources available when others
were able to provide this care.
TABLE 27 Case data: Mr Corner
Participant Data collection




Observation of medication storage
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FIGURE 40 Ecogram: Mr Corner.
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Appendix 2 Frequency of prescribed
medication by case
Medications are listed by frequency of prescription, rather than alphabetically, to illustrate whichclassifications of medications were most frequently prescribed. The table includes both brand
and generic names for medications, as reported by participants and their record reviews. Some cases
had more than one drug prescribed from the same group.
Medicine classification
Number of cases in which these
medicines were prescribed
Opioid analgesics 18








Calcium and vitamin D analogues 6
Beta2 agonists 6
Emollient creams and ointments 6
Nitrates 6













Factor Xa inhibitors 3
Neuroprotectives 3
Non-steroidal anti-inflammatory drugs 3
Antihistamines 2
Antimalarials 2
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Medicine classification





Calcium channel blockers 2
Corticosteroid creams 2
Dopamine receptor agonists 2
Gliptin 2
Iron, oral 2





Serotonin (5-HT3) receptor antagonists 2
Sulfonylureas 2
Vitamin K antagonists 2





















Bone resorption inhibitors 1
ACE, angiotensin-converting enzyme.
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